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Abstract
Elevation of intracellular Ca^ "^  and cAMP are key triggering events leading to 
hippocampal long-term potentiation (LTP, a form of synaptic plasticity) induction. In this 
study, the aim was to compare the ability of elevated Ca^  ^influx (achieved via the Ca^  ^
ionophore, A23187) or increased intracellular cAMP levels (achieved via adenylate 
cyclase activator, forskolin) to modulate the expression or activation of selected proteins 
involved in LTP, with emphasis on the CA3 region of the hippocampus. The proteins 
investigated include: aCaMKII, MAP2, p-activin, Pyk2 and MAPK. They have all been 
implicated in LTP in CAl and dentate gyrus (DG) regions of the hippocampus.
To test the hypothesis that Ca^  ^influx or cAMP elevation might activate Pyk2 and 
MAPK, the levels of phosphorylated Pyk2 and MAPK were measured in acute rat 
hippocampal slice preparations after exposure to A23187 (5p,M) or forskolin (SOjiiM). 
Using an immunoprécipitation assay, the levels of phosphorylated Pyk2 were increased in 
the presence of A23187 with a peak effect around 10 minutes. When the CAl and CA3 
regions of the hippocampus were investigated separately, phosphorylation of Pyk2 was 
achieved in both regions after exposure to A23187, suggesting a key role for Ca^ "^  in both 
regions. Staurosporine, a general PKC inhibitor, and chelerythr ine, a PKM^ inliibitor, 
were compared for their ability to attenuate the effect of A23187. Exposure of acute 
hippocampal slices to chelerythrine or staurosporine prior to A23187 application resulted 
in the reduced phosphorylation of Pyk2, suggesting that PKM^ and novel PKC may be
involved in Pyk2 activation by Ca^ "^ . Application of forskolin to acute slices resulted in 
the reduced activation of Pyk2 below basal level, suggesting that cAMP inhibits Pyk2. 
MAPK was phosphorylated for more than 20 minutes in the presence of either A23187 or 
forskolin suggesting an important role for Ca^  ^and cAMP in the activation of MAPK in 
acute hippocampal slices. However, when CAl and CA3 regions were investigated 
separately, A23187 and forskolin only activated MAPK in the CAl region, with no effect 
in the CA3 region, hence suggesting a different mode of activation of MAPK in the two 
regions.
The effect of elevation of intracellular Ca^  ^and cAMP via A23187 and forskolin 
respectively, on the expression of aCaMKII, MAP2 and P-activin protein were studied in 
organotypic slice cultures of rat hippocampus by immunocytochemistry or western blot. 
The levels of MAP2 expression were increased 4 hours after forskolin treatment, but 
were unaffected by A23187 treatment. Conversely, the levels of aCaMKII expression 
were increased 4 hours after A23187 treatment, but were unaffected by forskolin. The 
regulation of the expression of these proteins was the same in the CA3 region as in the 
CAl and dentate gyrus of the hippocampus. While rapamycin reduced the basal levels of 
MAP2 expression, it did not affect the ability of either forskolin or A23187 to enliance 
MAP2 or aCaMKII levels. These results suggest that cAMP and Ca^ "^  differentially 
modulate the expression of these two plasticity-related genes, and that translational 
enhancement via the mammalian target of rapamycin kinase is not involved in these 
effects. The expression of p-activin was enhanced in the presence of A23187 or forskolin 
in both the CAl and CA3 regions, again suggesting a similar pathway in both regions,
XI
and that both increased intracellular Ca^  ^and cAMP levels can participate in the 
regulated expression of this protein.
These results suggest that Ca^ "^  and cAMP mediate distinct components of neurochemical 
changes that underlie LTP maintenance. The proteins monitored in this study showed 
clear differences in their response to these two second messengers. However, in general 
the alterations in protein expression in the CA3 region corresponded with those in the 
CAl and DG regions, suggesting that the pathways regulating the expression of a given 
protein may not be cell-specific.
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Introduction
Chapter 1 
Introduction
1.1 Two major forms of memory
Learning and memory are not a unitary process— not a single faculty of the mind— but a 
family of distinct processes each with its own rules. Learning is the process of acquiring 
new information about the world and memory is considered to be the process by which 
knowledge is retained.
Recent studies have shown that memory can be divided into at least two major categories 
(Polster a/., 1991):
(i) Explicit or declarative memory— conscious recall of knowledge
(ii) Implicit or non declai’ative memory— non-conscious recall of motor skills 
These categories involve different neural circuits (Squire, 1992). Explicit memory 
uniquely depends on temporal lobe and diencephalic structures e.g. hippocampus, 
subiculum and entorhinal cortex, while the implicit form is dependent upon the same 
sensory, motor, or associational pathways used in the expression of the learning process 
(Bailey et a l, 1996). Explicit memory is studied in mammals, while the implicit form can 
effectively be studied in both non-mammalian vertebrates and higher invertebrates. Both 
explicit and implicit forms of learning are gi aded and the duration of memory is related to 
the number of training trails. There are at least two temporally distinct phases of memory 
storage:
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(i) Short term memory lasting seconds, minutes and hours
(ii) Long teim memory lasting days, weeks or years.
Each phase of memory storage employs a cascade of molecular events of molecular 
events that occur during their consolidation period.
Short-teim memory depends on second messenger-mediated covalent modification of 
proteins which have been previously synthesised and hence modulate the properties of 
nerve cells and their synaptic connections (Schwartz, et a l, 1971; Kandel and Schwartz, 
1982; Livingstone, 1985). Acquisition and retention of information for short-term 
memory, in certain invertebrates (e.g. Aplysia, Hermissenda and Drosophila), does not 
require the synthesis of new proteins (Schwartz, et a l, 1971). The process of acquisition 
involves the activation of receptor-linked enzymes by neurotransmitters. These enzymes 
are responsible for the synthesis of intracellular messages which in turn activate protein 
kinases that phosphorylate substrate proteins required for the plastic neuronal 
modification (Goelet et a l, 1986). The duration of the covalent modification of pre­
existing proteins and maintenance of the activity of the enzyme responsible for second 
messenger synthesis are necessary for the retention process of plastic changes (Goelet et 
al, 1986). It was proposed that covalent modifications similar to the ones in short-temi 
memory become self-reinforcing for certain instances of long-term memory (Crick, 1984; 
Lynch and Baudry, 1984; Lisman, 1985). This was not the case, however. Studies have 
illustrated that in the process of acquisition of information whose memory lasts more than 
one-day, specific nerve cells need to express genes that are not required in short-term 
memory (Davis and Squire, 1984).
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Goelet et al. (1986) concluded that the same modulatory neurotransmitters that induce 
cytoplasmic messengers during learning in short-tenn memory are also responsible for 
the activation of at least tliree overlapping memory processes, either thiough the same or 
additional second messenger systems. Each memory process has its own time course of 
retention. These overlapping memories include;
(i) Intermediate memory which lasts many hours and is dependent on self- 
reinforcing covalent modification
(ii) Long-term memory lasting more than one-day is dependent on the induction of 
new proteins which results from second messengers involved in short-tenn 
memory
(iii) Memory lasting weeks and months which is dependent on early regulatory genes 
whose protein products trigger the maintained expression of late effector genes.
Behavioural studies of learning in vertebrates suggest that memory lasting days or weeks 
can be disrupted by the inhibition of protein synthesis (Nader et al,  2000; Schafe and 
LeDoux, 2000). However, at least in some models, vertebrates do not experience any 
deficit in long-term memory if exposure to the protein synthesis inhibitor is delayed by as 
little as one-horn* after training (Davis and Squire, 1984). Invertebrates have been used to 
address the question of whether the disruption of protein synthesis by the inhibitors in 
behavioural studies is due to motivation, motor performance or some other complex brain 
system. Invertebrates were also used to determine if this protein disruption reflected a 
fundamental property of long-term information storage in specific nei*ve cells of the 
circuit responsible for the modified behaviour. Studies on long-term sensitisation of the
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gill-withdrawal reflex in Aplysia showed that the basic synaptic connection between 
sensory and motors neurons is enlianced in both short and long-term sensitisation (Bailey 
et al,  1996). Long-term facilitation associated with the memory of long-term 
sensitisation is blocked by both translational and transcriptional inhibitors. This is in 
contrast to short-term facilitation. The blockage of protein synthesis in Aplysia during a 
two-hour training period blocked the retention of long-term facilitation assayed one-day 
later; this was similarly observed in equivalent models in vertebrates (Goelet et a l ,
1986). These studies hence indicate that genes and proteins are necessary for the cellular 
mechanism underlying long-term memory.
The cortex, amygdala and hippocampus have been implicated in learning. The cortex is 
widely assumed to store traces of experience underlying both explicit and implicit 
learning (Martin et al,  2000). In explicit learning, the hippocampus is thought to be 
involved in the earlier stages of encoding and storage resulting in the eventual 
consolidation of information in the cortex whereupon the participation of hippocampal 
fonnation is no longer required (Martin et al, 2000), The hippocampus is widely thought 
to be involved in infonnation processing functions related to spatial memory (O’Keefe 
and Conway, 1978) as well as declarative (Squire, 1992) and episodic memory (Vargha- 
Khadem et al, 1997). Studies on fear conditioning have implicated the amygdala in many 
foims of learning. In the classical fear conditioning, the condition stimulus (CS) such as a 
tone or light, is paired with aversive unconditioned stimulus such as foot shock. After a 
number of pairings, the CS alone evokes responses such as freezing, increase heart rate, 
and the potentiation of the startle reflex (Davis et al, 1993; LeDoux, 1995). Lesions of
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the lateral amygdala affected the expression of conditioned fear implicating the amygdala 
as the sole site of long-term storage (LeDoux et al, 1990; Martin et al, 2000). There has 
been some scepticism over these results since the lateral/basolateral amygdala does not 
seem to be involved in cognitive/explicit aspects of conditioned fear (Cahill et al, 1999).
1.2 Hippocampus
The hippocampus is a C-shaped structure (Figure 1.1) in the coronal section and is also 
known as the Ammon’s horn (cornu ammonis) (Amaral and Witter, 1989). The 
hippocampal formation is made up of different cortical regions: dentate gyi*us, the 
hippocampal proper and the subicular complex (made up of subiculum, presubiculum and 
parasubiculum) (Amaral and Witter, 1989). Transverse (coronal) section reveals that the 
hippocampus proper has three areas or sectors: CAl, CA2 and CA3 (CA) stands for 
cornu ammonis. Three layers are identified in the hippocampal cortex (Andersen et al, 
1971):
(i) The molecular layer, consisting of interacting axons and dendrites. This synaptic 
layer is continuous with the molecular layers of the dentate gyrus and neocortex.
(ii) The pyi amidal layer which is made up of large neurons, many of them pyi amidal 
in shape. These pyramidal cells are the principal cells of the hippocampus. The 
dendrites of these principal cells extend into the molecular layer. Schaffer 
collaterals are branches, which pass through the polymorphic and pyramidal cell 
layers to synapse in the molecular layer with the dendrites of other pyramidal 
neurons.
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(iii) The polymorphic layer contains axons, dendrites and intemeurons.
The dentate gyrus (DG) also has three layers. However, in the DG the pyramidal cells are 
replaced by a gi'anule cell layer of small neurons, which are the principal cells in the 
region.
The trisynaptic pathway, a basic circuitry of the hippocampal formation, is series of 
connections from superficial entorhinal cortex to the hippocampus. These connections are 
excitatory, largely unidirectional, and dense in some planes of section oriented 
perpendicular to the long axis of the hippocampus (Andersen et al,  1971, Witter et al, 
2000). The trisynaptic pathway is comprised of entorhinal layer II stellate neuronal 
projections (the perforant pathway) to the apical dendrites of the dentate granule cells. 
Efferent fibres from the dentate gyrus known as mossy fibres (ME) project into area CA3 
where they terminate on the proximal apical dendrites of pyramidal neurons (Figure 1.1). 
Axons on the CA3 pyramidal cells leave the hippocampus via the alveus and collaterals 
(Schaffer collaterals) and ascend to cross the cell layer and terminate predominantly on 
the proximal apical dendrites (stratum radiatum) of CAl (Amaral and Witter, 1989; 
Witter et al, 2000). A fourth synapse occurs in the subiculum as a result of CAl 
pyramids projection onto subicular cells (Amaral et al, 1991). Subiculum is one of the 
principal outputs of the hippocampal region with projections to hypothalamus, 
mammillary nucleus, nucleus accumbens, septum and the parahippocampal cortices 
(Naber and Witter, 1998). The output of the subiculum can take several paths, with 
respect to cortical connections (Witter et al, 2000). One output of the subiculum is into 
the deep layers of entorhinal cortex via the alveus. Ascending collaterals of deep layer
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neurons onto the superficial layer of neurons completes a long loop from the entorhinal 
cortex through the hippocampus. Another pathway is into the adjacent presubiculum. The 
coimection between the presubiculum, parasubiculum and entorhinal cortex complete the 
entorhinal-hippocampal circuit with a different set of intervening connections. A key 
anatomical feature of area CA3 is that its pyramidal cells receive the majority of their 
inputs from other CA3 pyramidal cells (Amaral and Witter, 1989; Amaral et al, 1990). 
The resulting recurrent network has been extensively explored as a plastic attractor model 
of the way that the hippocampus stores episodic memory (McNaughton and Morris, 1987; 
Levy, 1996; Rolls, 1996, 2000). Other anatomical studies indicated that other pathways 
parallel to the existing system (the trisynapic loop) and these by-pass the dentate gyrus 
relaying the information directly from the entorhinal cortex to CAl or CA3 (Amaral and 
Witter, 1989).
All the major pathways within the hippocampal formation (perforant pathway, mossy 
fibre and Schaffer collaterals) use the excitatory amino acid glutamate as 
neurotransmitters (Malenka and Nicoll, 1999). Other neurotransmitters have also been 
shown to play a role in the hippocampal signalling; these neurotransmitters include, 
dopamine (Huang and Kandel, 1995; Gurden et al, 1999), 5-HT (Kulla and Manahan- 
Vaughan, 2002) and acetylcholine (Anagnostaras et al, 2003; Colgin et al,  2003). p- 
adrenergic agonist has also been shown to play role in hippocampal signalling (Huang 
and Kandel, 1996; Lin et al, 2003). The excitatory glutamate neurotransmitters act on 
ionotropic as well as metabotropic glutamate receptors located both pre- and
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postsynaptically. The abundance of these receptors in the tlnee regions of the 
hippocampus will be discussed in detail in the next section.
1.3 Amino acid receptors
Ionotropic glutamate receptors are ligand-gated ion channels, that mediate rapid 
excitatory neurotransmission in the central nervous system (CNS) and they include N- 
methyl-D-aspartate (NMDA), y-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
(AMP A) and kainate (KA) types of receptor, named according to their prototypical 
agonists. These receptors play a role in synaptic plasticity (Sommer and Seeburg, 1992; 
Bliss and Collingridge, 1993; Settler and Mulle, 1995).
Four closely related subunits of AMPA-selective ionotropic glutamate receptors have 
been identified using molecular cloning and are termed GluRl, GluR2, GluR3 and GluR4 
(Sommer et al, 1991; Gasic and Hollmann, 1992; Hollmann and Heineman, 1994; 
Wenthold et al, 1996) and this gives rise to two splice variants, flip and flop (Sommer et 
al, 1990). Each contain 850-950 amino acids and share some 70-80% similarity. In the 
CAl, AMPARs are composed mainly of GluRl-GluR2 and GluR2-GluR3 heteromers 
(Wenthold et al,  1996). AMPARs have been shown to contribute to excitatory synaptic 
transmission in a population of hippocampal and neocortical nonpyi’amidal, and spinal 
dorsal horn neuions (McBain and Dingledine, 1993; Itazawa et al, 1997) and are 
assumed to contribute to long-term modification of synapses and neurological disorders 
(Pellegrini-Giampietro et al,  1997, Tanaka et a l,  2000).
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KA receptors (KAR) consist of various combinations of GluR2/6/7 and KAl/2 subunits 
(Bettler et al, 1990, 1995; Egebjerg et al, 1991; Herb et al, 1992; Patemain et al,
2000). KAR are concentrated in a few specific areas of the CNS, generally 
complementary to the distribution of NMD A and AMP A receptors (Wisden and Seeburg, 
1993; Porter et al, 1997). Radioligand binding studies suggested that kainate binding 
sites are highly localised on the stratum lucidum in the CA3 region, where the MF 
terminates (Monaghan and Cotman, 1982). In the hippocampus, CA3 pyramidal cells 
were stained more densely than CAl pyramidal cells with high levels of GluR6/7 
subunits (Petralia et al, 1996). In situ hybridisation studies revealed that transcripts of 
most KAR subunits are expressed in the presynaptic dentate gyrus and postsynaptic CA3 
pyramidal cells (Wisden and Seeburg, 1993), it seems likely that the MF-CA3 synapse 
expresses KARs with subunit composition containing at least GluR6 or GluR7 at both 
pre- and postsynaptic sites. One unique feature of presynaptic KARs is that their 
activation modulates transmitter release bi-directionally; weak activation enhances 
glutamate release, while strong activation leads to inhibition (Kamiya, 2002). This 
mechanism of action might be due to their ionotropic action resulting in axonal 
depolarisation, which in turn regulates several voltage dependent channels involved in 
action potential-dependent Ca^ "^  entry processes.
Four* subunits of NMD A ionotropic glutamate receptors have been identified are: NRl, 
NR2A-D, NR3A-B (Seeburg, 1993; Nakanishi and Masu, 1994, Riedel et al, 2003). The 
NR2 subunits are only 20% homologous to N R l. It is thought that every NMDA receptor
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contains both NRl and NR2 subunits (Seeburg, 1993; Nakanishi and Masu, 1994). 
Subunits are composed of a pentameric structure based on NRl combining with NR2A-D 
or NR3A-B subunits (Ciabana et al, 1995; Hollmann and Heineman, 1994; Matsuda et 
u/.,2002).
NMDA receptors differ from AMP A and KA receptors because the application of agonist 
when the cell is polarised does not activate the integral ion channel due to inhibition of 
the receptor by physiological extracellular concentrations of Mg^ "*". The Mg^ "^  ion blocks 
the chaimel. When the membrane is depolarised, the Mg^ "^  block is removed and the 
channel can open when agonist is present. The open channel allows influx of Na"^  and 
Ca^ "^  with a 10:1 ratio of permeabilities of Ca^ "^ : Na"^  (Riedel et al, 2003). The NMDA 
receptor is a novel combination of a ligand-activated and voltage-operated channel, 
requiring both glutamate and depolarisation for activity. All synapses in the CAl region 
of the hippocampus have been shown to contain NMDARs (Watanabe et al, 1998; Racca 
et al, 2000). All thi'ee subunits of NMDARs were also detected in the dentate gyrus as 
well as neurophil layers of CA3 (Watanabe et al, 1998). The NRl and NR2 subunits of 
NMDAR were found in low levels in the stratum lucidum, a mossy fibre-recipient layer 
of the CA3 subfield (Watanabe et al, 1998) and hence it was concluded that the selective 
scarcity of NMDARs in this region reflects different synaptic targeting mechanisms 
(Watanabe et al, 1998). Distribution of NMDA receptors at the Schaffer collateral 
synapse in the CAl area differs from that of the AMPA receptors with every Shaffer 
collateral synapse onto the CAl pyramidal spines containing NMDA receptors (Racca et 
al, 2000). AMPA receptors only make up 75-85% of these synapses (Takumi et al.
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1999; Racca et al, 2000, Nusser 2000). AMPA and NMDA are co-localised in only 75- 
85% of these synapses (Takumi et al, 1999; Racca et al, 2000).
Genetic studies have indicated the existence of seven different metabotropic receptors 
designated mGluRl-8 (Riedel et al, 2003). There are three categories of mGluR 
members based on their amino acid sequence homology, pharmacological profiles and 
second messenger coupling. Group I mGluRs (mGluRl and 5 and their splice variants) 
stimulate the hydrolysis of inositol-bis-phosphate to inositol-1,4,5-trisphosphate (IP3), 
this is achieved via activation of phospholipase C (PTC). PLC also activates 
diacylglycerol which co-activates protein kinase C while IP3 promotes Ca^  ^release from 
internal stores (Riedel et al, 2003). Group II (mGluR4, 6-8, including splice variants) 
inhibit adenylate cyclase hence reducing intracellular levels of cAMP. Group III regulate 
glutamate release due to their autoreceptor function. Hippocampal mGluRs are 
particularly important in mediating memory consolidation. In fear conditioning studies, 
mGluR5 expression was enhanced in the CA3 after one day post-training, but this 
enhancement diminish at ten days and was replace by an overexpression of mGluR5 that 
was strong in the CAl and somewhat weaker in the dentate gyrus (Casabona et al, 1997; 
Riedel et al, 2000). These data indicates the temporal involvement of hippocampus in 
fear conditioning and a strong hint at an early involvement of CA3 followed by a later 
prolong activation of CAl (Riedel et al, 1993).
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1.4 Synaptic plasticity
1.4.1 General principles
Synaptic plasticity is an activity dependent change in the efficiency of synaptic 
transmission which requires:
(i) Pre and/or postsynaptic activity
(ii) Biochemical and/or morphological changes in dendritic spines (Halpain, 2000) 
These requirements (i and ii) result in changes in synaptic strength. Synaptic plasticity 
differs when comparing associative and non-associative plasticity (section 1.4.3). There is 
also a difference in plasticity with respect to protein synthesis dependent versus 
independent form (section 1.4.7). Synaptic plasticity is thought to underlie higher 
cognitive functions such as learning and memory. This idea was first refined by Hebb 
(1949). Hebb proposed that when two interconnected neurons fire at the same time, the 
synapse between them became stronger and remain so for a considerable time afterwards.
Many different forms of synaptic plasticity exist and they vary in a number of respects:
(i) Duration: from milliseconds to days, months or years
(ii) Location in the brain
(iii) Induction mechanism (NMDA receptor-dependent/independent)
(iv) Expression (maintenance) mechanisms (pre/postsynaptic)
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Long-tenu potentiation (LTP) is a form of synaptic plasticity that is thought to underlie 
some forms of learning and memory. It was first described by Bliss and Lomo (1973) 
when they demonstrated that application of a relatively brief burst of high frequency 
stimulation (HFS) resulted in long lasting enhancement of synaptic responses in the 
manunalian hippocampus.
The phenomenon of LTP has been shown in different parts of the brain. LTP was shown 
in kittens’ visual striate cortex synapses (Komatsu et al, 1981) as well as in synapses 
formed by the brachium of the interior colliculus in the medial genticultae nucleus of 
auditory system (Geinen and Weinberger, 1983). Racine et al (1983) also showed LTP in 
the synapses in the limbic system. LTP-like mechanisms were also involved in amygdala 
fear conditioning and learning-related cortical plasticity (Martin et a l,  2000). Hence, LTP 
is not restricted to the hippocampus. However, hippocampal pathways show significantly 
larger LTP effects than do the non-hippocampal pathways (Beimett, 2000).
LTP was initially associated with learning by Morris et al (1986) through chronic 
intraventicular infusion of the NMDA antagonist, aminophosphonovaleric acid (AP5) 
into rats. This caused a selective impairment of place learning, a process thought to be 
dependent on the hippocampus (O’Keefe and Conway, 1978). However, it was not 
possible to test whether the NMDA receptor antagonist might be blocking some part of 
the motor pathway that is uniquely utilised in learning process. Other studies attempted to 
associate LTP with learning involved stimulation of the pyriform pathway to the dentate 
gyms in vivo (McNaughton et al, 1986; Castro et al,  1989). These studies concluded that
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spatial memory involves at least temporary storage in the fascia dentate through the 
mechanism of LTP,
Expression of LTP results in the persistent increase (lasting hours, days or weeks) in the 
size of the synaptic component of the evoked response recorded from individual cells or 
from population of neurons. LTP is induced in a number of ways, most conveniently by 
delivering a tetanus (typically a train of 50-100 stimuli at 100 Hz or more) (Bliss and 
Collingridge, 1993). Modest stimuli which fall within certain critical ranges can also 
induce LTP examples include theta-burst stimulation (Bliss and Collingridge, 1993).
Long-term depression (LTD) is another form of synaptic plasticity, which results in a 
lasting decrease in synaptic effectiveness. It is made up of two types:
(i) Heterosynaptic LTD, which can occur at synapses that are inactive, normally 
during high-frequency stimulation of a converging synaptic input.
(ii) Homosynaptic LTD, which can occur at synapses that are activated, normally 
at low frequencies (Bear and Abraham, 1996).
Homosynaptic LTD requires NMDA receptor change in post-synaptic Ca^  ^(Holland and 
Wagner, 1998; Connor et a l,  1999) in CAl region, while the heterosynaptic LTD has 
been observed in the DG (Christie and Abraham, 1992; Christie et al, 1995).
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1.4.2 Silent Synapses
The concept of ‘silent synapse’ in the CNS has been around for a few years. Studies by 
Dimitri Kullmann (Kullmann, 1994) inferred the existence of synapses without AMPA 
receptors via statistical analysis. This was followed by direct evidence, which showed 
that the failure rates for synaptic transmission was greater at hyperpolarised potentials 
(pure AMPA EPSCs, excitatory postsynaptic currents) than at depolarised potentials 
(mixed AMPA and NMDA EPSCs) (Liao et al, 1995). Liao and co-workers together 
with other groups went on to show that LTP was associated with the apparent activation 
of previously silent AMPA synapses via insertion of these receptors into the membrane 
(Liao et al, 2001; Lu et al, 2001). Studies have shown that early on in the development 
of the CAl (Durand et al, 1996) (e.g. postnatal day 1-2), synapses are mainly silent (i.e. 
lack AMPARs) at resting potentials, but possess functional NMDARs. It seems that LTP- 
inducing stimuli can ‘switch on’ these immature synapses so that synaptic transmission 
can occur at resting membrane potentials. Hence, the concept of silent synapses provides 
an important impetus for relating AMPA receptor trafficking mechanisms to the 
expression of LTP as well as spine maturation. In fact, studies have shown that 
maintenance of spine morphology requires AMPARs (McKinney et a l,  1999).
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1.4.3 Properties of hippocampal LTP
CAl LTP is characterised by three basic properties (Malenka and Nicoll, 1999);
(i) Cooperativity— this describes the existence of an intensity tlireshold for induction, 
hence LTP cannot be triggered by a ‘weak’ tetani which activates relatively few 
afferents (McNaughton et al, 1978)
(ii) Input specificity— LTP specific to those pathways which receive conditioning stimuli 
(Malenka, 1991)
(iii) Associativity— pairing a weak stimulus with strong input induces LTP in the weak 
input (Malenka, 1991)
The three properties can be explained on the assumption that potentiation of the synapse
is only achievable when it is active at the time when the region of dendrite on which it
terminates is sufficiently depolarised.
1.4.4 LTP induction at the Schaffer collateral/CAl pyramidal cell synapses
The most intensely studied form of LTP is the NMDA receptor dependent LTP in the 
CAl region of the hippocampus (Malenka and Nicoll, 1999, Martin et a/. ,2000). LTP 
induction requires the activation of postsynaptic excitatory amino acid receptors (NMDA 
and AMPA receptors which are co-localised) by glutamate neurotransmitters. Sufficient 
activation of AMPA receptors causes depolarisation of the postsynapse, which alleviates
16
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the voltage-dependent Mg block of NMDA receptors, allowing influx of Ca^ ,^ which 
causes the biochemical cascade leading to LTP. Depolarisation of AMPA receptors is 
limited due to strong inhibitory influences provided by simultaneously released gama 
aminobutyric acid (GABA) acting on postsynaptic G A B A a and GABAg receptors. 
Therefore NMDA can only be activated under strong postsynaptic depolarisation (tetanus 
or pairing) or when inhibition has fatigued due to GABA acting on inhibitory GABAg 
autoreceptors.
The involvement of several amino acid receptor subtypes in the induction of LTP has 
been determined largely by the use of antagonists (Collingridge et al,  1983). Blockage of 
LTP induction by NMDA receptor antagonist APV (AP5; D-2-amino-5- 
phosphonopentanoate) indicates the requirement of NMDA receptors for LTP. DGG (y- 
D-glutamylglycine) is a mixed AMPA and NMDA receptors antagonist which also 
blocks LTP.
GABAb autoreceptors regulate induction of LTP. Application of GABAg antagonist 
(CGP35348) has been shown to block postsynaptic GABAg-mediated IPSC (at lOOpM 
concentration) and at ImM, it blocks presynaptic GABAg-mediated PPD (paired-pulse 
depression) and enhances primed-burst stimulation. ImM CGP35348 blocks induction of 
primed-burst LTP (Davies et al, 1991).
There also exists an NMDA receptor independent fonn of LTP that has been studied in 
the CAl region of the hippocampus. The NMDA receptor independent foim of LTP can
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be achieved via bath application of the channel blocker tetraethylanunonium (TEA) 
(Aniksztejn and Ben-Ari, 1991) or very high frequency stimulation (Grover and Teyler,
1990). Both forms of LTP are dependent on postsynaptic Ca^ '*' influx. Application of 
nifedipine resulted in the blockage of both NMDA receptor dependent (Grover and 
Teyler, 1990) and independent (Huang and Kandel, 1995; Powell et a l,  1994) forms of 
LTP in CAl. NMDA dependent form of LTP results in an increase in the quantal AMPA 
current, together with an increase in the quantal content of this current (Strieker et al
1996). The NMDA independent form of LTP results in no change in the quantal current, 
the increase in synaptic strength is due to an increase in the quantal content of the AMPA 
current (Sticker et al, 1999).
Involvement of mGluR in the induction of LTP has been controversial especially in the 
use of selective mGluR antagonist, a-methyl-4-carboxyphenlglycine (MCPG). MCPG 
was shown to block the induction of CAl and mossy fibre LTP (Bashir et al, 1993; 
Breakwell et al, 1996; Bortolotto and Collingridge, 1999). However, some groups were 
unable to reproduce these results in the CAl (Selig et al, 1995; Manzoni et al,  1994) or 
mossy fibre (Manzoni et al, 1994; Hsia et al, 1995). A ‘priming’ phenomenon was used 
to explain the discrepancy of the results (Bortolotto et al, 1994): mGluRs were not 
involved in the induction of LTP if the hippocampal slice had been ‘primed’. Slices could 
show mGluR-dependent LTP only when they are not ‘primed’ (i.e. naïve). Primed slices 
could be rendered naïve by repeated low-frequency stimulation. This scenario indicates 
that mGluRs act as molecular switches, which once thrown can result in mGluR- 
independent LTP. hi addition, studies have shown that mGluR priming of LTP results
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from biochemical cascades triggered by activation of phospholipase C coupled to group I 
mGluRs in CAl hippocampal slices (Cohen and Abraliam, 1996; Cohen et al, 1998).
1.4.5 Role of in the induction of LTP
Ca^ "^  plays an important role in the induction of LTP. Filling of CAl neurons with 
calcium chelator EGTA blocked the induction of LTP (Lynch, 1983). Collingiidge and 
co-workers (Collingridge et al, 1983) also showed that the blockade of NMDA receptors 
with D-APV blocked the induction of LTP and therefore concluded that calcium influx 
required for the induction of LTP may enter via the NMDA receptor channel. There is 
considerable evidence that the release of Ca^ "^  from internal stores is also required for the 
induction of LTP (Harvey and Collingridge, 1992; Matias et al, 2002). Indeed, synaptic 
activation of NMDA receptors causes the release of calcium from internal stores, ‘trigger’ 
Ca^  ^entering via NMDA channel causes the subsequent release of calcium from internal 
stores (Alford et al,  1993). Since it is assumed that NMDA receptors are located on 
dendritic spines (a specialise structure in a mature brain), it is believed that spines may 
act to localise the Ca^’*' signal (Connor et a l,  1994; Halpain, 2000). Diffusion of calcium 
is restricted by the spines (Connor et al,  1994; Korkotiaii and Segal, 2000) but it is not 
known if this occurs in LTP. However, LTP has been shown to cause increases in spine 
size as well as spine numbers (Yuste and Bonhoeffer, 2001).
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1.4.6 Mossy fibre LTP (MF LTP)
Mossy fibre (MF) LTP is NMDA receptor independent. MF LTP may not be associative 
(Zalutsky and Nicoll, 1990) nor show cooperativity. MF LTP may involve mGlu 
receptors (metabotropic glutamate receptors, G-protein coupled receptors). This has been 
highly controversial with evidence for (Bashir et al,  1993; Conquet et a l,  1994) and 
against (Hsia et al, 1995). The opioid peptide dynorphin has been shown to play an 
important inhibitory role in the induction of MF LTP via kappa 1 receptors in the guinea 
pig hippocampus (Salin et al, 1995). Studies have shown a presynaptic mechanism for 
induction via Ca^”^ influx through P- or N-type Ca^  ^channels (Castillo et al, 1994). This 
causes an enhancement of transmitter release; resulting in a presynaptic potentiation of 
synaptic transmission via a cAMP-dependent PKA-mediated mechanism (Weisskopf et 
al, 1994).
1.4.7 Temporal phases of LTP
Research suggests that there are three distinct temporal phases of LTP (Roberson et al, 
1996b). These include LTPl (Early LTP, E-LTP) which lasts for <3h duration and LTP2 
(Intermediate LTP, I-LTP), which last 1-6 hours after the initial induction (Morris, 1996). 
LTP3 (late-LTP) is more stable and lasts for up to 8 hours (Frey et al, 1993) in CAl 
region of hippocampal slices and for days in the intact animal (Abraham et al,  1993).
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E-LTP can be produced by a single train of presynaptic action potentials and is protein 
synthesis independent (Bliss and Collingridge, 1993). It results from covalent 
modifications of pre-existing proteins mediated by the c AMP-dependent protein kinase 
(PKA) in MF/CA3 synapses (Weisskopf et ah, 1994). In the CAl, E-LTP depends on 
Ca^VCalmodulin-dependent protein kinase (CaMKII) (Malinow et al, 1989; Ito et al, 
1991; Huang and Kandel, 1994; Liu et al, 1999), protein kinase C (PKC) (Akers et al, 
1986; Klan et al, 1991) and tyrosine kinases (O’Dell et al, 1991). Blitzer et al (1995) 
suggested that the E-LTP in CAl region also involves the cAMP signalling pathway 
which results in PKA activation. Apart from receptor phosphorylation, PKA also acts to 
gate LTP by regulating the activity of phoshoprotein phosphatases.
LTP2 is induced by multiple trains and is suppressed by calcineurin in the CAl region 
and like E-LTP is gene transcription independent but unlike E-LTP is dependent on 
protein synthesis (Winder et al, 1998). Calcineurin is a calcium-sensitive 
serine/threonine phosphatase that is present at high concentrations in the hippocampus 
and is enriched at the synapses (Kuno et al, 1992). Activated calcineurin can act on 
protein substi'ates both directly or indirectly and hence regulate specific cellular functions 
by dephosphorylating target proteins or modulating an even larger variety of substrates 
via dephosphorylating inhibitor 1 (I-l). For example, the suppression of phosphatase 
activity by PKA during LTP2 via phosphorylation of I-l, may simply act to allow a more 
robust utilisation of mechanism recruited for E-LTP. Activated I-l causes 
dephosphorylation of protein phosphatases 1 (PPl), a suppression which requires a
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stronger stimulus than the one 100 Hz train necessary to produce E-LTP (Winder et al, 
1998).
L-LTP requires repeated trains, activation of PKA and synthesis of new proteins and 
RNA (Frey et al, 1988; Frey et al, 1993; Huang and Kandel, 1994). The late phases of 
LTP in MF and Schaffer collateral pathways are similar in outline (Huang et al, 1994). 
Both pathways use a cAMP-mediated mechanism and are dependent on new RNA and 
protein synthesis. Use of protein synthesis inhibitor, anisomycin, and mRNA synthesis 
inhibitor, actinomycin, has indicated that the proteins necessary for the maintenance of 
LTP over 6 hours is synthesised in the DG from pre-existing mRNA without the 
involvement of protein in the cell bodies of the afferent fibres (Otani and Abraham,
1989). The synthesis of these proteins was completed within 15 minutes of tétanisation 
(Otani et al, 1989). The group concluded that there might exist two phases of LTP, one 
short phase independent of new protein synthesis and a later phase which is dependent on 
synthesis of proteins. Other studies have shown that shown the involvement of PKA in L- 
LTP in CAl region (Frey et al, 1993).
1.5 Protein Kinases
Protein kinases are enzymes that covalently attach phosphate groups to the side chain of 
serine, threonine and tyiosine, other modification of cellular function include 
glycosylation (attachment of a sugar unit such as glycan) and ubiquitinoylation (covalent 
addition of ubiquitin residues to proteins). They are attractive candidates for role in LTP,
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due to the fact that phosphorylation represents an effective but reversible means for 
modulating protein function. Another reason is that many protein kinases are regulated 
by second messengers.
Kinases which have been shown to play a role in NMDA-dependent LTP include non­
receptor tyrosine kinases, protein kinase C (PKC), mitogen activated protein kinases 
(MAPK), calcium-calmodulin dependent protein kinase II (CaMKII), and cAMP- 
dependent protein kinase (PKA) (Roberson et al, 1996a).
1.5.1 Non-receptor tyrosine kinases and LTP
Two families of neuronal protein tyrosine kinases (PTK) have been described (Cantley et 
u/., 1991): receptor and non-receptor PTKs. The receptor PTKs are single transmembrane 
protein with an intracellular region which often contains more than one copy of the 
catalytic domain. These are activated by signalling growth factors (Schlessinger and 
Ullrich, 1992), which bind to the receptor in the extracellular domain. Non-receptor PTKs 
are intracellular proteins with one catalytic domain, which is normally located neai* the C- 
terminus (Girault et al 1999).
The best characterised members of non-receptor PTKs are the Src-related PTKs. Src is 
the lead member of a family of PTKs with ten members, six of which are located in the 
brain (Src, Pyk2, FAK, Yes, Lyn, Fyn and Lck) (Ali and Salter, 2001). The primary 
sequence similarity between PTKs lies in;
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(i) The catalytic domain— also referred to as the Src homology 1 (SHI) domain. This 
domain can be divided into 11 sub-domains that are shared by all the PTKs (Avraham 
et al., 2000)
(ii) The Src homology 2 (SH2) domain— capable of high affinity binding to 
phosphotyrosiiie-containing peptide sequences that promote protein-protein 
interaction.
(iii) The SH3— binds proline-rich peptide sequence and also promotes protein-protein 
interaction.
Many neuronal proteins have been identified as the substrates of PTKs, an example of 
which are glutamate receptors (Moss et al, 1993). The use of PTK inhibitors such as 
lavendustin A and genistein have implicated these kinases in LTP induction. O’Dell et 
a/., (1991) showed that the application of these inhibitors blocked the induction of LTP. 
The use of transgenic mice was employed to study further the involvement of particular 
PTKs in LTP. Fyn-knockout mice showed impairment of both LTP (although strong 
stimulation resulted in LTP) and spatial learning (water maze) (Grant et al, 1992; Kojima 
et al, 1997). However, fyn knockouts also showed an abnormal hippocampal homology, 
thus complicating the interpretation of the analysis.
Focal adhesion kinase (FAK) and Pyk2, like fyn are also a family of non-receptor PTKs 
with molecular mass between 110-125KDa. This sub-family has a closely related overall 
structure, which will be discussed in Chapter 3. Two spliced isoforms of Pyk2 have been 
identified and these are characterised by the presence or absence of an exon that codes for
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42 amino acids between the two pro line rich sequences of the C-terminal region (Figure 
1.2). The unspliced form of Pyk2 is predominant in the brain.
1.5.2 Protein Kinase C
Ca^'^/phospholipid-dependent protein kinase or PKC has been implicated in the molecular 
mechanisms of brain development, synaptic plasticity, epilepsy, ischemia and neuronal 
cell death (Tanaka and Nishizuka, 1994). PKC is a multigene family of at least ten 
isoforms, nine of which are present in the brain (a, pi, pll, y, 5, e, q, Ç i/X). Nishizuka 
(1988) has divided the PKC isoform family into three groups:
(i) Conventional— a, pi, pil and y which are activated by both the lipid second 
messenger, diacylglycerol (DAG) and Ca^^
(ii) Novel— 5, e, and q which are activated by DAG, but not Ca^^
(iii) Atypical— and i/X which are activated by neither DAG nor Ca^  ^but by an 
alternative set of lipid second messengers, including arachidonic acid (Nakanish and 
Exton, 1992).
PKC was the first kinase to be implicated in LTP (Akers et al, 1986) (Figure 1.4). Use of 
PKC inliibitors resulted in blockage of the induction of LTP; in most studies the 
inhibitors had no affect on short-term potentiation (STP). This was first suggested by 
using the inhibitory peptides PKC( 19-31) applied directly into the post-synaptic neuron 
(Malinow et al, 1989; Malenka et al, 1989). Use ofPKCy knockout mice has implicated 
PKCy in LTP (Abeliovich et al, 1993). The knockout mice displayed no LTP (or indeed
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STP) in response to tetanus, therefore the PKCy isoform was suggested to have a 
regulatory role in LTP expression. These studies are complicated by the fact that other 
PKC isoforms may have compensated for loss of PKCy. However, in behavioural studies, 
these mice were shown to have mild memory deficits in contextual learning tasks 
(Abeliovich a/., 1993).
Recent studies have discovered the role of other PKC isoforms in LTP. Studies of the 
PKC isoform, PKM^, in the CAl region of the hippocampus has implicated the enzyme 
in both the initial induction and the sustained maintenance phases of LTP (Klann et al., 
1993; Sacktor et al,  1993). Autonomous activation of PKC resulting from persistent 
activation is known to occur during E-LTP (Roberson et al, 1996a). The best 
chai'acterised mechanism for obtaining autonomous activation of PKC is via proteolytic 
activation (Inoue et a l,  1977). Proteolytic activation of PKC results in cleavage at 
specific sites between the regulatory domain and catalytic domain (Figure 1.4). This 
results in a 45-50kDa catalytic fragment, known as PKM (an atypical PKC).
1.5.3 Mitogen-activated protein kinases (MARK)
MARK is a prototype for a family of signalling cascades that share the motif of three 
serially linked kinases regulating each other by sequential phosphorylation. These kinases 
include MAP kinase kinase kinases (MAPKKK, Raf-1 and B-Raf) which activate the 
second kinase, a MAP kinase kinase (MAPKK, MEK), which then activates MARK.
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MAPKs are proline-directed serine\threonine kinases of which p44 MAPK (also known 
as extracellular-signal regulated kinase 1, ERKl) and p42 MAPK (ERK2) isofonns are 
the best characterised. These isofonns act as critical transducers of growth factors 
signalling to the nucleus in mammalian cells. MAPKs are abundantly expressed in the 
neurons of mature central nervous system and thus raising the question of the function of 
these prototype molecular regulators of cell division and differentiation in non-dividing, 
terminally differentiated neurons (Fiore et al, 1993).
During the regulation of cell proliferation ERKl/2 are activated via the ubiquitous Raf-1 
pathway (Figure 4.4). This pathway is activated by Ras, which is stimulated by growth 
factor tyrosine kinases, which act via the adaptor protein, Grb2 and Sos. The Grb2 and 
Sos pathways are also stimulated by PKC, which interacts with either Ras or Raf-1. 
Activated Raf-1 causes the activation of MEK and consequently ERKs. MAPKactivation 
can occur independent of PKC (Ebinu et al, 1998) via the second messenger DAG, 
which can stimulate a family of phorbal ester-binding Ras/Rap guanine nucleotide 
exchange factor (GEFs) resulting in elevated Ras and Rap activity. The Ras/Raf-1 
pathway is inhibited by PKA via inhibition of Raf-1 (Sweatt, 2001). However, PKA can 
also activate MAPK via the Rap 1/B-Raf pathway. MAPK can also be activated by cAMP 
independently of PKA via c AMP-responsive GEF (de Rooij et al,  1998). Hence the 
effect of increased cAMP levels on MAPK activity is hard to predict, and may depend on 
which of these signalling intermediates are present in the cell.
27
Introduction
Other effectors of MAPK activity include Ca^’’, which enters the cytosol via voltage- 
gated calcium channels (VGCC) or NMD A receptors. This increase in intracellular Ca^  ^
activates Ras via Sos and Grb2 which in turn activates MEK/MAPK pathway 
(Mazzucchelli and Brambilla, 2000). Intracellular increases in Ca^ "^  as well as PKC 
activation have also been shown to cause the activation of Pyk2 that then causes the 
modulation of ion channel function (NMDAR) and activation of MAPK signalling 
pathway in PC 12 cells (Lev et al, 1995) (Figure 1.7 and Figure 4.4). A potential link 
between CaMKII and MAPK has been established involving a GTPase activating protein, 
SynGAP. This involves CaMKII activation of MAPK via inhibition of SynGAP’s 
GTPase-regulating activity (Chen et al, 1998) (Figure 1.7).
Behavioural studies have also shown the importance of MAPK activation for memory 
processes. Contextual fear conditioning results in the activation of MAPK in the 
hippocampus (Sweatt, 2001). Application of the NMDA receptor antagonist, MK801, 
before training of the animals resulted in attenuation of learning and MAPK activation 
(following assaying of the hippocampus 1 hour after training) and hence indicated a 
necessity for NMDA receptor activation for learning associated MAPK activation 
(Sweatt, 2001). Inhibition of MEK, and hence MAPK, also reduces the performance of 
rats in spatial learning task (Blum et al, 1999; Selcher et al, 1999) consistent with this 
kinase cascade playing a critical role in learning-related plasticity in the hippocampus. 
However, it has been suggested that MAPK activation is not important for the expression 
of MF LTP (Kanterewicz et al, 2000).
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Metabotropic glutamate receptor activation as well as activation of muscarinic 
acetylcholine activation and dopamine (DA) receptors resulted in the activation of 
hippocampal MAPK (Roberson et al, 1999). This MAPK activation, mediated by 
metabotropic and muscarinic receptors agonists was blocked by PKC inhibitors 
(Roberson et al, 1999). Hence, neuromodulatory receptor agonist studies coupled with 
studies indicating that both PKC and PKA pathways can elicit hippocampal MAPK 
activation suggest that either (or both) PKA and PKC might be utilised to couple synaptic 
stimulation to MAPK activation (Sweatt, 2001).
Evidence suggests that one MAPK isoform in particular, the 42kDa MAPK isoform (p42 
MAPK), might be a component of the biochemical machinery supporting LTP. 
Stimulation of NMDA receptors results in activation of p42 MAPK in hippocampus, 
metabotropic glutamate receptor stimulation also leads to increased p42 MAPK 
activation in cortical cultures (Bading and Greenberg, 1991; Fiore et al,  1993). However, 
p44 MAPK must also be activated, based on the other studies discussed in this section. 
Thus a great deal of evidence supports an important role for MEKs and MAPKs in 
hippocampal synaptic plasticity, at least in the CAl and DG regions.
1.5.4 Ca^" /^Calmodulin dependent protein kinase II (CaMKII)
CaMKII, a calcium-activated protein kinase, is highly expressed in the brain and emiched 
at synaptic stmctures especially the post-synaptic density (PSD). CaMKII makes up ~2% 
of total protein in the hippocampus and has been shown to be necessary for LTP (Figure
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1.5) due to increases in intracellular calcium (Petitt et al, 1994). Calcium binds to a Ca^ """- 
binding protein known as calmodulin. Calmodulin is a small protein consisting of a single 
polypeptide chain of about 150 amino acids. Calmodulin binds four Ca^  ^ions with high 
affinity resulting in a large conformational change to reveal sites that allow it to interact 
with target proteins which include CaMKII.
The CaMKII enzyme, a heteromultimer consists of two types of individual subunits, 10- 
12 of which together form one single CaMKII holoenzyme. These two types of subunits 
are known as a and p (derived from different genes) and can combine in various ratios to 
give active CaMKII molecules. Each single-subunit is made up of an active site and a 
calmodulin binding site (Roberson et al, 1996a).
A variety of techniques have been used to study the role of CaMKII in both LTP 
induction and maintenance, including pharmacological and knockout studies. The use of 
calmodulin inhibitors (calmidazolium, calmodulin binding peptides) (Malenka et al, 
1989) or CaMKII inliibitors such as CaMKIl273-302 (Malinow et al, 1989) resulted in the 
inhibition of the induction of LTP in the CAl region. Mice with targeted deletion of the 
a-isoform of CaMKII had reduced ability to exhibit LTP in the CAl region (Silva et al,
1992) and were unable to perform behavioural tasks (water maze) (Silva et al,  1992). 
Hippocampal slices transfected with vaccina virus, expressed high quantities of CaMKII 
that resulted in occlusion of LTP in the CAl region and the authors concluded that 
CaMKII is both necessary and sufficient to generate LTP (Pettit et al, 1994).
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CaMKII activation results in its autophosphorylation at Thr-286 located within the 
regulatory domain thus converting the enzyme from Ca^^-dependent to a Ca^ "^ - 
independent (constitutively active) form (Fukunaga and Miyamoto, 2000). This is known 
to occur during E-LTP, suggesting that CaMKII plays a role in the expression of E-LTP 
in the CAl region (Roberson et al,  1996a). The ability of CaMKII both to phosphorylate 
and enhance the activity of postsynaptic AMPA-type glutamate receptors are two features 
which suggest that CaMKII activity is particularly important for inducing LTP 
(McGlade-McCulloh et a l,  1993; Pettit et al, 1994; Lledo et al, 1995; Barria et al,
1997). Phosphorylation of AMP A receptors via phosphorylation of the GluRl subunit by 
CaMKII during LTP results in an increase in the single-channel conductance of the 
receptor ion channel (Barria et al, 1997). hi addition, CaMKII may be important for 
translocating AMP A receptors to the synapses (Fukunaga and Miyamoto, 2000). Other 
substrates of CaMKII include MAP2 which undergoes phosphorylation during LTP 
induction (Fukmiaga et al, 1995). Functions of MAP2 in LTP induction will be discussed 
later (section 1.12). Induction of LTP in freely moving rats results in a transient increase 
in CaMKII expression in the DG region of the hippocampus (Thomas et al, 1994), 
suggesting a role in LTP maintenance in that region.
It is unclear if CaMKII plays a role in synaptic plasticity in the CA3 region of the 
hippocampus. However, CaMKII is important for NMDAR-dependent LTP in other brain 
regions such as the visual cortex (Gordon et al, 1996).
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1.5.5 Cyclic AMP-dependent protein kinase (PKA) and Adenylate cyclases
Elevation of cAMP is due to the activation of adenylate cyclases. So what are adenylate 
cyclases? They are enzymes, which convert ATP to cAMP and are activated by a variety 
of hormones, neurotransmitters and other regulatory molecules.
Nine mammalian adenylate cyclases isotypes (AC 1-AC9) have been identified 
(Kiiipinski et al, 1989; Bakalyar and Reed, 1990; Feinstein et al,  1991; Gao and 
Gilman, 1991; Katsushika et al, 1992) and each is distributed and regulated uniquely 
(Choi et al, 1993; Iyengar , 1993; Sunahara et al, 1996). The mRNAs of ACl (Xia et al,
1993), AC2 (Furuyama et al,  1993), AC3 (Glatt and Snyder, 1993), AC8 (Cali et al,
1994) and AC9 (Premont et al,, 1996) have all been detected in the mammalian 
hippocampus. AC2 and AC4 have been shown to be localised in the mouse hippocampal 
formation and colocalised with MAP2 (Baker et al, 1999). They have also been 
suggested to play a role in certain fonns of synaptic plasticity (Baker et al,  1999). 
Ca '^"'-stimulated adenylate cyclases (ACl and AC8) have been shown to play a role in 
synaptic plasticity in the hippocampus (Choi et al, 1993; Weisskopf et al, 1994; Wu et 
al, 1995; Villacres et al, 1998), but other isofonns may also be necessary. Elevation of 
cAMP has been shown to be necessary for MF-LTP (Huang et al, 1994; Weisskopf et 
al, 1994) as well as long lasting LTP (L-LTP) in area CAl (Frey et al, 1993). ACl 
knockout mice failed to induce MF LTP (Villacres et al, 1998), thus indicating the 
importance of ACl in MF LTP.
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Earl Sutherland discovered cAMP, a second messenger, in his studies of glycogen 
metabolism (Sutherland, 1970). Formation of cAMP is a result of metabolism of ATP 
catalysed by adenylate cyclase (refer to Adenylate cyclase section). The main effector of 
cAMP is PKA although may other effectors exist. PKA is a holoenzyme which is a 
heterotetramer comprised of two catalytic units, which have phosphotransferase activity, 
and two regulatory subunits, that have both a cAMP binding activity and an 
autoinliibitory domain which blocks catalytic subunit activity (Figure 1.6). In the absence 
of cAMP, inactive PKA exists as a tetrameric holoenzyme. Upon binding the two 
molecules of cAMP to each regulatory subunit, a conformational change occui’s resulting 
in dissociation of the catalytic subunits and hence expression of enzymatic activity. 
(Figure 1.6) (Roberson et al, 1996a).
Levels of cAMP are elevated immediately after LTP inducing stimuli (Chetkovich et al,
1991) and this production of cAMP occurs downstream of the calcium trigger for LTP, as 
it depends on both extracellular' calcium and activation of NMDA receptors (Chetkovich 
et al, 1991), Calcium activates calmodulin resulting in Ca^Vcalmodulin complex which 
activates the Ca^Vcalmodulin-sensitive adenylate cyclase type 1 (ACl) found in the 
liippocampus (Chetkovich and Sweatt, 1993). Elevation of cAMP immediately after LTP 
induction, results in activation of PKA (Roberson and Sweatt, 1996).
Studies indicated that activity of PKA was not required to support LTP during the initial 
phases of LTP and that PKA inhibitors only interfere with a late phase of LTP (L-LTP), 
which develops after 3-4 hours (Frey et al, 1993; Matthies and Reymann, 1993).
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However, work by Blitzer et al. (1995) suggested that E-LTP in the CAl region involved 
a cAMP signalling pathway which resulted in PKA activation. Thus PKA also acts to 
gate LTP by regulating the activity of phosphoprotein phosphatases. Blitzer et al. (1995) 
suggested that the gating pathway involves the influx of Ca^  ^via NMDA receptors, Ca^ "*" 
then binds to calmodulin and the Ca^Vcalmodulin complex activates Ca^Vcalmodulin 
dependent adenylate cyclase which in turn activates PKA. PKA inactivates protein 
phosphatases resulting in an increased response to protein kinase stimulation. Ablation of 
gene targeting of a catalytic subunit isoform or a regulatory subunit isoform of PKA 
produced a selective defect in ME LTP (Huang et al, 1995).
PKA has been linked to changes in gene expression. Transcription of genes is induced by 
PKA which activates a transcription factor which then interacts with the cAMP response 
element (CREs) found upstream of certain genes (Montminy and Bilezikjian, 1987). This 
CRE-binding protein (CREB) is phosphorylated by PKA and the phosphorylated-CREB 
stimulates transcription of downstream genes (Yamamoto et al, 1988). The hypothesis is 
that PKA phosphorylates CREB at the early stages of LTP resulting in a cascade of 
changes in gene expression which eventually produces the L-LTP. Increased 
phosphorylation of CREB occurs during LTP induction in CAl and DG regions (Schulz 
et al, 1999). Studies have shown that ME LTP may be dependent on the phosphorylation 
of CREB by PKA (Kanterwicz et al,  2000). Also, CREB knockout mice have abnormal 
LTP and deficiencies in long-term learning tasks (Bourtchuladze et al,  1994). Hence 
these studies point to a link between PKA and CREB to plasticity in the CA3 region.
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1.6 Microtubufe-associated protein 2
Microtubules (MTs), components of the cytoskeleton, are thought to be essential for 
neurite formation and maintenance (Sanchez et al, 2000). The cytoskeleton is a major 
detenninant of neuronal morphology. The main function of MTs are to provide inner 
scaffolding for the growth of neurites and also act as tracks for transport of organelles 
between neuronal cell bodies and neurite endings. MTs consist of a core cylinder built 
from heterodimers of a and p tubulin monomers (Mandelkow et al, 1995; Desai and 
Mitchison, 1997). Microtubule associated protein 2 (MAP2) binds to tubulin polymers 
and regulates their functions (Sanchez et al, 2000). MAP2 have been shown to play an 
important role in the neurite outgrowth and neuronal plasticity (Diaz-Nido et al, 1990; 
Sheetz et al, 1998; Woolf, 1998).
MAP2 isoforms expressed in neurons are a result of alternative splicing of a pre-mRNA 
transcribed from a single gene (Shafit-Zagardo and Kalcheva, 1998). There are two 
gi'oups of MAP2 isoforms in the mammalian brain:
(i) High molecular weight MAP2 (HMW MAP2), and this includes MAP2a and 
MAP2b with molecular weights of 280 and 270kDa respectively.
(ii) Low molecular weight MAP2 (LMW MAP2), consisting of MAP2c and MAP2d 
with molecular weights of 70 and 75kDa respectively.
LMW MAP2 contains the N- and C- terminal regions of HMW MAP2 linked together 
but lacks the central domain (CD) (Figure 1.8) (Kindler et al, 1990). The presence of the
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pro line-rich region (PRD) just before the tubulin-binding domain in all MAP2 iso forms 
could result in the regulation of the isofonns (Goode et al,  1997; Preuss et al,  1997). A 
unique sequence of 31 amino acids in the N-terminal of MAP2 constitutes the binding 
region of the regulatory subunit RII of the PKA (Obar et al, 1989). The difference 
between a and b isoforms of MAP2 is due to the presence in MAP2a of an additional 
sequence of 83 amino acids (Shafl-Zagardo et al., 1997).
The expression of MAP2 occurs primarily in the nervous system (Schoenfeld and Obar,
1994). HMW MAP2 is specifically expressed in neurons (Cacares et al,  1984; Tucker,
.1990) while LMW MAP2 is present also in glial cells (Rosser et al, 1997, Matsunaga et 
al, 1999). While MAP2b is present all through development of the nervous system, 
MAP2a expression occurs in the adult brain (Sanchez et al, 2000).
The levels of MAP2c protein and mRNA are detectable at early developmental stages, 
while MAP2d protein is detected in rat brain after postnatal day 5, even though its mRNA 
is present all through the various developmental stages (Sanchez et al, 2000). This 
differential expression of MAP2 isoforms may be an indication of the complexity of their 
regulation at both transcriptional and translational levels. HMW MAP2 has been shown 
to be located in neui'onal cell bodies and dendrites where it associates with MT. It has 
also been shown to co-localise with actin in the dendritic spines and postsynaptic 
densities (Cacares et al,  1983, 1984; Langnaese et al, 1996). LMW MAP2 in contrast is 
widely distributed in every neuronal compartment (Albala et al, 1995).
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Several experiments in neuronal cells have implicated MAP2 in neuronal outgrowth and 
polarity (Ferreira et al,  1989). Suppression of MAP2 expression in neuronal cultures 
resulted in no neurite outgrowth (Dinsmore and Solomon, 1991; Cacares et al, 1992). 
Similarly overexpression of MAP2 in cultured non-neuronal cells resulted in outgrowth 
of cytoplasmic elongations similar to neurites (Boucher et al, 1999).
1.7 Activin/l n h ibin
Activin and inliibin belong to the transforming growth factor-p (TGF-P) super-family of 
molecules and activin has been implicated in nerve cell survival and inhibition of 
differentiation in vitro (Hashimoto et al, 1990; Schubert et al, 1990). Both activin and 
inhibin are dimeric proteins which were first isolated from the ovary and were able to 
modulate follicle stimulating hormone (FSH) release from the pituitary in a long loop 
endocrine fashion (Halvorson and Dechemey, 1996; Ling et al, 1986b). Both dimeric 
proteins are sulphydryl-linked comprising two of three distinct inhibin proteins subunits 
(a, pA, pB). While inhibins are heterodimers composed of one a-subunit and one p- 
subimit, resulting in inhibin A (a~pA) or inhibin (a-pB) (Mason et al, 1986), activins are 
dimers made up of any combination of the p-subunits resulting in activin A (PA-pA), 
activin AB (PA-pB) and activin B (pB-pB) (Ling et al,  1986a; Vale et al, 1986). Activin 
produces its effect via binding to a heterotrimeric receptor complex with transmembrane 
serine/threonine kinase activity (Mathews, 1994). The role of activin P-A in LTP 
induction will be discussed in section 7.1.
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1.8 mRNA localisation in Neurons
Neurons are thought to employ three strategies for the activity-dependent regulation of 
protein synthesis and targeting. The first strategy focuses on the translation of proteins in 
the soma from newly transcribed mRNAs e.g. activation of transcription factors such as 
CREB in response to a particular form of synaptic stimulation (Alberini et al, 1994) 
results in increased transcription of specific target genes, followed by translation of the 
corresponding mRNAs. This process is thought to involve the creation of ‘tags’ at the 
activated synapses (Frey and Morris, 1997). These ‘tags’ act to capture the newly 
synthesised proteins, at the synapse that has been potentiated, as they are transported out 
along the dendrites. The second strategy also involves activity-dependent gene 
transcription but involves the transportation of newly transcribed mRNAs to activated 
synapses where they are thought to be translated. This mechanism was recently described 
for Arc (activity-regulated cytoskeleton-associated protein), an immediate early gene 
whose transcription is tightly regulated by synaptic activity (Steward et al, 1998;
Steward and Worely, 2002). The third and final strategy for achieving activity-dependent 
regulation of protein synthesis is via the regulation of mRNA localised at synapses. This 
will be the focus of some of this investigation.
The discovery of synapse-associated polyribosome complexes (SPRCs) sparked an 
interest in RNA localisation in neui'ons. SPRCs are clusters of polyribosomes and 
associated membranous cisterns that are selectively localised beneath postsynaptic sites 
in the dendrites of CNS neurons (Steward et al, 1996). It was suggested that a particular
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subset of mRNA would be localised in dendrites, enabling a localised synthesis of certain 
proteins at postsynaptic sites. In situ hybridisation analysis looked at the features of 
mRNA localisation in the dendrites and the following were ascertained;
(i) The mRNAs in dendrites encode proteins of different functional types and these 
include MAP2, Ai*c, and aCaMKII as well as other proteins of unknown function 
(Steward et al, 1996).
(ii) Different mRNAs ai*e localised in the dendrites of different neuron types e.g. the 
mRNA of MAP2 and aCaMKII are prominent in the dendrites of neurons in the 
cortex and hippocampus.
(iii) Different mRNAs are localised in different domains within the dendrites, with 
mRNA for aCaMKII distributed throughout the dendrites and MAP2 mRNA 
concentrated in proximal dendrites (Steward et al,  1996).
Recent work has established a direct link between local mRNA translation and synaptic 
plasticity. As already mentioned above (section 1.6) the NMDA receptor dependent form 
of LTP results in the elevation of MAP2 mRNA and the corresponding protein.
Ouyang et al (1999), showed that tetanic stimulation of the Schaffer collateral pathway 
in the CAl region of hippocampus results in the increased expression of aCaMKII 
protein in the dendrites via dendritic protein synthesis. Anisomycin was used to block the 
increase, which was detected by both quantitative immunoblot and semi-quantitative 
immunocytochemistry. L.A. Roberts et al (1996) also showed an increase in the levels of 
aCaMKII mRNA following induction of LTP in the CAl neurons in rat hippocampal 
slices maintained in vitro.
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The mechanism by which dendritic mRNAs become transitionally active may involve 
regulated polyadenylation by CPEB (cytoplasmic polyadenylation element binding 
protein) (Wu et al, 1998). Understanding of the role of CPEB in neurons is based on 
work in oocyte maturation. The CPE (cytoplasmic polyadenylation element) is bound by 
CPEB which contains two RNA recognition motifs (RRMs) and a zinc finger- all of 
which are important for CPE-dependent RNA binding. CPEB is activated by a single 
phosphorylation event (Wells et al,  2000) and this phosphorylation in the Xenopus is 
catalysed by serine/threonine kinase, Erg2. A possible mechanism of Erg2 is to recruit or 
stabilise the binding of CPSF (cleavage and polyadenylation specificity factor) which in 
turn recruits poly(A) polymerase to the end of the mRNA (Wells et al,  2000). Hence the 
process of polyadenylation initiates mRNA translation. CPEB is highly expressed in the 
cell bodies and dendritic layers of the hippocampus (Wu et al, 1998). The 3’ untranslated 
region (UTR) of aCaMKII mRNA contains two CPEs. Therefore, CPEB binds this 
3’UTR in a CPE-depedent manner and the 3’UTR can regulate protein translation in a 
CPE dependent manner in a heterologous system (Wu et al, 1998). However, MAP2 
mRNA contains no CPEs, and Erg2 has never been linked to hippocampal plasticity, so 
firm evidence that this pathway is operative in LTP is lacking.
1.9 The mTOR Kinase
Rapamycin is a lipophilic macrolide, isolated from a strain of Streptomyces 
hygrosocopicus which is indigenous to Easter Island (Raught et al,  2001). FKBP12
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(FK506-binding protein) is a small ubiquitous receptor protein to which rapamycin binds 
intracelluiarly in all eukaryotes (Harding et al, 1989). Rapamycin and FKBP12 bind to 
form a “gain of function” complex which then interacts with specificity to the 
evolutionarily conserved mammalian target of rapamycin (mTOR) protein resulting in 
potent inhibition of signalling of targets downstream (Raught et a l,  2001). A single 
mTOR protein has been cloned from several species. mTOR is also known as FRAP 
(FKBP12 and rapamycin associated protein) or RAPT (rapamycin targets) (Raught et al, 
2001). In this thesis, the kinase will be refened to as mTOR.
The TOR protein belongs to a protein family teimed phosphatidylinositiol kinase-related 
kinases (or PIKKs), a large group of signalling molecules (Raught et al,  2001). 
Rapamycin has been used recently to study a growth factor-regulated signalling pathway 
that results in entranced translation of a specific sub-set of mRNAs via mTOR activation. 
Rapamycin significantly inhibits translation of mRNAs derived from a few genes (Brown 
and Schreiber, 1996). The class of mRNAs whose translation is inhibited by rapamycin 
posses a 5’ terminal oligo-pyrimidine tract (5’ TOP), these mRNAs are present in 
mammalian cells (Jefferies et al, 1997). Rapamycin sensitive genes include those 
encoding ribosomal proteins (S3, S6, 814 and 824), translation elongation factors 
(eEFl A and eEF2), and a secreted peptide growth factor called insulin-like growth factor 
II (IGFII) (Brown et al,  1996). It is likely that more 5’ TOP mRNAs are yet to be 
identified.
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mTOR controls the mammalian translation machinery in response to amino acids and 
growth factors, via activation of p70®^  ^protein kinase and via inhibition of the elF4E 
(eukaryotic translation initiation factor 4E, directs the translation machinery to the 5’ end 
of the mRNA) inhibitor, 4EBP1 (Figure 1.9). Activation of p70^^^ resulting in 
phosphorylation of the 40S ribosomal protein, S6, ultimately drives translation of 5’TOP 
mRNAs (Schmelzle and Hall, 2000). Regulation of p70^^^is complex and involves a 
hierarchical phosphorylation of several sites in p70^^^by different kinases (Schmelzle 
and Hall, 2000); rapamycin principally affects only one of these sites. Rapamycin inhibits 
the phosphorylation of S6 kinase at threonine 399 but not at threonine 239 (Khan et al, 
2001).
Using the techniques of western blot and immunostaining, the translational machinery 
mTOR, 4EBP, and elF4E, were shown to be localised in the soma and dendrites in the 
hippocampus (Tang et al,  2002). Tang et al (2002) suggested that the localisation of this 
translational signalling pathway in the postsynaptic sites may provide a mechanism for 
controlling local protein synthesis at potentiated synapses. The group went on to show 
that the disruption of this translational signalling pathway with rapamycin inhibited 
expression of LTP from 2-3 hours after tetanus. Tskas et al (2002) looked at the effect of 
blockage of phosphorylation of p70^^^ by rapamycin and indicated that induction of L- 
LTP is associated with dendritic activation of translation initiation pathways.
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1.10 A23187 and Forskolin
A23187 is a Ca^  ^ionophore that has been shown to elevate intracellular Ca^  ^levels at 
6pM concentrations in PC 12 cells (Lev et al., 1995) and lOpM concentration in 
hippocampal cells (Siciliano et al, 1996). Forskolin is a naturally occurring diterpene 
which has been shown to activate adenylate cyclase at 50pM concentration resulting in 
increased levels of cAMP which then activates PKA (Weisskopf et al, 1994, Huang et 
al, 1995). Hence, elevation of cAMP via application of forskolin is important in MF LTP 
and this is achieved by activation of Ca^ "^  /calmodulin sensitive AC (Weisskopf et al,
1994). In the L-LTP, the CAl and CA3 regions of the hippocampus were shown to 
require cAMP-mediated mechanism (Huang et al, 1994).
1.11 Aims of the study
Ca^ "^  and cAMP are the two major effectors of NMDA receptor activation with Ca^ "*" 
entering via activated receptor and cAMP elevation due to Ca^^-sensitive adenylate 
cyclase activation. LTP2 is dependent on mRNA translation but is independent of de 
novo protein synthesis (Morris, 1996) and its lasts between 1-6 hours. aCaMKII and 
MAP2 mRNAs are present in neuronal dendrites and cell soma and have been shown to 
be associated with various forms of neuronal plasticity. Most of the studies have looked 
at the increased levels of MAP2 mRNA and aCaMKII mRNA which were detected after 
LTP induction at least in the DG and CAl regions of the hippocampus, it is not known 
yet if similar increases are observed in the CA3. In the case of |3-activin, increases of the
43
Introduction
mRNA encoding (3-activin were also detected in the CAl and DG regions with little 
known about the CA3. The effect of the two messengers on the activation of Pyk2 
(chapter 3) and MAPK (chapter 4), and on the levels of protein expression of aCaMKII 
(chapter 5), MAP2 (chapter 6) and (3-activin (chapter 7) in the acute or organotypic 
hippocampal slices was investigated. The increase of MAP2, aCaMKII and (3-activin 
proteins were investigated by using A23187 (Ca^  ^ionophore) and forskolin (adenylate 
cyclase activator). The effect of inhibition of mTOR on the expression of MAP2 and 
aCaMKII proteins in organotypic hippocampal slices was also investigated to determine 
whether the rapamycin-sensitive translational pathway was involved in their expression.
Using the teclmiques of acute hippocampal slice preparations, the effect of Ca^  ^and 
cAMP on the phosphorylation of Pyk2 and MAPK was investigated. Like MAP2, 
aCaMKII and (3-activin, most of the studies on the two enzymes have been carried out in 
the CAl and DG with little known about the CA3. In case of Pyk2, inliibitors of novel 
PKC, staurosporine, and atypical PKC (PKM), chelerythrine were used prior to 
activation, in order to investigate the role of Pyk2 in LTP maintenance since PKM has 
been implicated in LTP maintenance (Ling et al,  2002).
Therefore the thesis is set out to answer the following questions:
i. Is PyK2 activation affected by intracellular elevation of Ca^ "^  or cAMP in the 
hippocampus? If so, is that the case in CA3 region?
ii. Are these changes in Pyk2 affected on the application of PKC inhibitors?
44
Introduction
iii. Is MAPK activation affected by increases in the level of intracellular Ca^ "^  or 
cAMP elevation in the CA3 region?
iv. Are the expressions of aCaMKII, MAP2 and (3-activin affected by Ca^ "^  or cAMP 
intercellular elevation in the CA3 region?
V. Is rapamycin-sensitive pathway involved in the expression of aCaMKII and 
MAP2?
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Figure 1.1: Hippocampal formation of rat brain. The hippocampus is an elongated C- 
shape structure made up of dentate gyrus, hippocampal proper (CA3, CA2 and CAl, 
only CAl and CA3 regions shown) and subicular region. The CAl region is blown up 
to show the different laminae while the blown CA3 regions shows its pyramidal cells 
receiving the majority of their inputs from other CA3 pyramidal cells. In the dentate 
gyms the pyramidal layer is replaced with the granular layer. Adapted from Amaral 
and Witter, 1989.
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Figure 1.2: The stmcture of Pyk2. The length of the peptide chain is indicated 
without the alternatively splice exons, which are represented as boxes with the 
corresponding number of amino acids inserted below the sequence. The position of 
the autophosphorylated tyrosine residue is Tyr402. Adapted from Girault et a/., 1999.
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Figure 1.3: Model for the role of protein kinases Src and Pyk2 (CAKP) in LTP 
induction in the CAl region, a) At rest, the Src and CAKp are inactive in the post­
synapse and the inhibits but does not completely block NMDAR currents, b) 
Tetanic stimulation results in the release of the Mg^  ^block, causing an increase in the 
NMDAR currents resulting in the activation of CAKp (CAKp*) and Src (Src*) and 
increase sensitisation of NMDAR to raised in intracellular levels ofNa^. c) There is 
an increased in intracellular Ca^  ^as a result of upregulation of NMDAR, this increase 
causes activation of CaMKII and the expression of LTP results from insertion of 
AMPARs into postsynaptic membrane. Adapted from Ali and Salter, 2001. 
Abbreviation: CAKp- cell adhesion kinase p
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Figure 1.4: Mechanism for activation of PKC during LTP. The diagram shows 
different 2"  ^messengers and enymes involved in the activation of the different 
isoforms of PKC (Adapted from Roberson et al, 1996a).
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Figure 1.5: Mechanism of C aMKII activation in LTP. The mechanisms of transient 
and auotphosphorylated activation of CaMKII are highlighted. Adapted from 
Roberson £z/., 1996a.
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Figure 1.6: Schematic diagram of the effect of cAMP on PKA. Binding of cAMP to 
the regulatory subunit results in conformational change that causes the release of the 
active catalytic subunit. The activated PKA phosphorylates CREE resulting in 
synthesis of new proteins via activation of late response genes. Abbreviation: CREB- 
cAMP response element binding protein.
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Figure 1.7: Schematic diagram summarising the activation of the following protein 
kinases: Src, PyK2, PKC, CaMKII, PKA and MAPK. The diagram also indicates the 
substrates of the kinases. Activation of Pyk2 due to increases in intracellular Ca^ "^  
results in the activation of Src, which in turn increases potentiation of NMD A 
receptors. Actiavtion of PKC (due to increases in Ca^ "^  levels or activation of mGluR) 
also activates Pyk2. CaMKII activation results in phosporylation of the AMP A 
receptor, while activation of PKA (due to increase levels of cAMP) causes the 
activation of MAPK. MAPK then activates CREB resulting in gene expression.
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Figure 1.8: Structure of MAP2 iso forms showing the MAP2 domains. Two groups of 
MAP2 isofonns exist, the HMW MAP2 which includes MAP2A and MAP2B and 
LWM MAP2 which includes MAP2C and MAP2D. The LMW MAP2 lacks the 
central domain (CD) but contains N- and C-terminal regions of HMW MAP2 linked 
together. Adapted fi'om Sanchez et al,  2000. Abbreviations: Rll-regulatory subunit of 
PKA; TBD-tubulin binding domain; PRD-proline-rich domain; CD-central domain.
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Figure 1.9: Model of the effectors of mTOR signalling pathway in mammalian cells. 
Arrows indicate activation while the bars represent inhibition. mTOR activates the 
translation machinery, i.e. p70^^^ and phosphorylates 4E-BP1 hence allowing 
translation. Adapted from Schmelzle and Hall, 2000. Abbrevaitions: PDKl-3’- 
phosphoinositide-dependent protein kinase 1 ; pRb-retinoblastoma protein; PI3K- 
phosphotidylinositol-3-kinase; x- unknown enzyme/protein.
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Chapter 2 
Methods
2.1 Organotypic Slice Culture
Many different techniques have been tested to maintain explants of nervous tissue in culture. 
Roller tube teclmique was one of the most successful procedures (Gahwiler, 1988). This 
procedure enabled the culturing of slices from different areas of the central nervous system. 
One characteristic of this procedure was the organotypic organisation of the explant and the 
monolayer aspect. The monolayer developed over a period of 2-3 weeks, enabling the 
visualisation of individual cells with phase contrast microscopy. A different and simple 
method was developed in which the explants were placed on a membrane at the interface 
between air and medium. This also allowed maintenance of explant of central nervous system 
and more specifically hippocampal slices in culture. The results obtained with this teclmique 
were similar to roller tube technique, but the major advantages of this method were the 
simplicity, the well preserved organotypic organisation of the tissue and suitability of this 
technique for the studies of physiological mechanisms occurring during the first day or 
weeks in culture (Stoppini et aL, 1991).
Organotypic slice cultures were prepared according to the method of Stoppini et al (1991). 
Neonatal, Wistar rats, between ages 6-10 days were injected with a lethal dose of anaesthetic 
[Euthatal, (Rlione Merieux), 0.2mg/kg]. After decapitation the brain was quickly removed 
and placed in ice cold HBSS (Hanks’ Balanced Salt Solution, GIB CO™) buffer which had 
been gassed (95% O2 and 5% CO2) for 10-15 minutes. The dissection took place in the 
solution and the hippocampus was placed on the tissue chopper after extraction. The tissue
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chopper was set to 250pm and the hippocampus cut transversely. The sliced hippocampus 
was placed in a fresh ice-cold gassed (95% O2 and 5% CO2) HBSS and the slices teased apart 
using sealed glass micropipettes (Clarke Instruments).
Between 12-16 hippocampal slices were normally obtained. The slices were then placed in 
another solution of fresh ice-cold gassed HBSS and transferred to the culture room.
In a laminar flow cabinet, the slices were transferred to 6-well plates (Iwaki). 1ml of a Wilde 
medium [BME (Basal Medium Eagle) Ix liquid with Earle’s salt without L-glutamine 
(88.5%), horse serum heat inactivated (17.7%), glucose (22.5g/L), glutamax™-! Supplement 
(0.46%), penicillin/streptomycin solution (5%)] was added to 4 wells each. Inserts of 0.2 pm 
pore (Falcon) were placed in the 4 wells and placed in the humidified, 37 C, 95 % O2 and 5% 
CO2 incubator for 30 minutes prior to dissection. All the contents of the Wilde medium were 
purchased from GIBCO™.
Two sterile pastettes (Alpha Laboratories Ltd) were used to transfer the slices onto the 
inserts. One to extract the 4 hippocampal slices from the oxygenated HBSS and one to 
remove the excess HBSS on the inserts. This procedure was repeated until all the slices had 
been placed in the wells (normally 4 slices/well). The 6-well plates with their contents were 
then placed in the incubator.
The Wilde medium was changed after 24 hours incubation. This involved the use of two 
sterile needles and syringes. One syringe was used to extract the old medium from the wells 
while the second syringe was used to add 1ml of the fresh medium. The slices were 
incubated for 7-8 days changing the medium again after 3-4 days. At the end of 7-8 days the 
slices were ready for drug treatment and immunocytochemistry or western blot.
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2.2 Acute Slice Preparations
An adult rat (weighing 150-200g) was culled by injecting a lethal dose of an anaesthetic 
(Euthatal, 1.5mg/kg). After decapitation the brain was removed. This involved opening of the 
skull with a pair of scissors and removal of the brain using a spatula. The brain was 
hemisected in ice-cold (at 4°C) high Mg^ "^  (lOmM) artificial cerebrospinal fluid (aCSF) 
which was made up of 124mM NaCl, 3mM KCl, 26mM NaHCOa, 1.25mM NaIÏ2P0 4 , 
lOmM MgS0 4 (H2 0 ), 18.02mM D-glucose and 2mM CaCh. All the compounds used were /
purchased from BDH Laboratory Supplies apart from glucose which was purchased from 
Fisher Scientific.
The hippocampus was removed from the rest of the brain by using spatulas, and using a 
tissue chopper, 300pm transverse hippocampal slices were obtained. The slices were then 
placed in a petri dish of fi*esh ice cold high Mg^ '  ^aCSF solution (same composition as above) 
in a petri dish and allowed to recover for 60 minutes in an gassed chamber (95% O2 and 5%
CO2) at room temperature. An hour after recovery the temperature was increased to 32°C and 
the slices were left for a further hour after which the slices were ready for drug treatment.
2.3 Drug Treatment
The drugs used in this set of experiments were: 5pM of A23187 (Sigma), 50pM forskolin 
(Sigma), 20nM rapamycin (Calbiochem), IpM chelerythrine (CN bioscience) and lOOnM 
staurosporine (CN bioscience). The stock solution of these drugs was dissolved in dimethyl 
sulfoxide (DMSO, BDH laboratories Supplies), apart from staurosporine which was 
dissolved in methanol.
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The drugs (A23187, forskolin and rapamycin) were diluted in HBSS, and HBSS with DMSO 
was used as the control for cultured slices since HBSS was the saline solution. After the 
incubation, the cultured slices were treated by placing 1.5 pi of the drug/control on top of 
each slice. The procedure was performed in a sterilised laminar flow cabinet. In the case of 
acute slices, the drugs were diluted in high Mg^ "^  aCSF and high Mg^ '*' aCSF with DMSO was 
used as control. The slices were then placed in a gassed aCSF solution containing the drugs 
of interest. High Mg^ "^  was used in this study in order to prevent neurotoxicity as result of 
NMDA activation.
2.4 Dissection of the CA1 and CA3 sub-regions of acute hippocampal slices
After drug treatment, the acute hippocampal slices were placed in an ice-cold, high Mg^ "^ , 
gassed aCSF [containing ImM sodium ortho vanadate (Na3V0 4 , Sigma, inhibits protein 
phosphatases) and 50mM sodium fluoride (NaF, Sigma)]. The CAl and CA3 were dissected 
from the rest of the hippocampus using sealed glass micropipettes and carbon steel surgical 
blades (Swann-Moiton), using a dissection microscope (Figure 2.1). CAl and CA3 sub- 
regions of acute hippocampal slices were then ready for immunoprécipitation.
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2.5 Electrophysiological Recordings
Slices from mice (5-10 weeks old) were prepared and used in electrophysiology according to 
the method described in the Appendix. After induction and measurement of the late phase of 
LTP, the slices were quickly frozen in liquid nitrogen and the CAl region was removed from 
the rest of the hippocampus. The CAl region was then thawed and placed in an ice-cold 
(4°C) RIPA buffer, according the method describe in section 2.4. The CAl region was then 
ready for western blot teclmique (see section 2.9).
2.6 Determination of Protein Concentration
Protein concentrations fi'om cultured or acute slices were initially determined, before 
performing the technique of Western Blot, by using the BIO-RAD micro protein assay, based 
on the method of Bradford (1976), with BSA used as a standard. 4pl of the sample was 
diluted in 400pl of dHzO and 200pl of diluted BIO-RAD reagent (1:1 dHaO). The samples 
were then placed in 96 well plate (Iwaki) and using the Plate Reader Program (Thermo Life 
Sciences) set at 595nm, the concentrations were measured.
2.7 Immunocytochemistry
The cultured slices were fixed for 30 minutes using 3% buffered formaldehyde (Riedel-de 
Haen) and then processed for immunocytochemistry as described previously (Morris, 1997). 
The buffer used was phosphate buffered saline solution (PBS) made up of 130mM NaCl, 
8mM Na2HP0 4 , 2mM NaH2P0 4  and 500ml of distil H2O, pH 7.5. Fixation was followed by 
2x5 minutes washes in PBS.
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The slice cultures were then blocked in blocking serum [15%of normal goat serum 
(purchased from Law Hospital, Carluke, Scotland) and 1ml of PBS] for Ihour. Hippocampal 
slice cultures were left overnight at 4°C in primary antiserum [primary antibody diluted to 
required concentration, 3% normal goat serum, 0.5% Triton xlOO (Sigma) and 1ml PBS]. 
After 3x5 minute washes in PBS, the slice cultures were then incubated for Ihour in 
secondary antiserum [0.5% of biotinylated anti-mouse/anti- rabbit antiserum (Vector 
Laboratories Ltd), 1.5% of normal goat semm and 1ml PBS]. The slice cultures were then 
washed 3x5 minutes in PBS and incubated for 1 hour with ABC reagent [2% of solution A, 
2% solution B (Vector Laboratories Ltd) and 1ml of PBS]. Following another 3x5 minute 
washes in PBS the slice cultures were incubated in peroxidase substrate kit (Vector VIP™, 
catalogue number 4600, Vector Laboratories, consisting 3 drops of reagent 1, 3 drops of 
reagent 2, 3 drops of reagent 3 and 3 drops of H2O2) with 5mls PBS, for between 5-10 
minutes. Afteiwards the slice cultures were washed for 5 minutes in PBS followed by 
5minutes in distilled H2O, and then placed for 30 minutes in 70%, 90%, 100%, 100%, 100% 
ethanol respectively. Slices were allowed to dry briefly and then placed in histoclear 
(National Diagnostics) overnight. The following day slices were histomounted using a 
histomount (National Diagnostics) and coverslipped (using BDH microscope slides and 
coverglass).
In all experiments, vehicle controls were performed alongside drug treated slices, the control 
and treated slices were processed identically in the immunocytochemical procedure.
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2.8 Immunoprécipitation (IP)
The hippocampal slices (acute slices), CAl or CA3 sub-regions were placed in 100-200pl of 
ice-cold (4°C) radioimmunoprecipitation (RIPA) buffer [IM Tris pH 8 (Boehringer 
Mannheim), IM NaCl, 0.5% IGEPAL CA-630 (NP40, Sigma), 0.5% deoxycholate (DOC, 
Sigma), 10% sodium dodecyl sulfate (SDS, Fisher Scientific International Company), ImM 
EGTA (Sigma), ImM EDTA (Sigma), ImM Na3V0 4 , 1 protease inhibitor cocktail tablet 
(Roche Diagnostic) and 10 ml of distilled H2O].
The acute slices were homogenised, using pellet pestle (Sigma), in 100-200pl of RIPA 
buffer, and underwent 10,000g centrifligation at 4°C for 10 minutes. The supernatant was 
removed and was centrifuged again at 10,000g, 4°C for 10 minutes. The volume of the 
resultant supernatant was increased to 500pl, ensuring there was enough volume to incubate 
in the secondary antibody.
A primary antibody [anti-Pyk2, 1:100 dilution. Table 2.1] was added to the supernatant 
samples. The samples were placed in a rotator for 2 hours at 4°C. A 50pl proteinG-sepharose 
(Sigma) was added to the samples which were left for 1 hour at 4°C in the rotator.
After 1 hour, the samples were centrifliged at 400g for 30 seconds. lOOpl of the supernatant 
and the sepharose (the pellet in this case) were kept. The samples were kept at 4°C for the 
duration of the washes. The sepharose was washed tlrree times in IP washing buffer (lOOmM 
(N-[2-Hydroxyethyl]piperazine-N’-[2-ethane-sulfonic acid]), HEPES (Sigma), lOOmM NaCl 
and 0.5% NP40} and after each wash the solution was centrifuged (400g for 30 seconds) and 
the IP washing buffer removed. The sepharose was then washed for the last time in IP 
washing buffer without NP40 and centrifuged (400g for 30 seconds). Once the washing
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buffer had been removed, lOOpl of 2x NuPAGE ™LDS Sample Buffer (Invitrogen) was 
added to the sepharose. A reducing agent (Ix), NuPAGE ™ Sample reducing agent (lOx) 
purchased from Invitrogen, was also added to the sample (lOpl of reducing agent in lOOpl of 
sample solution) and mixed. The reducing agent (which contains p-mercaptoethanol) 
prevents aggregation due to disulfide formation between newly exposed cysteins of protein 
samples.
The samples were placed in a heating block set at 70°C for ten minutes, to denature the 
sample protein. After mixing the sample, it was centrifuge at 400g for 30 seconds. The 
resultant supernatant was then ready for electrophoresis as explained in the Western Blot 
protocol (see section 2.9).
2.9 SDS PAGE and Western Blotting
After drug treatments the slices (acute or organotypic cultures) were placed in a REPA buffer. 
The slices were homogenised as in the immunoprécipitation protocol (section 2.8). A Ix final 
concentration of sample buffer and reducing agent were added to the resultant supernatant. 
Placing them in a heating block at 70°C for 10 minutes denatured the samples.
The samples were run in a NuPAGE ™ 12% Bis-Tris precast gels [based upon Bis-Tris-HCl 
buffered (pH 6.4) polyacrylamide gel] with rainbow markers (Amersham Life Science) for 1 
hour at 150V in a NuPAGE ™ MES mnning buffer. The running buffer contained NuPAGE 
™ anti-oxidant (1:400 dilution). Into each well of the gel, 15pi of the sample was placed. 
After the hour, the samples were transferred to a PVDF membrane (Invitrogen). The process
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took place in a Ix transfer buffer (NuPAGE ™ lOx transfer buffer, Invitrogen), 10% 
methanol and NuPAGE ™ anti-oxidant (1:100) and the voltage was set to 30V.
After 2 hours, the PVDF membrane was removed and rinsed in distilled water. The 
membrane was “blocked” for 1 hour with continuous shaking in PBS containing 0.05% 
Tween (Sigma) (PBST) and 5% skimmed milk powder (Amersham Life Science).
The membrane was then washed briefly in distilled water before being left overnight on a 
shaker at 4°C in the 1:1000 dilution primary antibody [same antibodies as in 
immunocytochemistry, anti-Pyk2 phosphospecific, p-Actin, or anti-MAPK phosphospecific. 
Table 2.1]. The solution containing the antibody was made up of 3-5% skimmed milk 
powder in PB ST.
The blot was washed the following day for 15 minutes and then 2x 5 minutes in PBST. The 
membrane was then placed in a secondary antibody, anti-mouse or anti-rabbit (1:1000 
dilution, Diagnostic Scotland) for 1 hour on a shaker. The antibody was diluted in 3-5% 
skimmed milk powder and PBST. After the blot had been washed 3x PBST as above, an 
ECL detection kit from Amersham Life Science (97.6% solution A and 2.4% solution B) was 
used to visualise the protein bands. The ECL was placed on the blot and left for 5 minutes 
with shaking. The blot was again washed three times in PBST. It was then covered in cling 
film and placed in an x-ray film cassette. In a dark room a sheet of autoradiography film 
(Hyperfilm"^  ^ECL, Amersham Life Science) was placed on the top of the blot for 1 -5 
minutes exposure. The film was then placed in a automatic developing machine (Amersham).
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2.9.1 Stripping of the PVDF membrane
Once the required bands were obtained the PVDF membrane was placed in a stripping 
solution [80mM Tris, 2% SDS and 68% p-mercapto-ethanol (Sigma)] for 30 minutes at 
60°C. The membrane was then washed in a copious amount of H2O for 5-10 minutes. The 
membrane was re-probed with a different primary antibody (P-actin, Sigma) and then 
processed for immunoblot (section 2.9).
2.10 Image Analysis
For immunocytochemistiy the staining was quantified by using “hnage” software 
(W.Rasband, NIH) as described (Simpson and Morris 2000). The measurements were made 
in the stained cell bodies and dendrites of individual neurons of cultured slices, a circle or 
square was used to highlight the area of interest and the mean density was measured. An area 
in the cultured hippocampus with no cell bodies or dendrites was highlighted in order to 
measure the mean density of the background. Ten areas with cell bodies/dendrites were 
randomly measured in each region of the hippocampus and the same applied for 
measurement of the background. Therefore, ten values of the mean density were used per 
region of the cultured hippocampal slice. The number of slices per animal was 16 and the 
number of animals used was more than three. In order to avoid bias, the microscope settings 
were not altered until all the samples had been measured.
In western blot and IP, the bands were quantified also by using the “Image” software. A 
rectangle highlighted the band of interest and the mean density as well as the area of 
rectangle were measured. A rectangle of the same size was then used to measure the 
background over an area with no staining adjacent to the band.
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2.11 Statistics
For immunocytochemistry, the mean density of the background was subtracted from the 
mean density of the cell bodies/dendrites in order to obtain a specific staining of the cell 
bodies/dendrites. The mean for the ten random values (mean densities of cell 
bodies/dendrites) was calculated. Once the mean values of more than three slices were 
calculated, a mean and standard error of the means of these values were calculated using the 
Minitab statistical package.
The intensity of staining in drug-treated slices was expressed as a percentage of the staining 
in parallel vehicle-treated slices. The significance was determined using analysis of variance 
(ANOVA) with post hoc Fisher’s test for multiple pairwise comparison and one-sample 
Wilcoxon signed rank test using Minitab statistical program. The Wilcoxon signed rank test 
of the median was the preferred choice for determining the significance because the data was 
non-parametric. In analysis of a non-parametric data, there is no assumption of a specific 
distribution for the population.
In Western blot and IP, the product of mean density and area of rectangle for the bands was 
deducted from the product of its corresponding background, in order to obtain the specific 
integrated band intensity. The mean densities of phosphorylated Pyk2 and phosphorylated 
MAPK were expressed as the ratios of the corresponding Pyk2 (total) and (3-actin 
respectively. The ratio of drug-treated acute slices was then expressed as a percentage of 
ratios in parallel vehicle treated acute slices. The significance was determined using one-
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sample Wilcoxon signed rank test of the median using the Minitab statistical program. The 
data was considered significant if the P<0.05.
The histogram of the values for both the cultured and acute slices was derived using the 
Prism software (GraphPad Prism Project). The mean and standard error of mean of values as 
well as the ‘n’ number of experiments were used.
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Antibody Concentration/
Dilultions
Source Species Supplier Catalogue
Number
Monoclonal Anti- 
P-Actin
2.9pg/mL
(WB)
Hybridoma produced by fusion 
of mouse myeloma cells and 
splenocytes from immunized 
mouse
Mouse Sigma A5441
Anti-human
inliibin
beta/activin
1:1000,
(ICH)
Synthetic peptide corresponding 
to the 82-114 residues of Beta A 
subunit o f Human inhibin A and 
activin A
Mouse Serotec MCA950S
Anti calmodulin- 
dependent protein 
kinase II 
monoclonal
O.lpg/mL, 
(WB, ICH)
Partially purified rat CaMKII Mouse Chemicon
Intemation
al
MAB3119
Monoclonal anti- 
MAP2
3.9pg/mL, 
(WB, ICH)
Same as P-actin Mouse Sigma M4403
Pliospho-p44/42 
MAP kinase 
monoclonal 
antibody
1:1000,
(WB)
Mice immunized with synthetic 
phospho-Tlu'202 and phospho- 
Tyr204 peptide corresponding to 
residues Thr202/Tyr204 of 
human p44 MAP kinase
Mouse New
England
BioLabs
9106L
Pyk2/CAKP 25pg/mL,
(IP)
Generated from rat Pyk2 Mouse BD
Transducti
on
Laboraotii
es
610548
Polyclonal Anti- 
Pyk2 [pY'*®^ ] 
phosphospecific
0.5pg/mL,
(IB)
Chemically synthesized 
phospho-peptide derived from 
tire region of human Pyk2 that 
contains tyrosine 402
Rabbit Biosource
Internation
al
44-618
v-Src monoclonal 
antibody
1:1000,
(IB)
Immunizing BALB/c mice with 
purified Src protein and fusing 
with P3X63 Ag8.653 myeloma 
cells
Mouse Oncogene
research
products
OP07,
OP07L,
OP07A
Table 2.1; List of antibodies used in this study. Abbreviations: WB- western blot, IP- 
immunoprécipitation, ICH- immunocytochemistry, IB- immunoblot.
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Figure 2.1: Schematic image of the hippocampus showing the DG and hippocampus 
proper (i.e. CAl and CA3 regions). The bold lines across the hippocampus indicate 
the points of dissection of the CAl and CA3.
Methods
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Chapter 3 
Activation of Pyk2
3.1 Introduction
Proline rich tyrosine kinase (Pyk2), which is also referred to as cell-adhesion kinase p 
(CAKp), related adhesion focal kinase (RAFTK), Ca^^-dependent tyrosine kinase 
(CADTK), or focal adhesion kinase 2 (FAK2) (Herzog et al, 1996), is a non-receptor 
tyrosine kinase that has been implicated in LTP (O’Dell et al, 1991). Pyk2 belongs to 
a focal adhesion kinase family, which includes focal adliesion kinase (FAK). FAK 
and Pyk2 exhibit approximately 48% amino acid identity (65% similarity, i.e. high 
degree of sequence similarity). Both kinases exhibit a similar domain structure: a 
unique N-terminus, a centrally located protein tyrosine kinase domain and two 
pro line-rich regions at the C-terminus (Avraham et al, 2000), (Figure 3.5). Both 
tyrosine kinases are highly expressed in the CNS, but are thought to be differentially 
regulated by neurotransmitters and depolarisation (Siciliano et al, 1996).
There are two isoforms of Pyk2, the alternatively spliced (lacking 42 amino acids in 
the C-terminal region) isofoim (Dikic and Schlessinger, 1998) and the unspliced 
isoform known as Pyk2-related non-kinase (PRNK). PRNK appears to be 
predominant in the brain especially in the hippocampus (Xiong et al, 1998) and in 
fact Pyk2 expression was shown to be abundant in DG, and hippocampal proper (i.e. 
CAl and CA3) (Menegon et al, 1999).
■1;
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Reports have indicated that the unspliced Pyk2 is phosphorylated/activated by various 
stimuli, including raising intracellular Ca^ "^  (Siciliano et al, 1996) indirectly. 
Stimulation of PKC due to a rise in intracelluar Ca^ "*" levels is thought to cause direct 
activation of Pyk2 (Lev et al, 1995; MacDonald et al, 2001) via phosphorylation. 
Upon activation, Pyk2 autophosphorylates on tyrosine 402, resulting in a SH2 ligand, 
which then binds to SH2 domain of Src, thereby activating it (Dikic et al, 1996). 
Studies have shown an association between Pyk2 and Src (Huang et al, 2001). Lauri 
et al, 2000 indicated that high frequency stimulation (HFS) enhanced association 
between Src and Pyk2 in the CAl region of the hippocampus. Activation of Src by 
Pyk2 is thought to boost influx of Ca^ *^  through NMDARs and sets in motion the 
downstream cascade (Huang et al, 2001; Salter 1998). Huang et al, 2001, also 
showed that Pyk2 acts downstream of Src in the signalling cascade by which tyrosine 
phosphorylation enhances NMDA receptor function. Src is thought to produce its 
effect on NMDA by causing the phosphorylation of the tyrosine residue in NR2A and 
NR2B subunits (Moon et al, 1994).
PKC has been shown to be an upstream regulator of Pyk2 (Huang et al, 1999; Lu et 
al, 1999; Huang et al, 2001). PKC inhibitors and activators have been shown to 
inhibit or activate Ca '^*'-induced activation of Pyk2 (Siciliano et al, 1996). 
Chelerythrine and staurosporine, PKC inhibitors, have been used to study the effect of 
PKC on both induction and maintenance of LTP (Muller et al, 1992; Mathies et al, 
1991; Demiy et al, 1990; Grosshans and Browning 2001; Bortolotto and Collingridge 
2000). Staurosporine, a general kinase inhibitor, blocks conventional and novel PKCs, 
but not atypical PKCs such as PKM^. Chelerythrine, a highly selective PKC inhibitor, 
at low concentrations inhibits PKMÇ relative to conventional and novel PKCs (Ling et
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al, 2002). Ling et al (2002) proceeded to show that the maintenance of LTP in the 
hippocampus requires PKMÇ, by blocking expression of CAl LTP in low 
concentrations of chelerythrine. Atypical forms of PKC, such as PKM^ (Figure 3.6), 
are highly activated neither by DAG nor Ca^  ^directly compared to conventional PKC 
(refer to section 1.5.2). Naik et al, 2000, showed using immunoblots that PKM^ was 
located in the DG, CA3 and CAl.
Hence, evidence suggests that PKMÇ is particularly important for the expression of 
LTP at least in the CAl region, but it remains unclear whether PKMÇ is also involved 
in Pyk2 phosphorylation and activation. Equally, it is not clear if Pyk2 is involved in 
the plasticity in other areas of the hippocampus other than the CAl region. Although 
Pyk2 activation by stimuli that increases intracellular Ca^ '^  has been extensively 
investigated, very little work has been done on the possible regulation of Pyk2 by 
cAMP elevations.
The study aims to investigate the following:
(i) The time points at which the phosphorylation of Pyk2 reaches its maximal 
expression in the acute hippocampus using A23187, Ca^ "^  ionophore
(ii) The effects of A23187 on the phosphorylation of Pyk2 in CAl and CA3 sub- 
regions of the hippocampus
(iii) The effect of chelerythrine and staurosporine on the phosphorylation of Pyk2
(iv) The effect of forskolin on the phosphorylation of Pyk2
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3.2 Drug treatments
The methods used were in general as described in chapter 2 (Methods) with the 
following modifications: Once the slices had recovered in the gassed chamber for 2 
hours (Acute Slice preparation, section 2.2), chelerythrine (IpM) and staurosporine 
(lOOnM) were applied 30 minutes, prior to the activation of the acute slices for 10 
minutes with A23187.
After stimulation the slices were placed in an ice-cold RIPA buffer in order to stop the 
intracellular signalling. The CAl and CA3 sub-regions of the hippocampus were then 
dissected out (Figure 2.1, section 2.4). The tissue was then processed for 
immunoprécipitation as described (section 2.8)
3.3 Results
3.3.1 A23187 increases the phosphorylation of Pyk2 in acute 
hippocampai siice preparations
A23187 (5pM) increased phosphorylated Pyk2 levels significantly (*P<0.05, n=5) 
between 5 and 10 minutes by 23±12% and 34±9% (mean increase ± SEM) 
respectively (Figure 3.1a, upper panel and 3.1b). The levels of phosphorylated Pyk2, 
recovered back to basal levels within 20minutes (Figure 3.1b). The PVDF membrane 
was stripped twice. After the first strip, the blot was reprobed with an antibody against 
total Pyk2 (0.25pg/ml) and the results showed that equal concentrations of Pyk2
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protein were loaded into each well of the precast gel (Figure 3.1a, middle panel). 
Following a second stripping of the membrane blot, it was then reprobed with Src 
antibody (Oncogene, O.lpg/ml), Figure 3.1a (lower panel) and this indicated an 
association between Src and Pyk2. This data was representative of n=3. The Src was 
associated with all the different levels of phosphorylated Pyk2 (Figure 3.1c).
3.3.2 A23287 increases the phosphoryiation of Pyk2 in both CA1 and 
CA3 sub-regions of acute hippocampai slice preparations
In Figure 3.2a, upper panel and Figure 3.2b, the levels of phosphorylated Pyk2 were 
significantly elevated in the two sub-regions of the hippocampus, CAl and CA3 after 
A23187 treatment (*P<0.05). The mean levels of phosphorylated Pyk2 increased by 
30±11% in CAl and 83±35% in CA3. On stripping the blot and reprobing with an 
antibody against total Pyk2, equal concentrations of Pyk2 protein were detected in 
each lane of the precast gel (Figure 3.2a, lower panel).
3.3.3 Cheierythrine and Staurosporine reduce the phosphorylation of 
Pyk2 in acute hippocampai siice preparations
Basal levels of phosphorylated Pyk2 was not convincingly altered by chelerythrine 
(IpM) or by staurosporine (lOOnM) treatment, 91±2% and 81±11% respectively 
compared to non-treated vehicle (Figure 3.3a, upper panel, b, upper panel and c). In 
contrast, both chelerythrine (76±8% reduction, *P<0.05 compared to vehicle) and 
staurosporine (53±7% reduction) dramatically attenuated the A23187 induced
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increase in phosphorylated Pyk2 (154±12%, ~P<0.05 compared to vehicle). The blots 
were stripped and reprobed with antibody for Pyk2, and the results showed that equal 
Pyk2 concentrations were loaded into each well of the precast gel.
3.3. Forskolin inhibits the phosphoryiation of Pyk2 in acute hippocampal 
slice preparations
Expression of phosphorylated Pyk2 was significantly reduced (*P<0.05, n=5) by 
20±9when acute hippocampal slices were treated with forskolin (50pM). The levels 
of the phosphorylated Pyk2 seem to recover back to basal levels within 20 minutes. 
The significant reduction occurred after a 5 minute treatment of the slices with 
forskolin (Figure 3.4a, upper panel and Figure 3.4b). The membrane blot was stripped 
and reprobed with total Pyk2 antibody; the result indicated equal application of Pyk2 
protein into each well of the precast gel (Figure 3.4a, lower panel).
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Figure 3.1: Effect of A23187 (5|iM) on the phosphorylation of Pyk2 in an acute 
hippocampal slice preparation and association between Pyk2 and Src. 
Inununoprecipitation assay using anti-Pyk2 (total) and blotting with anti-Pyk2 
(phoshospecific) antiserum indicated a significant (*P<0.05 versus 100%, n=5, one- 
sample Wilcoxon signed rank test of the median) increase in the phosphorylation of ir 
Pyk2 between 5 and 10 minutes (figure a, upper panel and figure b). The blot was 
stripped twice, once to indicate that the levels of protein in each well of precast gel 
were of equal concentration (middle panel) and second to indicate an association 
between Pyk2 and Src (lower panel), figure a and c. Results are expressed as a 
percentage of the specific signal at t=0.
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Figure 3.2: Effect of A23187 (5pM) on the phosphorylation of Pyk2 in both CAl and 
CA3 acute slice preparations. Immunoprécipitation assay using anti-Pyk2 (total) and 
blotting with anti-Pyk2 (phoshospecific) anitserum indicated a significant increase in 
the levels of phosphorylated ir Pyk2 in both CAl (*P<0.05 versus 100%, n=5, one- 
sample Wilcoxon signed rank test of the median) and CA3 (*P<0.05 versus 100%, 
n=5, one-sample Wilcoxon signed rank test of the median), figure a and b, upper 
panel. The PVDF membrane was stripped and re-probed with total Pyk2 (figure a, 
lower panel), which indicated an equal concentration of proteins loaded into each well 
of precast gel. Results are expressed as a percentage of the specific signal at t=0.
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Figure 3.3: Effect of chelerythrine (IpM) and staurosporine (lOOnM) on the 
phosphorylation of ir Pyk2 in both A23187 (5pM) and vehicle-treated acute 
hippocampal slice preparations. Chelerythrine reduced phosphorylation of ir Pyk2 at 
basal level and significantly in the presence of A23187 (*P<0.05, n=5, one-sample 
Wilcoxon signed rank test of the median) in hippocampal slices while staurosporine 
did not have any significant effect on the basal phosphorylation of Pyk2, however it 
attenuated the A23187 effect (figure a and b, upper panel, and figure c). A23187 
significantly elevated phosphorylation of ir Pyk2 (~P<0.05 compared to vehicle, 
chelerythrine, staurosporine, n=5). Stripping and reprobing the PVDF membrane 
showed equal concentrations of Pyk2 in each well of the precast gel (figure a and b, 
lower panel. Results are expressed as a percentage of the specific signal, t=0. 
Abbreviations: chel- chelerythrine, stau- staurosporine, A23- A23187
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Figure 3.4: Effect of forskolin (50fiM) on the phosphorylation of Pyk2 in acute 
hippocampal slice preparations. Immunoprécipitation assay using anti-Pyk2 (total) 
and blotting with Pyk2 (phosphospecflc) antiserum indicated that the levels of 
phosphorylated ir Pyk2 were significantly reduced after 5minutes (*P<0.05 versus 
100%, n=5, one-sample Wilcoxon signed rank test of the median), figure a, upper 
panel and figure b. Stripping the blot and reprobing with total Pyk2 indicated that 
equal concentrations of the protein in each well of the precast gel. Results are 
expressed as a percentage of the specific signal at t=0.
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3.4 Discussion
Phosphospecific Pyk2 (Shi et al, 2000 and Keely et al., 2000), Pyk2 (Lev et al, 
1995; Dikic et al, 1996 and Sasaki et al,  1995), and Src (Bolen et al, 1984 and 
Cartwright et al, 1985) antibodies had all been previously characterised. Pyk2 was 
generated from rat Pyk2 and phosphospecific Pyk2 was chemically synthesised in a 
phospho-peptide derived from the region of human Pyk2 that contains tyrosine 402 
(Table 2.1). The Src antibody was obtained from BALB/c mice that have been 
immunised with purified Src protein. For each antibody, single bands were obtained. 
Using the rainbow marker, the band obtained when using Pyk2 antibody was 
approximately 116kDa while that for Src was around 60kDa, hence this supports 
claims of specificity.
The effect of vehicle treatment over time has not been tested and therefore it remains 
theoretically possible that effects due to addition of drug/vehicle, might not be due to 
the drug. However, this is very unlikely, since only small volumes of the dmgs were 
added; in addition forskolin and A23187 affects act in opposite directions, so it is 
unlikely to be due to vehicle.
3.4.1 A23187
The phosphorylation of Pyk2 was elevated significantly between 5 and 10 minutes by 
23% and 34% respectively on the application of A23187 (Lev et al, 1995; Wang and 
Brecher, 2001), a Ca^"^ionophore, on acute hippocampal slices (Figure 3.1). This
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suggested that Ca^  ^plays a role in the phosphorylation of tyrosine kinase, Pyk2. This 
is in agreement with previous studies which indicated elevation of phosphorylated 
Pyk2 levels for 15 minutes in PC 12 cells on application of 6pM A23187 (Lev et al., 
1995). In addition, studies had shown that Pyk2 could be activated by stimuli that 
increase intracellular Ca^  ^levels especially depolarisation (Siciliano et al, 1996) in 
the hippocampus.
The levels of Pyk2 seem to recover back to basal levels within 20 minutes, which 
could be due to the tyrosine phosphatases (PTPs). In fact PTPs had been shown to be 
highly expressed in the CNS and their inhibition potentiated NMDA cuinents (Wang 
and Salter, 1994).
Phosphorylation of Pyk2 reportedly resulted in the activation of Src (Lev et al, 1995; 
Girault et al, 1999; Ali and Salter, 2001) and the data obtained here indicated an 
association between Pyk2 and Src (Figure 3.1b) since Src was immunoprecipitated by 
Pyk2 antibody. Src had been shown to enhance the potentiation of NMDA receptors 
(Salter, 1998) via phosphorylation of tyrosine residue in NR2A subunit of NMDA 
receptor (Salter, 1998; Lau and Huganir, 1995) so it has been suggested that this 
interaction is crucial of the expression of LTP. However, the results reported here 
showed no evidence of increased association of Src with Pyk2 afEer Pyk2 activation. 
This raises the possibility there is no Src activation by Pyk2 after Ca^ "^  influx alone 
and that some other signalling pathway activates Src.
Previous studies have shown the expression of Pyk2 in DG and hippocampal proper 
(i.e. CA3 and CAl) (Menegon et al, 1999). But most of the electrophysiological
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studies on tyrosine kinases were carried out in the CAl region, looking at the role of 
Pyk2 in LTP (Huang and Hsu, 1999; Lauri et al, 2000). The data in this study showed 
that there was a significant elevation of phosphorylated Pyk2 levels in both CAl and 
CA3 on the application of A23187 for 10 minutes (Figure 3.2). The levels of 
phosphorylated Pyk2 were elevated by 31% and 83% in CAl and CA3 regions 
respectively. This might imply that the intracellular signalling in the CA3 was similar 
to CAl.
As already mentioned (section 1.6 and 1.8), LTP induction in Schaffer collaterals 
fibres in the CAl region is NMDAR dependent while the MF LTP in CA3 region is 
NMDAR independent, but both forms of LTP require calcium influx. Therefore, it is 
possible to suggest that although different forms of LTP are activated the CAl and 
CA3 regions of hippocampus, they still might share a common intracellular pathway.
3.4.2 Chelerythrine and Staurosporine
Pyk2 is reportedly stimulated by activation of protein kinase C (PKC) (Lev et al, 
1995; Siciliano et al, 1996). PKC had been shown to play an important role in LTP 
(Roberson et al, 1996a). PKM( ,^ a constitutively active form of an atypical PKC, has 
been shown to be necessary and sufficient for LTP maintenance in CAl region of the 
hippocampus (Ling et al, 2002) when using the PKC inhibitors, chelerythrine and 
staurosporine. Chelerytluine has been shown to block LTP maintenance at a dose of 
0.3pM (Bortolotto and Collingridge, 2000) while staurosporine blocks the induction 
(Muller et al, 1992). Staurosporine was less effective than chelerythrine in inhibiting
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the protein kinase activities of PKCÔ and PKM^ when compared to PKCa (McGlynn 
et al, 1992).
In this study, the role of these two PKC inhibitors on phosphorylation of Pyk2 in 
acute hippocampal slices was investigated. The concentrations used were those 
reported to confer specificity (Ling et al, 2002). Chelerythrine had minimal effect on 
basal levels of phosphorylated Pyk2 (9% reduction), however it attenuated effect of 
A23187 on phosphorylated Pyk2 (19% reduction) (Figure 3.3). Grosshans and 
Browning (2001) have previously used chelerythrine (lOpM) to block tyrosine 
phosphorylation (Src phosphorylation) and obseiwed a reduction of 12%. These 
results might suggest that endogenous phosphorylated Pyk2 was regulated by PKMÇ, 
since application of PKMif^  selective inhibitor, chelerythrine, resulted in reduced 
phosphorylation of Pyk2. Since a similar dose of chelerythrine blocks LTP 
maintenance it can be suggested that phosphorylated Pyk2 might play a role in the 
maintenance of synaptic plasticity.
Since the reductions in the levels of activated Pyk2 were in the whole hippocampus, it 
seems logical to assume that signalling in the three regions of the hippocampus was 
similar although this has not been shown. Also it was already suggested in this study 
that the intracellular* signalling in CAl and CA3 regions were similar in case of Pyk2 
phosphorylation. Staurosporine did not have any effect on the basal phosphorylated 
levels of Pyk2. This indicates that the basal levels of phosphorylated Pyk2 are 
maintained independently of a general PKC inhibitor, staurosporine. However, as 
with chelerythrine, staurosporine completely blocked the ability of A23187 to elevate 
Pyk2 phosphorylation (Figure 3.3). This suggests that other form of neuronal PKC
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and PKMÇ are both required for Pyk2 activation after Ca^ "^  influx. Previous studies 
have shown that the use of different general PKC inhibitors, R 031-8220 and 
GF109203X, resulted in the inhibition of Pyk2 phosphorylation in the hippocampus 
(Siciliano et al, 1996).
3.4.3 Forskolin
The levels of phosphorylated Pyk2 were significantly attenuated (Figure 3.4) when 
forskolin was applied to acute hippocampal slices. The reduction (21%) occurred 5 
minutes after the application of forskolin. Forskolin, a diterpene, directly activates 
adenlyate cyclase (Seaman and Daly, 1986) producing cAMP and the subsequent 
activation ofPKA. This might indicate that, elevation of cAMP and activation of 
PKA have a negative effect on Pyk2, which results in reduced phosphorylation of 
Pyk2 targeted proteins. Studies by Derkindem et al (1996) showed that the level of 
phosphorylation of FAK, a member of non-receptor tyrosine express in the neurons, 
were elevated via anadamide (an endogenous ligand for central caimabinoid) release 
due to depolarisation (Figure 3.7). This ligand inhibited adenylate cyclase thus 
reducing the levels of cAMP. Hence inhibition of adenylate cyclase might have a 
positive effect on Pyk2 (i.e. cause phosphorylation of Pyk2) similar to the effect on 
FAK (Figure 3.7).
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3.4.4 Summary
Therefore this data had shown the following:
(i) Intracellular increase in Ca^  ^between 5 and 10 minutes played a role in the 
increased phosphorylation of Pyk2 in the acute hippocampus
(ii) The intracellular signalling pathway regulating Pyk2 in the CA3 sub-region of 
acute hippocampus is similar to the CAl
(iii) Concentration of chelerythrine and staurosporine that reportedly inhibit PKMÇ 
and novel PKC respectively both reduced A23187-induced phosphorylation of 
Pyk2 in acute hippocampal slices suggesting that parallel PKC pathways may be 
involved in Pyk2 activation
(iv) Elevation of cAMP levels reduced the phosphorylation of Pyk2 and this might 
be the first evidence for a cAMP-activated pathway suppressing Pyk2, analogous 
to that proposed for FAK
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Figure 3.5: Schematic presentation of homology comparison of the N-terminus, 
kinase domain and C-terminus between Pyk2 and FAK. (Adapted from Avraham et 
al, 2000)
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Figure 3.6: Schematic diagram of the major domains of conventional (a, pi, pll and 
Y), novel (Ô, 0, Tj and s), and atypical (Ç and i) PKC Adapted from Naik et al, 2000. 
The independent catalytic domain of PKC is the PKM.
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Figure 3.7: Schematic diagram indicating the intracellular signalling that regulate the 
non-receptor tyrosine kinases, Pyk2, Src and FAK'*' in rat hippocampal slices 
(Adapted from Girault et al, 1999). A raise in intracellular Ca^ '*' results in the 
activation of Pyk2 via activation of PKC. FAK is also activated by PKC as well as by 
camiabinoid CBi-receptor agonists such as anadamide. The available evidence 
suggests that the following might occur. Pyk2 interacts with Src and leads to the 
formation of multiprotein complexes which activates various signalling pathways 
including MAPK/ERK (mitogen-activated protein kinase/ extracelluar-signal 
regulated kinase) pathway. Src is also capable of phosphorylating receptors and 
cytoskeletal proteins. These pathways provide a possible mechanism for regulating 
synaptic plasticity. Abbreviation: inhibition.
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Chapter 4 
Activation of MAPK
4.1 introduction
There has been an increasing interest on the role of MAPKs in the regulation of neuronal 
functions. MAPKs have been shown to play a vital function in the signalling pathways 
associated with activity dependent regulation of neuronal function. A number of studies 
have identified novel pathways that include the incorporation of second-messenger 
systems such as cAMP/PKA and DAG in the regulation of MAPK signalling (Sweatt, 
2001).
MAPKs (p44 and p42) are expressed in abundance in post-mitotic neurons of the 
developed nervous system. Fiore et al (1993) have shown the expression of MAPK in 
the dendrites and somas of pyramidal cells of the hippocampus with little to no staining 
in the non-pyramidal cells. Hence activation of MAPK (especially p42) detected in 
assays would most likely occur in pyramidal neurons (English and Sweat, 1996).
In the CAl region, the cAMP pathway has been shown to utilise the MAPK cascade as 
an obligatory intermediate in regulating CREB (cAMP-response element binding 
protein), a constitutive transcription factor (Sweatt, 2001) (refer to PKA section), hnpey 
et al (1998) demonstrated CREB phosphorylation in area CAl in response to LTP- 
inducing stimulation, an effect that was blocked by MAPK inliibition. In CAl
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hippocampal region, activation of cAMP cascade led to a PKA activation of MAPK 
(Martin et al, 1997; Roberson et al, 1999).
MAPK activation has been shown to play a critical role in LTP induction. Studies have 
initially focused on NMD A receptor-dependent LTP in area CAl, using hippocampal 
slices in vitro (English and Sweatt, 1996, 1997; Atkins et al, 1998; Impey et al, 1998; 
Winder et al, 1999). MAPK activation was also shown to be necessary in NMDA 
receptor-independent LTP (Coogan et al, 1999), LTP in DG in vitro (Coogan et al, 
1999), and LTP in vivo (McGahon et al 1999; Davis et al, 2000). Use of MEK 
inliibitors, which blocked activation of ERKs, blocked L-LTP, indicating the importance 
of MAPK activation in L-LTP (English and Sweatt, 1996, 1997; hnpey et al, 1998). This 
effect was not restricted to L-LTP, as E-LTP was also reduced (Sweatt, 2001).
Upon activation after LTP-inducing stimulation, a fraction of MAPK translocates from 
the cytosol into the nucleus (Davis et al, 2000) where it is thought to alter gene 
expression by transcriptional control (Impey et al, 1998). CREB phosphorylation is an 
end product of activation of MAPK, which has been shown to play a role in gene 
expression (Roberson et al, 1999) in the CAl region.
The aim of this study was to investigate the effects of Ca^ '*’ influx and cAMP elevation on 
the activation of p42 MAPK in the CAl and CA3 sub-regions of acute hippocampal 
slices using western blot techniques (section 3.9).
89
Activation of MAPK
4.2 Results
Two bands (one for p42 MAPK and second for p44 MAPK) were usually detected when 
using the phosphospecific MAPK antiserum, but low MW (42KDa) was frequently 
detectable in this investigation.
4.2. A23187 increases phosphorylation of p42 MAPK
The levels of the phosphorylated p42 MAPK appeared elevated in the presence of 5p,M 
A23187 in acute hippocampal slice preparations. The levels appeared elevated after 10 
minute (164+36% of vehicle treated slices, n=4) stimulation of the hippocampal slices 
and were still appeared elevated after 20 minutes (150±48% of vehicle treated slices, 
11=4) stimulation (Figure 4.1a, upper panel). However, these effects did not reach 
statistical significance.
On reprobing of the PVDF membrane with p-actin, the concentration of proteins in each 
well of the precast gel were found to be of equal concentrations (Figure 4.1a, lower 
panel).
4.2.2 Forskolin increases phosphorylation of p42 MAPK
On application of forskolin (50pM), the levels of phosphorylation of p42 MAPK were 
significantly elevated (*P<0.05 versus 100% of vehicle-treated slices) in acute
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hippocampal slices (Figure 4.2a, upper panel). The levels were prominent after 5 
(165±9% of vehicle treated slices), 10 (172±30% of vehicle treated slices) and 20 
minutes (149±21% of vehicle treated slices) after stimulation of the whole hippocampal 
slice.
The blot was then stripped and reprobed with anti-P-actin antiserum (as an internal 
standard) (Figure 4,2a, lower panel).
4.2.3 A23187 and forskolin increase phosphorylation p42 MAPK in CA1 but 
not CA3 sub-regions of the hippocampus
A23187 (5pM) significantly increased the phosphorylation of p42 MAPK in the CAl 
region after 10 minutes (*P<0.05, 194+37% of vehicle treated slices) but had no effect on 
the phosphorylation of p42 MAPK in the CA3 (P>0.05,116+26% of vehicle treated 
slices) in acute hippocampal slice preparations (Figure 4.3a, upper panel and Figure 
4.3b).
Forskolin (50pM) also significantly increased the phosphorylation of p42 MAPK in the 
CAl region of the hippocampus (*P<0.05, 181±61% of vehicle treated slices) but had no 
effect on the phosphorylation of p42 MAPK in the CA3 sub-region (P>0.05, 78+10% of 
vehicle treated slices) (Figure 4.3a, upper panel and Figure 4.3b). The blot was then 
stripped and reprobed with anti-(3-actin, which was used as an internal standard (Figure 
4.3a, lower panel.
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Figure 4.1: Effect of A23817 (5pM) on the phosphorylation of p42 MAPK in acute 
hippocampal slices. Western blot analysis using anti-MAPK (phosphospecific) 
indicated an increase in the phosphorylation of p42 MAPK isoform, between 10 and 
20 minutes. However, the increase did not reach statistical significance (P>0.05) 
(figure a, upper panel and figure b). The histogram and error bars represent the mean 
and SEM respectively. Stripping and reprobing of the PVDF membrane with p-actin 
shows equal concentrations of protein in each well of precast gel (figure a, lower 
panel). n=4
Abbreviations: SEM- standard error of the mean.
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Figure 4.2: Effect of forskolin (50|iM) on the phosphorylation of p42 MAPK in acute 
hippocampal slices. Western blot assay using anti-MAPK (phosphospecific) 
antiserum indicated a significant increase in the phosphorylation of p42 MAPK 
isofoim between 5 and 20 minutes (*P<0.05 versus 100%, n=4, one-sample Wilcoxon 
signed rank test of the median) (figure a, upper panel and figure b). The histogram 
and error bars represent the mean and SEM respectively. The blot was then strip and 
reprobed with anti-p-action antiserum (figure a, lower panel).
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Figure 4.3: Effect of A23187 (5p,M) and forskolin (50pM) on the phosphorylation of 
p42 MAPK in the CAl and CA3 sub-regions of acute hippocampal slices. Western 
blot analysis using anti-MAPK (phosphospecific) antiserum indicated a significant 
increase in the phosphorylation of p42 MAPK isoform in the CAl region (*P<0.05 
versus 100%, n=4, one-sample Wilcoxon signed rank test of the median) after 10 
minute stimulation with either A23187 or forskolin (figure a, upper panel and figure 
b). However, A23187 or forskolin had no effect on the phosphorylation of p42 MAPK 
isoform in the CA3 region (P>0.05, n=4) (figure a, upper panel and figure b). The blot 
was stripped and reprobed with anti-p-actin anti-serum (figure a, lower panel). 
Abbreviations: mins- minutes.
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4.3 Discussions
Phospho-p44/42 MAPK antibody (Marshall et al, 1995; Kang et al, 2001) and p-actin 
antibody (North et al, 1993) had previously been characterised, and are highly specific 
for their respective antigen. Phospho-p44/42 MAPK antibody recognises the doubly 
phosphorylated threonine 202 and tyrosine 204 of p44 and p42 MAPK respectively; 
while the monoclonal p-actin antibody detects an epitope located on the N-terminal end 
of p-isoform of actin (Table 2.1).
4.3.1 A23187
The relative weak signal obtained for p44 MAPK precludes any study of its regulation by 
A23187 and forskolin. Clearly, p42 MAPK is the predominant phosphorylated species in 
the hippocampus, a result consistent with previous reports (English and Sweatt, 1996,
1997). The levels of phosphorylated p42 MAPK were elevated in the presence of 5pM 
A23187, a Ca^ "*" ionophore. The elevations occurred between 10 and 20 minutes (Figure 
4.1), but were not significant (P=0.1 for both time points). The study was carried out on 
acute hippocampal slices while most of the studies on the activation of p42 MAPK were 
performed on the CAl (English and Sweatt, 1996, 1997) and DG (Coogan et al, 1999) 
regions of the hippocampus. The MAPK cascade has been shown to be necessary for the 
NMDA receptor-dependent LTP in area CAl (English and Sweat, 1997; Atkins et al,
1998) and the DG (Coogan et al,  1999) of the hippocampus. Hence, the Ca^’*’ ionophore 
would be predicted to elevate the levels of p42 MAPK in the area CAl and DG. The
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effects of A23187 has not been previously investigated in the CA3 sub-region also. Stage 
two of the study was to investigate the effect of Ca^  ^influx in both the CAl and CA3 
sub-regions of the hippocampus. A23187 elevated the phosphorylation of p42 MAPK in 
the CAl region while phosphorylation of p42 MAPK in the area CA3 was not affected. 
Hence, the lack of effect of A23187 on the phosphorylation of p42 MAPK in CA3 sub- 
region might explain the insignificant effect of the Ca^ "*" influx on the whole 
hippocampus.
In the CAl area, Ca^ '*' influx was thought to cause activation of p42 MAPK via activation 
of PKC (English and Sweat, 1996). Therefore, an increase in intracellular Ca^”*" was 
thought to activate MAPK via the Ca^^-PKC-Ras/Rafl -MEK-MAPK cascade (Figure 
4.4). In the CA3 sub-region of the hippocampus, the regulation of p42 MAPK might 
follow a different pathway. Kanterewicz et al (2000) had shown using MEK inhibitors 
that MF-LTP in area CA3 does not require MAPK signalling while LTP in CAl region 
requires MAPK signalling. These results support the concept of a differential role for 
MAPK in the response to Ca^ '*' influx in the CAl and CA3 regions.
4.3.2 Forskolin
In a second series of studies, the effect of adenylate cyclase activator, forskolin (50pM) 
on p42 MAPK activation was investigated. Forskolin caused an increased 
phosphorylation of p42 MAPK between 5 and 20 minutes (Figure 4.2). As with Ca^ "*" 
influx, cAMP elevations were studied mostly in the CAl sub-regions (Roberson et al,
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1999) of the hippocampus. In contrast, the effect of p42 MAPK activation in the CA3 
sub-region remains largely unknown. Forskolin significantly elevated the 
phosphorylation of p42 MAPK in the CAl region while the levels of p42 MAPK in area 
CA3 were unaffected (Figure 4.3). Forskolin induced activation of the PKA signalling 
cascade has been shown to be coupled to activation of p42/p44 MAPK in the CAl sub- 
region (Roberson et a l,  1999). Hence cAMP was thought to produce its effect on MAPK 
via the PKA/Rap 1 -B/Raf-MEK/MAPK cascade. In area CA3, forskolin at a concentration 
sufficient to induce MF LTP (Weisskopf et al, 1994) did not seem to have any effect on 
the phosphorylation of p42 MAPK, again suggesting an alternative pathway to the CAl 
sub-region. Kanterewicz et al (2000) showed that MAPK signalling cascade was not 
necessary for the forskolin-induced potentiation of mossy fibre synapses and hence 
suggested that activation of p42/p44 MAPK is not necessary for induction of MF LTP. 
Clearly there is substantial expression of MAPK in the CA3 region, yet it is not activated 
either by Ca^  ^or cAMP stimulation. The stimuli that cause MAPK activation in the CA3 
region remain to be identified.
4.3.3 Summary
The present data complements previous studies carried out by Kanterewicz et al (2000) 
in the CA3 region of the hippocampus. In summary, PKA and PKC coupled activation of 
p42 MAPK was not essential in the CA3. Thus activation of any effectors (such as 
CREB) of p42 MAPK in the CA3 may occur through an alternative pathway.
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Figure 4.4: Upstream regulators and downstream effectors of MAPK cascade 
(Adapted from Sweat 2001). There are two pathways by which MAPK is activated; 
the PKC-Rafl-MEK-MAPK signalling and the PKA-B-Raf-MEK signalling. 
Downstream effects of MAPK activation include gene expression, via activation of 
CREB, ion channel activation, and protein synthesis. Abbreviations: AC, adenylate 
cyclase; CREB, cAMP respond element binding protein; GFR, growth factor receptor 
tyrosine kinase; PKC, protein kinase C, PKA; cAMP-dependent protein kinase; SOS, 
son of sevenless.
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Chapter 5 
Expression of aCaMKII
5.1 Introduction
Induction of LTP in the CAl and DG regions of the hippocampus is dependent on 
activation of NMDA class of glutamate receptors while in the CA3 region; it is primarily 
dependent on increased cAMP levels (Collingridge and Bliss, 1993). LTP as already 
mentioned (General Introduction) is divided into three temporal phases - early (dependent 
on covalent modification of pre-existing proteins), intermediate and late phase 
(dependent on both transcription and translation). LTP2 appears between 1-6 hours after 
initial stimulation, depending on the experimental model, is dependent on mRNA 
translation and de novo protein synthesis but independent of gene transcription (Abraham 
et al., 1993). Thus, it will be of interest to identify the proteins which are synthesised at 
this time in response to stimulation and the mechanisms which regulate their expression.
In the CNS few mRNA species have been detected in the dendrites as most are restricted 
to the cell body. mRNA species located in the dendrites are in close proximity to the 
afferent synapses and therefore are in a position to be affected rapidly by synaptic 
activity. These plasticity-like dendritic mRNAs include aCaMKII mRNA (Thomas et a l , 
1994; L.A Roberts, e ta l ,  1996).
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CaMKII is present in high levels in the forebrain and cerebellum where it makes up -2% 
of the total protein in the hippocampus. The kinase can be visualised in the cytosol of 
neuronal cell bodies (Erondu and Kennedy, 1985; Apperson et al, 1996).
Biochemical studies have shown that persistent activation of CaMKII occurs during LTP 
and mediates persistent phosphorylation of GluRl (Barria et al, 1997; Fukunaga et al, 
1993; 1995; Lee et al, 2000), implicating CaMKII in LTP maintenance. Maintenance of 
LTP has been shown by several groups to require de novo protein synthesis (Fazeli et al, 
1993; Frey e/a/., 1989; Krug <3/., 1984),
A number of studies have reported increased levels of aCaMKII after LTP induction. 
Most of the studies on the effect of synaptic stimulation on the levels of aCaMKII mRNA 
(L.A. Roberts et al, 1996, 1998) and hence the corresponding aCaMKII protein have 
been carried out in the CAl region (Ouyang et al, 1999) and the DG (Steward and 
Halpain, 1999). Therefore it is not clear whether increased aCaMKII expression is also a 
feature of LTP in the CA3 region, where Ca^  ^influx is relatively less important for 
plasticity. Equally, the signalling pathways involved in the induction of aCaMKII mRNA 
following high frequency stimulation are unclear. Therefore in these studies, the effect of 
stimulation, using A23187 (a calcium ionophore) and forskolin (an adenlyate cyclase 
activator), on the levels of aCaMKII mRNA have been investigated, since Ca^  ^and 
cAMP are major effectors of NMDA receptor activation.
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In addition the effect of rapamycin, a protein synthesis inhibitor, on the expression of 
aCaMKII in both stimulated and non-stimulated organotypic slices was investigated. The 
major target for rapamycin in cells is FRAP or mTOR (Brown and Schreiber, 1996). 
Activation of mTOR leads to phosphorylation of the ribosomal protein, S6, resulting in 
increased translation (Jefferies et al, 1997; Peterson and Schreiber, 1998). Therefore, the 
study aimed to investigate a possible role for mTOR in the regulation of aCaMKII 
expression.
5.2 Results
5.2.1 A23187 but not forskolin increases the expression of aCaMKII on 
hippocampal organotypic slice culture preparations
Neurons in all the sub-regions of the hippocampus were stained with aCaMKII antibody; 
this staining was prominent in the soma and dendrites (Figure 5.1). Application of 5pM 
A23187 resulted in a significant increase in the intensity of staining of aCaMKII in the 
cell bodies (*P<0.05 versus vehicle-100%, n-15. Figure 5.2d, e and f, 5.3a) of 
hippocampal formation i.e. DG, CA3 and CAl with no significant difference in the 
expression of aCaMKII between the sub-regions (One way ANOVA with post hoc Fisher 
test, P=0.71). A significant increase in staining intensity of aCaMKII also occurred in the 
dendrites (Apical dendrites) of DG, CA3 and CAl (*P<0.05 versus vehicle-100%, n=10, 
Figure 5.2d, e and f, 5.4b) upon application of 5pM A23187. Similar to cell bodies, there
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was no significant difference in the expression of aCaMKII between hippocampal sub- 
regions.
In contrast 50|rM forskolin (Huang et al, 1994) had no significant effect on the 
expression of aCaMKII in both the soma and dendrites of all the sub-regions of the 
organotypic hippocampal slice culture (Figure 5.3 and 5.4).
5.2.2 Rapamycin had no effect on the expression of aCAMKif in both 
vehicle-treated and A23187-treated organotypic slice preparation
Hippocampal slice cultures were pre-treated with rapamycin for 30 minutes before being 
stimulated with A23187 (5fxM) for 4 hours. In the cell bodies the expression of aCaMKII 
was not significantly affected by pre-treatment of hippocampal slices with 20nM 
rapamycin (Khan et al,  2001; Jefferies et al, 1997) (P>0.05, n=4, Figure 5.5), but 
A23187 significantly increased the intensity of staining of aCAMKII in both vehicle- 
treated and rapamycin pre-treated slices (+P<0.05 versus corresponding region after pre­
treatment alone-ANOVA with post hoc, Fisher’s test) (Figure 5.5). These increases 
occuiTed in the DG, CA3 and CA l. Similar to the cell bodies, pre-treatment of 
hippocampal slices with rapamycin (20nM) had no significant effect on the expression of 
aCAMKII (+P<0.05 versus corresponding region after pre-treatment alone-ANOVA with 
post hoc, Fisher’s test) (Figure 5.6) in the dendrites. The intensity of staining of 
aCAMKII was significantly increased by A23187 in the dendrites (Figure 5.6) of the 
CA3 and CAl.
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5.2.3 Western blot analysis shows A23187 but not forskolin increased 
expression of aCaMKII
A23187 (5pM) appeared to increase the expression of aCaMKII in organotypic 
hippocampal slice preparations as assessed by western blotting (Figure 5.7a, upper panel 
and Figure 5.7b). The levels of expression appeared to be increased after 4 hour treatment 
(110±10 of vehicle treated slices, n=4). However, these effects did not reach statistical 
significance. Forskolin (5gM) did not have any effect on the expression of aCaMKII after 
4 hour treatment of organotypic slices as assessed by western blotting.
On reprobing of the PVDF membrane with an antibody to detect (3-actin, the levels of P- 
actin in each pair of control and treatment well of the precast gel were found to be of 
equal concentration (Figure 5.7a, lower panel).
5.2.4 Tetanus induced LIP  elevates the expression of aCaMKII in the CA1 
sub-region of acute hippocampal slice preparations
Acute hippocampal slices undeiwent three tetanic stimulations in stratum radiatum in the 
CAl region, followed by a signal stimulus every 30 seconds for 2.5 hours or 3.5 hours 
(Appendix, Figure 1 and 2). The CAl was then removed, and prepared for Western blot 
analysis. The analysis showed that the expression of aCaMKII appeared to be elevated in 
expression after 3.5 hours (153±15% of vehicle-100%, n-3) (Figure 5.8). Nevertheless, 
these effects did not reach statistical significance.
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Figure 5.1: Image of organotypic slice culture. The image shows the hippocampal 
fonnation, DG, CA3 and CAl. The slice has undergone no drug treatment and has 
been stained to reveal immunoreactivity for aCaMKII. Scale bar: 0.4mm
Expression of aCaMKII
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Figure 5.2: Effect of A23187 (5pM) on the expression of aCaMKII in cultured 
hippocampal neurons. Organotypic hippocampal neurons were stained to reveal 
immunoreactivity for aCaMKII in DG (a, d), CA3 (b, e) and CAl (c, f). Organotypic 
slice cultures were treated 4 hours prior to fixation with either vehicle (a, b and c) or 
A23187 (d, e and f). Note that A23187 increased the staining intensity of aCaMKII in 
both the cell soma and dendrites of all the hippocampal regions. Arrow head indicates 
the dendrites (apical dendrites); and the arrows show the somata. Scale bar: 20jam for 
CAl and CA3, 12-15pm for DG
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Figure 5.3: Effect of forskolin (50pM) and A23187 (5pM) on the expression of 
aCaMKII in the soma (a) and apical dendrites (b) of cells of organotypic hippocampal 
slices cultures. Immunocytochemistry analysis using anti-aCAMKII antiserum 
indicated a significant increase (*P<0.05 versus vehicle in the same region-100%, 
one-sample Wilcoxon signed rank test for the median) in the staining intensity of 
aCaMKII in the presence of A23187 in all the three regions of the hippocampus, DG, 
CA3 and CA l. Forskolin had no significant effect on the three regions of the 
hippocampus (P>0.05)
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Figure 5.4: Effect of rapamycin (20nM) on the expression of aCaMKII in both 
vehicle-treated and A23187-treated (5pM) soma (a) and apical dendrites (b) of cells in 
organotypic hippocampal slice cultures. The staining intensity levels of aCaMKII in 
the presence of A23187 were significantly increased in all three regions of the 
hippocampus in both vehicle and rapamycin pre-treated slices (*P<0.05 versus 
coiTesponding region after vehicle treatment in the absence of rapamycin). The 
intensity of staining of aCaMKII in presence of rapamycin/A23187 was significantly 
increased in all thiee regions of the hippocampus (+P<0.05 versus corresponding 
region after rapamycin pre-treatment alone -  ANOVA with post hoc Fisher’s test, 
F=2.15)
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Figure 5.5: Western blot analysis of the effect of forskolin (50pM) and A23187 
(5pM) on the expression of aCaMKII in organotypic hippocampal slice culture. 
Western blot analysis using anti-aCaMKII anti serum indicated no significant change 
in the levels of aCaMKII in the presence of A23187 (109.58±9.66% of the vehicle- 
100%, n=4, P>0.05, one sample Wilcoxon signed rank test for median) or forskolin 
(86.30±11.80%, n=4, P>0.05 one sample Wilcoxon signed rank test for median), 
figure a, upper panel and figure b. The PVDF membrane was stripped and reprobed 
with antibody that detects p-actin (figure, a, lower panel). Abbreviations: C- Control, 
A- A23187, F- Forskolin
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Figure 5.6: Effect of LTP on the expression of aCaMKII in acute hippocampal slices. 
Western blot assay using anti-aCaMKII antiserum indicated an increased in the levels 
of aCaMKII after 2.5 hours (111±18, n=3, P>0.05 versus 100%, one-sample 
Wilcoxon signed rank test of the median) and 3.5 hours (153±15, n=3, P>0.05 versus 
100%, one sample Wilcoxon signed rank test of the median).
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5.3 Discussion
Characterisation of aCaMKII antibody had been previously reported (McKee et al, 1990; 
Erondu et al, 1985; Kennedy et a l,  1983; Hendry et al, 1986). The antibody was shown 
to identify the purified alpha subunit of CaMKII in rats and to identify a single band of 
identical molecular weight in gels of rat brain homogenate. In protocols used in these 
studies, omission of the primary antibody eliminated immunostaining completely, 
aCaMKII is the major protein found in postsynaptic densities and constitutes some 2% of 
total hippocampal protein (Erondu et al., 1985; Kelly et al, 1984).
A variety of different experimental approaches have revealed the importance of CaMKII 
for the expression of synaptic plasticity in the hippocampus (Barria et al,  1997;
Fukunaga and Miyamoto, 2000). Increased levels of aCaMKII in the hippocampal CAl 
nemons ai'e sufficient to result in a sustained increase in the efficiency of afferent 
synapses (Pettit et al, 1994)
5.3.1 A23187
Results of these studies showed that an increase in the influx of Ca^”^, using 5juM A23187, 
led to a significant increase in the staining intensity of aCaMKII in somas of DG (15 
±7% increase), CA3 (23±6% increase) and CAl (18±5% increase), sub-regions of the 
hippocampus (Figure 5.2 and 5.3a). Ca^ "^  influx also increased aCaMKII immunostaining 
in dendrites (apical dendrites) of DG (18±3 % increase), CA3 (13±2% increase) and CAl
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(10±4% increase) (Figure 5.2 and 5.3b). This suggests that an increase in intracellular 
concentration of Ca^  ^plays an important role in the expression of aCaMKII in both soma 
and apical dendrites of hippocampal sub-regions. This is the first time increased 
immimostaining of aCaMKII had been shown to be elevated in both soma and dendrites 
of CAB sub-region. These results might suggest that the intracellular signalling in the 
CAB region is similar to the CAl and DG regions. As with the DG and CAl regions, 
aCaMKII mRNA is present in the dendrites of CAB pyramidal cells. This may suggest 
that aCaMKII plays a similar role in relation to plasticity in the CAB region. Previous 
data had shown that the aCaMKII mRNA levels are elevated following plasticity in the 
cell bodies and dendrites in the DG (Johnston and Morris, 1995) and CAl (Roberts et al, 
1996; Ouyang et al, 1997; Ouyang et al, 1999), but no similar changes in aCaMKII 
mRNA in the CA3 region has been reported. Since, increased synthesis of proteins 
requires mRNA, it can be assumed that mRNA levels will also be distributed in both the 
soma and dendrites of CA3 region of the hippocampus.
Maintenance of LTP is said to be dependent on de novo protein synthesis (Krug et al, 
1984; Barzilai et al, 1989; Bliss and Collingridge, 1993; Huang et al,  1994; Frey et al, 
1996), but LTP2, which lasts up to 4 hours after initial induction (Abraham et al, 1993), 
is not dependent on de novo mRNA synthesis (Otani et al,  1989; Bliss and Collingridge, 
1993). This is reported to be true for the CAB region as well as the intensively studied 
DG and CAl. Therefore the increased aCaMKII expression detected here is consistent 
with aCaMKII playing a role in LTP maintenance. And, in dendrites the increased 
immunostaining of aCaMKII might be due to localised mRNA which regulates the
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synthesis of the aCaMKII (Morris, 1997) while in the soma increase aCaMKII 
expression can be attributed to mRNA elevation in the somata. This process of aCaMKII 
synthesis from dendritic and somata mRNA seems to be applicable to the CA3 region as 
well as the other hippocampal areas. Thus the aCaMKII synthesised from pre-existing 
aCaMKII mRNA in the CA3, might be required for the maintenance of LTP during 
LTP2.
One possible mechanism by which Ca^ "^  influx stimulates aCaMKII synthesis is via 
phosphorylation of CPEB protein, which is present in the hippocampal dendrites (Wu et 
al, 1998). Wu et al, (1998) provided evidence that binding of CPEB protein to CPE 
sites located in the 3’-end of the RNA message for aCaMKII can stimulate its translation 
rate. CPEB is responsible for cytoplasmic polyadenylation-induced translation. The same 
method of Ca^ "^  stimulation of hippocampal dendrites might also be applicable to the 
somas, since CPEB is distributed in the hippocampal neurons (Wu et al., 1998).
5.3.2 Forskolin
Elevation of cAMP levels using forskolin (50pM, adenylate cyclase activator) did not 
seem to elevate the levels of aCaMKII in either the soma or dendrites of DG, CAl or 
CA3 (Figure 5.2 and 5.3a, b). Studies have shown that cAMP is required for Mossy fibre 
LTP in the CA3 region (Weisskopf et al,  1994; Huang et al, 1994), but this requirement 
for LTP is achieved via activation of Ca^ *^  sensitive-type I adenylate cyclase 
(neurospecific) and results in activation of PKA (Villacres et al, 1998). These results
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suggest that while elevated cAMP is required to initiate LTP in the CA3 region, it is not 
sufficient to induce elevated aCaMKII expression.
Western blot analysis suggested that an increase in Ca^  ^influx might slightly elevate 
aCaMKII in the organotypic hippocampal slices (Figure 5.5a, upper panel and Figure 
5.5b), however these results did not reach statistical significance. An elevation would be 
expected as a result of stimulation of all the three regions of the hippocampus since 
immunocytochemistry results indicate an elevation in DG, CA3 and CAl regions. The 
lack of a significant change (P=0.091) suggests western analysis may be less sensitive 
than immunocytochemistry for detecting changes, or may reflect the smaller number of 
replicates in this experiment.
5.3.3 LTP induction
Studies were also carried out on acute hippocampal slices to investigate the effect of LTP 
on the expression of aCaMKII. The CAl region of the hippocampal slices was assayed 
2.5 and 3.5 hours after LTP induction, and the results appear to show an increase in the 
expression of aCaMKII after 3.5 hours. However, the data did not reach statistical 
significance (Figure 5.6). The levels of aCaMKII appeared to be more elevated after 3.5 
hours (53 ±15% increase) compared to 2.5 hours (10±17% increase). Since the 
immunocytochemistry results suggested a similar intracellular signalling in all three 
regions of the hippocampus, it can be proposed that the elevations resulting from LTP
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induction might also be applicable to CA3 region. The lack of statistical significance 
probably reflects the small number of replicates in this experiment.
These results are consistent with the general hypothesis that CaMKII is a target for 
calcium influx through activated NMDA receptors (Kennedy et al,  1983; Kennedy,
1989; L.A. Roberts et al, 1996), and in the CA3 region, there is evidence that Ca^  ^influx 
contributes to MF LTP (Weisskopf et al,  1994). It has been suggested that this may 
occur via Ca^ "^  permeable KA receptors (Huettner, 2001). Induction of aCaMKII may be 
a consequence of Ca^ '*' influx via this route. Other studies have shown that mossy fibre 
activity evokes Ca^ "^  release from internal stores via group I mGluRs activation (Kapur et 
al, 2001), hence in this study the role of group I mGluRs cannot be ruled out.
5.3.4 Rapamycin
The next stage of these studies was to investigate the effect of a protein synthesis 
inhibitor, rapamycin (20nM), on the immunostaining of aCaMKII in the soma and 
dendrites of all the tlrree sub-regions of the organotypic hippocampal slices. As 
mentioned above the major target of rapamycin is mTOR. Tang et al,  2002 indicated the 
presence of mTOR and other translational signalling components in soma and dendrites 
in cultured rat hippocampal neurons using immunostaining and western blot analysis. 
Inhibition of mTOR by rapamycin at a dose of 20nM blocked LTP in CAl region (Tang 
et al, 2002). Rapamycin had no effect on basal levels of aCaMKII in soma and dendrites 
of DG, CA3 and CAl regions of the hippocampus (Figure 5.4a, b). A23187 increased the
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levels of aCaMKII irrespective of pre-treatment of slices with rapamycin, this increased 
expression occurred in both soma and dendrites of all the regions of the hippocampus. 
The increased levels of immunostaining of aCaMKII in both the soma and dendrites of 
the CA3 region of the hippocampus are not blocked by rapamycin, again suggesting a 
similar intracellular signalling pathway between CA3, DG and CA l. This might suggest 
that the stimulation of expression of aCaMKII might follow a rapamycin insensitive 
pathway. There are other pathways leading to increased translational efficiency that do 
not involve mTOR- for example the pVO^ *^  ^pathway, and these may be involved. 
Alternatively, this could be due to pre-translational modification resulting from mRNA 
stabilisation (Morris, 1997).
5.3.5 Summary
In summary, the data in these studies have implicated Ca^  ^influx in the increased 
immunostaining of aCaMKII in all the sub-regions of the organotypic slice culture and 
this for the first time indicates there might be similar intracellular signalling for the 
regulation of aCaMKII expression between CA3 and the other regions i.e. DG and CAl. 
Elevation of cAMP levels in the hippocampus did not have a role in increasing the levels 
of aCaMKII in both the soma and dendrites of the hippocampus. Despite the reported 
dependence of LTP2 in CAl on activation of mTOR, rapamycin did not affect the Ca^ "^ - 
dependent stimulation of aCaMKII expression, suggesting that other pathways are 
involved.
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Chapter 6 
Expression of MAP2
6.1 Introduction
MAP2 belongs to a family of microtubule-associated proteins. MAP2 is expressed in the 
nervous system and consists of isforms resulting from the alternative splicing of a pre- 
niRNA transcribed from a single gene (Neve et al., 1986; Shafit-Zagardo and Kalcheva, 
1998). There are two isoforms of MAP2 in the mammalian brain as already mentioned 
(refer to section 1.12). HMW MAP2 and LMW MAP2.
MAP2 mRNA has been associated with various forms of neuronal plasticity (Ferreira et 
al., 1990; L.A. Roberts et al, 1996). MAP2 cross-links microtubule and facilitates 
changes in dendritic architecture (Caceres et al, 1988; 1992; Dinsmore et al, 1991) 
making it an attractive candidate for enabling the synaptic re-modelling associated with 
LTP.
The I-LTP, which lasts around 3-6 hours (Abraham et al, 1993), is dependent on mRNA 
translation and is independent of transcription. One of the mRNA species affected during 
this intermediate phase is the MAP2 mRNA. Levels of MAP2 mRNA have been shown 
to be elevated after LTP induction, at least in the DG (Thomas et al,  1994; Jolinston and 
Morris, 1994) and CAl (L.A. Roberts et al, 1998) regions of the hippocampus, but it is 
not known yet if similar increases are observed in the CA3 region. The induction of LTP
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in CAl and DG is dependent on activation of NMDA receptors while in the CA3 region 
the induction is dependent on increased cAMP levels (Bliss and Collingridge, 1993). 
There is evidence to suggest that the increases in MAP2 mRNA levels are the result of 
post-transcriptional regulation of existing mRNA in dendrites local to the region of 
stimulation (Morris, 1997). This local increase in mRNA is then translated into elevated 
levels of MAP2 protein. The mechanisms that trigger the induction of LTP, via 
glutamatergic activation of NMDA receptors, resulting in enhancement of MAP2 mRNA 
levels are unclear.
Two major effectors of NMDA receptor activation are Ca^  ^influx via activated NMDA 
receptors and cAMP via adenylate cyclase activation. Thus in this study, the effects of 
increased Ca^ "^  influx or raised cAMP levels on the expression of MAP2 was 
investigated. The effect of a protein synthesis inhibitor, rapamycin, on the levels of 
MAP2 in both stimulated and un-stimulated slices was investigated. Rapamycin produces 
its effect via inhibition of a kinase, mTOR. Therefore, the effect of mTOR on the 
regulation of MAP2 expression was investigated.
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6.2 Results
6.2.1 Forskolin but not A23187 increases the expression of MAP2 in 
organotypic slice preparation
MAP2 antibody stained the neurons of all the sub-regions of the hippocampus and this 
staining was prominent in the soma and dendrites (Figure 6.1). Following the treatment 
of organotypic slices with forskolin (50pM) or A23187 (5pM) for 4 hours ( a time point 
at which protein expression is widely believe to occur, Abraham et al, 1993), the slices 
were fixed and ready for immunocytochemical analysis. Application of 50|xM forskolin 
(Huang et al, 1994) on the organotypic cultures resulted in a significant increase in the 
intensity of staining of MAP2 in the cell bodies (Figures 6.2d, e, f  and 6.3a) of 
hippocampal fonnation i.e. DG, CA3 and CAl. This significant increase in the intensity 
of MAP2 was also produced in the dendrites (Figures 6.2d, e, f  and 6.3b) of hippocampal 
formation. A23187 had no significant effect on the expression of MAP2 in both the soma 
and dendrites of DG, CA3 and CAl regions (Figure 6.3a and b).
6.2.2 Rapamycin decreases the basal expression of MAP2 with no obvious 
inhibitory effects on forskolin
Neurons in the organotypic hippocampal slice cultures were stained with antibody for 
MAP2, with staining prominent in the soma and dendrites (Figures 6.5a, 6.6a and 6.7a).
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Having established the importance of forskolin in the increased expression of MAP2, the 
effect of rapamycin (20nM) pre-treatment on the expression of MAP2 in both the 
presence and absence of forskolin was investigated. Slices were pre-treated with 
rapamycin for 30 minutes prior to application of forskolin. Intensity of staining of MAP2 
at basal level was significantly reduced in the soma and apical dendrites after 
pretieatment of slices with rapamycin in the hippocampal formation i.e. DG (22% and 
14% decrease in soma and apical dendrites respectively), CA3 (20% and 5% decrease in 
soma and apical dendrites respectively) and CAl (20%and 12% decrease in soma and 
apical dendrites respectively) (*P<0.05 versus 100% vehicle-treatment of corresponding 
regions) (Figures 6.5b, 6.6b, 6.7b and 6.8a and b). However, forskolin was still able to 
increase MAP2 expression in presence of rapamycin (~P<0.05 versus corresponding 
region after rapamycin pretreatment alone-ANOVA with post hoc, Fisher’s test) but to 
lesser extend than in the absence of rapamycin (*P<0.05 versus 100% vehicle-treatment 
of corresponding regions) (Figure 6.8a and b). These increases of MAP2 expression in 
presence of forskolin after rapamycin pre-treatment occurred in soma and apical 
dendrites of hippocampal formation (Figure 6.5c, 6.6c, 6.7c, 6.8a and b). The increases of 
MAP2 expression in rapamycin/forskolin treated somata was 17% in DG, 9% in CA3 and 
14%in CAl while in the apical dendrites these increases were 17%, 24% and 23% in DG, 
CA3 and CAl regions respectively.
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6.2.3 Western blot analysis show that forskolin but not A23187 increases 
the expression of MAP2
After application of either 5gM A23187 or 50pM forskolin for 4 hours, organotypic slice 
cultures were homogenised in ice-cold RIPA and were thus ready for western blot 
analysis. The MAP2 antibody recognised three iso forms of MAP2 (MAP2a/b, Mr 
280kKDa and MAP2c, Mr 70kDa). Forskolin significantly increase the expression of 
MAP2 (Mr 280kDa; 217±59% of vehicle, n=5, *P<0.05, one sample Wilcoxon signed 
rank test for median) (Figure 6.5a, upper panel and 6.5b). Expression of MAP2, Mr 
70kDa, was also increased in the presence of forskolin (150±43% of vehicle)(Figure 6.5a, 
upper panel and 6.5b), but the increase did not reach statistical significance. A23187 had 
no significant effect on all the iso forms of MAP2.
The PVDF membrane was stripped and reprobed with an antibody that detects p-actin 
(Figure 6.5a, lower panel).
6.2.4 Tetanus induced LTP dramatically increases the expression of MAP2 
in the CA1 sub-region of the acute hippocampal slice preparations.
Three tetanic stimulations were applied in the stratum radiatum of CAl region of acute 
hippocampal slices, followed by single stimulus every 30 seconds for 3.5 hours 
(Appendix, Figure 2). The CAl region was then removed and prepared for western blot
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analysis. The analysis indicated that the expression of MAP2 (280kDa) was elevated 
substantially after 3.5 hours (1063±515% of vehicle, n-3)(Figure 6.11a, upper panel and 
Figure 6.11b). MAP2 with molecular weight of 70kDa was not detected.
The blot was then stripped and reprobed using anti-P-actin antiserum which is used as an 
internal standard (Figure 6.11a, lower panel).
121
Expression of MAP2
Figure 6.1: Image of organotypic slice culture. The image indicates the three sub- 
regions of the hippocampus, DG, CA3 and CAl. The slice has undergone no drug 
treatment and has been stained to reveal immunoreactivity for MAP2. Scale bar: 
0.4mm
Expression of MAP2
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Figure 6.2: Effect of forskolin (50pM) on the expression of MAP2 in cultured 
hippocampal neurons. Organotypic hippocampal neurons were stained to reveal 
immunoreactivity for MAP2 in DG (a, d), CA3 (b, e) and CAl (c, f). Organotypic 
slice cultures were treated 4 hours prior to fixation with either vehicle (a, b and c) or 
forskolin (d, e and f). Note that forskolin increased the staining intensity of MAP2 in 
both the cell soma and dendrites of all the hippocampal sub-regions. The arrow heads 
and arrows show the somata and apical dendrites respectively. Scale bar 20pm for 
CAl and CA3, 12-15pm for DG.
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Figure 6.3: Effect of forskolin (50pM) and A23187 (5pM) on the expression of 
MAP2 in the soma and dendrites (apical dendrites) of organotypic hippocampal slice 
cultures. Immimocytochemical analysis using anti-MAP2 antiserum indicated a 
significant increase (*P<0.05 versus vehicle-treatment in the same region, one-sample 
Wilcoxon signed rank test for the median) in the staining intensity of MAP2 in the 
presence of forskolin in hippocampal formation i.e. DG, CA3 and CAl. A23187 had 
no significant effect on the three regions of the hippocampus (P>0.05
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Figure 6.4: Western blot analysis of the effect of forskolin (50pM) and A23187 
(5pM) on the expression of MAP2 in organotypic hippocampal slice culture. Western 
blot analysis using anti-MAP2 antiserum indicated MAP2 with two different 
molecular weights (Mr: 280kDa and 70kDa respectively). There was a significant 
increase in the levels of MAP2 (Mr 280) in the presence of forskolin (216.9±59.10% 
of the vehicle-100%, n=5, P<0.05, one sample Wilcoxon signed rank test for median) 
and an increase in the levels of MAP2 (Mr 70) in presence of forskolin 
(149.20±42.70% of vehicle, n=5, P>0.05, one sample Wilcoxon signed rank test for 
median), figure a, upper panel and figure b. The PVDF membrane was stripped and 
reprobed with (3-actin (fig. a, lower panel) which indicated the concentration of 
proteins loaded into each well. Abbreviations: C- Control, A- A23187, F- Forskolin
Expression of MAP2
a)
280kDa ---- ►
70kDa ---- ^
42kDa -----►
b)
CMQ.
300-
•£ S) 200 -
s |
°  ^  100 -I0:
A
70 280
Molecular weight (KDa)
MAP2
p-actin
1 Forskolin 
■ A23187
■
125
Expression o f  M A P2
Figure 6.5: Effect of rapamycin (20nM) on the expression of MAP2 in DG region of 
organotypic hippocampal neurons. DG neurons in organotypic cultures were stained 
to reveal immunoreactivity for MAP2. Organotypic slice cultures were pre-treated for 
30 minutes with either rapamycin (b, d) or vehicle (a, c) followed by stimulation with 
50pM forskolin (c and d) for 4 hours prior to fixation. Note that rapamycin decreased 
the staining intensity for MAP2 in both cell soma and the dendritic region at basal 
levels (b) compared to vehicle (a), but had no effect on increased expression of MAP2 
in the presence of forskolin (d). The increased staining intensity in soma and dendrites 
of both vehicle/forskolin (c) and rapamycin/forskolin (d) were similar. The arrow 
heads and arrows show the somata and apical dendrites respectively. Scale bar: 12pm.
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Figure 6.6: Effect of rapamycin (20nM) on the expression of MAP2 in CA3 region of 
organotypic hippocampal neurons. CA3 neurons in organotypic cultures were stained 
to reveal iimnunoreactivity for MAP2. Organotypic slice cultures were pre-treated for 
30 minutes with either rapamycin (b, d) or vehicle (a, c) followed by stimulation with 
50pM forskolin (c and d) for 4 hours prior to fixation. Note that rapamycin decreased 
the staining intensity for MAP2 in both cell soma and the dendritic region at basal 
levels (b) compared to vehicle (a), but had no effect on increased expression of MAP2 
in the presence of forskolin (d). The increased staining intensity in soma and dendrites 
of both vehicle/forskolin (c) and rapamycin/forskolin (d) were similar. The arrow 
heads and arrows show the somata and apical dendrites respectively. Scale bar: 20pm.
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Figure 6.7: Effect of rapamycin (20nM) on the expression of MAP2 in CAl region of 
organotypic hippocampal neurons. CAl neurons in organotypic cultures were stained 
to reveal immunoreactivity for MAP2. Organotypic slice cultures were pre-treated for 
30 minutes with either rapamycin (b, d) or vehicle (a, c) followed by stimulation with 
50pM forskolin (c and d) for 4 hours prior to fixation. Note that rapamycin decreased 
the staining intensity for MAP2 in both cell soma and the dendritic region at basal 
levels (b) compared to vehicle (a), but had no effect on increased expression of MAP2 
in the presence of forskolin (d). The increased staining intensity in soma and dendrites 
of both vehicle/forskolin (c) and rapamycin/forskolin (d) were similar. The arrow 
heads and arrows show the somata and apical dendrites respectively. Scale bar: 20pm.
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Figure 6.8: Effect of rapænycin (20nM) on the expression of MAP2 in both vehicle 
treated and forskolin (50pM) treated soma and dendrites (apical) in organotypic 
hippocampal slice cultures. The staining intensity levels of MAP2 in the presence of 
forskolin were significantly increased in all three regions of the hippocampus in 
vehicle pre-treated slices (*P<0.05 versus corresponding region after vehicle 
treatment in the absence of rapamycin). Intensity of staining of MAP2 was 
significantly reduced in the presence of rapamycin/vehicle treatment in all three 
regions (*P<0.05 versus corresponding region after vehicle treatment in the presence 
of rapamycin). The staining intensity of MAP2 in rapamycin/forskolin treated slices 
was significantly different from rapamycin/vehicle treated slices in all three regions 
(~P<0.05 versus conesponding region after rapamycin pre-treatment alone- ANOVA 
with post hoc Fisher’s test, F=11.01, P<0.05)
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Figure 6.9: Effect of LTP induced in the Schaffer collateral/C A 1 synapses on the 
expression of MAP2 in acute hippocampal slices. Western blot assay using anti- 
MAP2 antiserum indicated an increased in the levels of MAP2 after 3.5 hours 
(1063±515%, n=3, P<0.05 versus 100%, one sample Wilcoxon signed rank test of the 
median), figure b and a, upper panel. The PVDF membrane was stripped and re­
probed with an antibody to detect p-actin (figure a, lower panel).
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6.3 Discussion
The antibody for MAP2 has been previously characterised (Woolf et al, 1999; Lim and 
Halpain, 2000). The antibody recognises both the HMW MAP2a, b and LMW MAP2c 
isoforms which have a molecular weights (Mr) of 280kDa and 70kDa respectively in gels 
of rat brain homogenate. In procedures used, the exclusion of primary MAP2 antibody 
resulted in the elimination of immunostaining of organotypic hippocampal slices, 
suggesting that the signal derives from the primary antibody. In view of the specificity of 
this antibody for MAP2, this strongly suggests that the immunohistochemcial staining 
represents authentic MAP2. MAP2 isoforms have been shown to be localised in neuronal 
cell bodies and dendrites (Burgoyne and Gumming, 1983; Woolf et ai,  1999; Lim and 
Halpain, 2000).
Prolonged stmctural changes thought to be associated with LTP might be due to 
alteration in gene expression (Chang and Greenough, 1984; Lisman and Harris, 1993) 
and one of the possible candidates includes the MAP2 gene, since altered MAP2 
expression has been linked to morphological changes in neurons (section 1.12).
6.3.1 Forskolin
These studies aimed to investigate the effect of Ca^ "^  influx and elevation of cAMP levels 
on the staining intensity of MAP2. The data indicates that the levels of staining intensity 
of MAP2 were significantly elevated on the stimulation of organotypic slice cultures with
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50pM forskolin (Figure 6.2d, e, f). These increases were prominent in the cell bodies of 
DG (19±7% increase), CA3 (13±4% increase) and CAl (15±7% increase) (Figure 6.3a). 
A similar result was also produced in the apical dendrites of DG (33±8% increase), CA3 
(12±5% increase) and CAl (18±6% increase) (Figure 6.3b). Therefore, the data suggests 
that the activation of adenylate cyclase (AC) by forskolin elevates cAMP levels which in 
turn increases the expression of MAP2 in the both the cell bodies and dendrites of DG, 
CA3 and CAl regions of the organotypic slice culture. Since the elevation occurred in 
whole hippocampal formation, it can be assumed that the intracellular pathways that 
increase MAP2 expression in CA3 region are similar to those in the CAl and DG. Thus it 
can be suggested that MAP2 plays a similar role in relation to plasticity in the CA3. It has 
been shown that LTP induction increases MAP2 expression in the DG and CAl (Roberts 
et al, 1998). The concentration of forskolin used here is known to induce LTP in the 
mossy fibre/CA3 synapses in acutely prepared hippocampal slices (Weisskopf et al, 
1994). Assuming the same is true in slice cultures, this is the first evidence that elevated 
MAP2 expression may be associated with plasticity in this region of the hippocampus.
Previous studies have shown that high frequency stimulation will result in increased 
levels of MAP2 mRNA in the CAl (Robert et al, 1998) and DG (Jolmston and Morris, 
1995; Roberts et al, 1998). The elevated mRNA will presumably be translated into 
corresponding MAP2 protein. It is therefore likely that the increased MAP2 protein in 
both the soma and dendrites of CA3 region of the hippocampus results from elevated 
MAP2 mRNA.
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Studies have shown that maintenance of LTP requires de novo protein synthesis (Krug et 
al, 1984; Barzilai et al., 1989; Bliss and Collingridge, 1993; Huang et al, 1994; Frey et 
al, 1996). However, the I-LTP, which last up to 4 hours after initial induction (Abraham 
et al, 1993) is not dependent on de novo mRNA synthesis (Otani et a l,  1989; Bliss and 
Collingridge, 1993). This can be suggested to be true for CA3 region as well as DG and 
CAl. Hence the increase in MAP2 expression is consistent with MAP2 playing a role in 
LTP maintenance. It can also be suggested that the increase in the immunostaining of 
MAP2 in dendrites might be attributed to localised dendritic mRNA which regulates the 
synthesis of MAP2 (Morris, 1997), while the increase in immunostaining of MAP2 in the 
soma might due to mRNA in the soma.
AC2 and AC4, isoforms of adenylate cycalse, have been shown to be expressed in the 
hippocampus formation and are co-localised with MAP2 (Baker et al,  1999). AC2 and 
AC4 have been labelled in the dendrites and cell bodies of DG, CA3 and CAl (Baker et 
al, 1999). Hence these two isoforms are likely to be involved in this effect. As 
mentioned above, elevation of cAMP levels as a result of AC activation results in MAP2 
elevation. Hence cAMP and PKA might act on the MAP2 mRNA via an unknown 
mechanism resulting in the elevation of MAP2 in the three regions of the hippocampus. 
cAMP and PKA have been shown to be essential for polyadenylation and translational 
activation of c-mos mRNA (Mailer and Krebs, 1998) and they are though to produce 
their effect via phosphorylation of an unknown target protein. This mechanism of 
activation might also be applicable to MAP2 mRNA.
133
Expression of MAP2
6.3.2 A23187
A23187 (5pM) had no significant effect on the staining intensity of MAP2 in both the 
ceil bodies and apical dendrites of hippocampal cultures suggesting that Ca^ "^  might not 
play a role in the expression of MAP2 (Figures 6.3a and b). While MAP2 mRNA levels 
have been shown to be elevated following NMDA receptor stimulation (Roberts et al,
1998), via high frequency afferent activity, these results suggest that one of the other 
signalling pathways recruited by NMDA receptor activation is responsible for MAP2 
stimulation. The results with forskolin imply that AC activation would be sufficient to 
induce MAP2 expression. It may be that there are Ca^'^-independent routes to AC 
activation following high frequency afferent activity. Clearly, Ca^ "^  is not the critical 
signalling intermediate for increased MAP2.
Western blot analyses were used in these studies to investigate the effect of 5pM A23187 
and 50pM forskolin on the expression of MAP2. In mammalian brain there are two 
isoforms of MAP2; a HMW MAP2a/b, Mr 280kDa and LMW MAP2c, Mr 70kDa. 
Forskolin appeared to increase the levels of ir HMW MAP2 and LMW MAP2 (Figure 
6.4a, upper panel and 6.4b). There was a significant increase in ir HMW MAP2 
(216±59% increase) but the increase in ir LMW MAP2 were not of statistical 
significance. These data support the immunocytochemical analyses, suggesting that an 
increase in cAMP levels appears to be important in the expression of MAP2 in 
organotypic cultures. The results did not clearly demonstrate a specific effect on either 
HMW or LMW MAP2.
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6.3.3 LTP
Western blot techniques were also used to investigate the effect of LTP in the CAl region 
of the hippocampus. The data indicated a significant increase in the levels of HMW 
MAP2, after 3.5 hour following tetanus stimuli (Figure 6.9a, upper panel and 6.9b).
HMW MAP2 was the only isoform detected since MAP2b is present throughout the 
development of the nervous system (Sanchez et a l , 2000) and MAP2a is mostly 
expressed in the adult brain (Sanchez et al, 2000). LMW MAP2 is expressed at only the 
early developmental stages (Sanchez et al, 2000). The animals used in these set of LTP 
experiments were mice whereas neonatal rats are used to prepare the slice cultures.
Since it was earlier shown that there was a similarity in the intracellular pathways 
regulating MAP2 expression in the three regions of the hippocampus, it can be assumed 
in this case that this increase in MAP2 might also occur in the CA3 region following high 
frequency stimulation as well as the DG particularly since CA3 LTP is dependent on 
elevation of cAMP levels.
Despite the fact that whole slices were used while only the CAl area was stimulated, the 
induction of MAP2 by high frequency stimulation was greater in this experiment than the 
induction when the whole slice culture was bathed in forskolin. This might imply a 
greater sensitivity of the mechanisms regulating MAP2 expression in the mice, or 
alternatively, it may suggest that other signalling pathways, other than Ca^ '^  or cAMP, 
also contribute to MAP2 induction. A study investigating the effect of LTP in the CAl
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region in slice cultures, or the effect of forskolin in acute adult slices, would address this 
question.
6.3.4 Rapamycin
Rapamycin, an immunosupresssant, was used to investigate the regulation of MAP2 
expression in the tliree regions of organotypic hippocampal slices. After pre-treatment of 
the organotypic slices for 30 minutes with 20nM rapamycin, 50pM of forskolin (or 
vehicle) was applied for 4 hours to stimulate the slices. Rapamycin reduced basal 
expression of MAP2 in DG, CAl and CA3 regions in both soma cells and apical 
dendrites, however forskolin after rapamycin pre-treatment significantly increased the 
expression of MAP2 in these regions (Figures 6.5c, 6.6c, 6.7c, 6.8a and b). These 
increases in the expression of MAP2 were less than the effect of forskolin alone in the 
absence of rapamycin (Figure 6.8a and b)
Again the results highlight the similarity in the signalling pathways between CAl, DG 
and the CA3 of hippocampal formation in the presence of rapamycin. At basal levels the 
translation of MAP2 mRNA seems to follow the rapamycin-sensitive pathway, but after 
pre-treatment with rapamycin, the forskolin induction of MAP2 expression seems to 
follow a rapaniycin-insensitive pathway. Rapamycin as mentioned in the previous 
chapter (Chapter 5) inliibits the mammalian target of rapamycin (mTOR). mTOR kinase 
stimulates the translation of specific mRNAs via phosphorylation of (p70^^^)
(Figure 6.10). At basal levels, cAMP activation of PKA might result in PKA activation of 
PKB (Atk)(Filippa et al, 1999). PKB might then cause the activation of mTOR (Figure
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6.10). Therefore, in both the cell bodies and dendrites of DG, CA3 and CAl sub-regions, 
pre-treatment with rapamycin will inhibit the PKA-PKB-mTOR-p70^^^ pathway. If this 
pathway is involved in sustaining the basal expression of MAP2, this might result in the 
decrease intensity of MAP2 in all the sub-regions of the hippocampus. However, mTOR 
does not seem to be involved in the forskolin-induced elevation of MAP2 expression.
This clearly indicates that distinct signalling pathways are involved in controlling basal 
and plasticity-regulated expression.
During cAMP elevation via forskolin stimulation of AC, activation of PKA might 
directly activate p70^^^ resulting in increased translation (Cass et al,  1999) and hence 
increase MAP2 levels in both the cell bodies and dendrites. p70®^  ^has been suggested to 
be important in LTP maintenance (Tskos et al, 2002). Therefore, two pathways might be 
involved in regulating the translation of MAP2 mRNA (Figure 6.10): one involving the 
PKA-PKB-mTOR-p70^^'^ and PKA-p70^^^ with the former pathway being dominant in 
the regulation of basal MAP2 and the latter pathway dominant in regulation of MAP2 
under activated conditions. PKA has been shown to directly activate p70®^^(Cass et al,
1999).
These results suggest that mTOR is not involved in the forskolin-induced elevation in 
MAP2 expression, despite evidence that rapamycin can reduce the magnitude of LTP 
(Tang et al, 2002). This may suggest that MAP2 is not one of the key proteins sustaining 
I-LTP, or alternatively as suggested above, that other pathways apart from Ca^ "^  and
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cAMP contribute to the elevation of MAP2 expression during LTP. These hypothetical 
additional pathways may involve mXOR.
6.3.5 Summary
Even though the mechanism of induction of LTP in CAl and DG differ from that of 
CA3, intracellular signalling pathways that lead to the elevation of MAP2 levels appear 
to be similar in all the three regions of the hippocampus. cAMP elevation plays a more 
prominent role in the increased levels of MAP2, while Ca^ "^  influx appears to have no 
effect at least in the organotypic hippocampal cultures. Two pathways seem to determine 
the expression of MAP2 in organotypic cultures; the rapamycin-sensitive pathway seems 
to control the basal levels of MAP2 while under activated conditions the rapamycin- 
insensitive pathway seems to play an important role in increased MAP2 expression.
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Figure 6.10: Schematic diagram of the activation of mTOR (FRAP) and its effect on 
downstream translational factors. mTOR is activated by a number of effectors. The 
effect of PKB which is activated via PKA might explain the effect of rapamycin 
inliibition on the basal levels of MAP2. Direct activation of p70 by PKA might 
explain the lack of effect of rapamycin on the expression of MAP2 in forskolin- 
stimulated slices. Abbreviations: PI3K-Phosphoinositol-3-kinase; PDKl/2 - 3 ’- 
phosphoinositide-dependent protein kinase 1/2; PKB -Protein kinase B; PKA -  
cAMP-dependent protein kinase.
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Chapter 7 
Expression of p-actlvin
7.1 Introduction
Using substractive hybridisation techniques, the identities of genes that may play a role in 
activity dependent plasticity in vertebrate brain were determined (Yamagata et al, 1993, 
1994). One of the cDNAs identified in differential screen of stimulated rat hippocampus 
demonstrated close similarity to the terminal 3’ sequence of human p-A activin. Studies 
have also shown that activin (3-A mRNA are elevated in the DG during excitatory 
synaptic input such as high frequency stimulation (HFS) which induces LTP (Andreasson 
and Worley, 1995; Inokuchi et al., 1996) and this elevation is dependent on NMD A 
receptor activation. Therefore, activin plays a role in the maintenance of neural plasticity 
(via enhancement of neuronal survival) in the adult rat brain (Inokuchi et a l, 1996) and 
developmental neuroplasticity (Andreasson and Worley, 1995). The I-LTP lasting 4 
hours (Abraham et a l, 1991) is dependent on de novo protein synthesis and will be of 
interest to find out if activin |3-A expression is elevated at this phase.
In this study, the effect of Ca^  ^influx and cAMP elevation was investigated in the CAl 
and CA3 sub-region of the organotypic hippocampal slice cultures. Elevation of Ca^  ^and 
cAMP as already mentioned are major consequences of NMD A receptor activation with 
Ca^  ^entering via the activated NMDA receptor and cAMP activated by adenylate cyclase 
(AC).
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7.2 Method
The methods used in general were as described (Chapter 2) with the following 
modification:
After incubation of organotypic slice cultures, for 4-5 days, the slices were then 
stimulated for 4 hours with vehicle or A23187 and vehicle or forskolin. The slices were 
then fixed followed by addition of 3% H2O2 (to remove the endogenous peroxidase 
activity) for ten minutes. After 10 minutes the slices were washed in PBS and the process 
of immunocytochemistry started (please refer to section 2.7).
7.3 Results
7.3.1 A23187 and forskolin increase the expression of activin p-A in 
organotypic slice preparations.
The activin/inhibin antibody, which recognises the (3-A subunit of both activin and 
inhibin, was used to stain all the sub-regions of the organotypic slice cultures where the 
staining was prominent in the CAl and CA3 regions (Figures 7.1, 7.2 and 7.3). 
Application of A23187 (5pM) for 4 hours resulted in significant elevation of the staining 
intensity of activin p-A (the intensity of staining was measured after 4 hours). This
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significant increase in staining was in the CAl (*P<0.05 versus the vehicle treated slices, 
142 ±4% of vehicle, n=4)(Figure 7.3c and 7.4) and CA3 (*P<0.05 versus the vehicle 
treated slices, 123.7±11.9% of vehicle, n=4) (Figure 7.3d, 7.4) of the organotypic slice 
cultures. The data in this section represents both the cell bodies and apical dendrites of 
each of the regions investigated i.e. CAl and CA3.
Forskolin (50pM) produced a significant increase in the staining intensity of activin p-A 
when applied for 4 houi's prior to fixation. This significant increase in activin p-A was 
intense in the CAl (*P<0.05 versus vehicle treated slices, 113±5% of vehicle, 
n=7)(Figure 7.2c, 7.4) and CA3 (*P<0.05 versus vehicle treated slices, 123±6% of 
vehicle)(Figure 7.2d, 7.4). As with the A23187 data, the data for this study represents 
both the cell bodies and dendrites of the regions investigated. The significance was 
determined using the Wilcoxon rank test of the median with the data considered 
significant when the P<0.05.
The increase in expression of activin p-A after treatment with A23187 was significantly 
greater than that detected in forskolin-treated slices. However, this was the case only in 
the CAl region of the hippocampus (~P<0.05 versus forskolin-treated slices, one way 
ANOVA with post hoc Fisher’s test. Figure 7.4), there was no significant difference 
between the increase in A23187-treated cultured slices and forskolin-treated cultured 
slices in the CA3 region of the organotypic hippocampal slice culture.
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Figure 7.1; Image of an organotypic slice culture. The hippocampal slice was 
cultured 4-5 days prior to staining with an antibody for the p-A subunit of activin and 
inliibin protein. The antibody stained specifically the three sub-regions of the 
hippocampus i.e. DG, CA3 and CAl. Scale bar:0.4mm
Expression o f  p-activin
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Figure 7.2: Effect of 50pM forskolin on the staining intensity of P-activin in 
organotypic slice cultures. The cultured neurons in the CAl and CA3 sub-regions 
were stained with an antibody for p-activin following 4 hour stimulation in vehicle (a, 
b) and forskolin (c, d). Note the increase in staining in the CAl (c ) and CA3 (d) in 
the presence of forskolin compare to the vehicle (a, CAl and b, CA3). Scale bar: 
100pm. Abbreviations: SO- Stratum Oriens; SP- Stratum Pyramidal; SR- Stratum 
Radiatum.
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Figure 7.3: Effect of 5pM A23187 on the staining intensity of p-activin in 
organotypic slice cultures. The cultured neurons in the CAl and CA3 sub-regions 
were stained with an antibody for p-activin following 4 hour stimulation in vehicle (a, 
b) and A23187 (c, d). Note the increase in staining in the CAl (c) and CA3 (d) in the 
presence of A23187 compare to the vehicle (a, CAl and b, CA3). Scale bar: 100pm. 
Abbreviations: SO- Stratum Oriens; SP- Stratum Pyramidal; SR- Stratum Radiatum.
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Figure 7.4: Effect of forskolin (50pM) and A23187 (5pM) on the expression of ir p- 
activin in CAl and CA3 sub-regions of organotypic hippocampal slices cultures. 
Immunocytochemistry analysis using anti-activin/inhibin antiserum indicated a 
significant increase (*P<0.05 versus vehicle treatment in the same region, one-sample 
Wilcoxon signed rank test for the median) in the staining intensity of activin/inhibin 
in the presence of A23187 and forskolin in CAl and CA3 sub-region of the 
hippocampal neurons. A23187 increased significantly the intensity of staining of 
activin/inhibin in the CAl sub-region when compared to forskolin-treated slices 
(~P<0.05 versus forskolin-treated slices in the same region using one way ANOVA 
with post hoc Fisher’s test).
Expression o f  P-activin
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7.4 Discussion
The activin/inhibin p-A antibody used in this study had been previously chai’acterised 
(Otani et a l, 1998) where it was used in the immunohistochemical localisation of activin 
A in human endometrial tissues during the menstrual cycle and early pregnancy. The 
antibody recognises the p-A subunit of both activin and inhibin proteins; however inhibin 
levels have been shown to be up-regulated under ischemic insult (Soriano et a l, 2000) 
hence inhibin is only expressed during pathological responses.
7.4.1 A23187
In these studies, application of the Ca^  ^ionophore (5pM A23187) caused a significant 
increase in the staining intensity of activin p-A subunit in the CAl and CA3 sub-regions 
of organotypic slice cultures. These immunocytochemical studies suggest that increases 
in the levels of intracellular Ca^ "^  via calcium entry tlrrough the Ca^ "^  pores are important 
in the elevation of activin P-A subunit. Ca^ '*' influx via NMDA receptors has been shown 
to elevate the expression of activin p-A mRNA in the DG (Inokuchi et a l, 1996). 
Therefore in these studies, under physiological conditions Ca^  ^entry via NMDA 
receptors, at least in CAl, might cause the elevation of activin p-A. LTP induction in the 
CA3 region is NMDA receptor independent, but pre-synaptic Ca^ "^  influx has been shown 
to be important in ME LTP. Hence in these studies an increase in intracellular Ca^  ^in the 
pre-synapse might cause the elevation of activin P-A levels post-synaptically, via an 
activation of a process, most likely involving Ca^Vcalmodulin-regulated adenylate
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cyclase (AC) resulting in the enhancement of evoked transmitter release (Nicoll and 
Malenka, 1995). This could then increase the levels of cAMP resulting in the activation 
of PKA-mediated mechanisms (Weisskopf et a l, 1994). Thus, the A23187-induced 
increase in the activation of p-A activin expression in the CA3 region could reflect 
activation of PKA-dependent processes. However, it is more likely to reflect a direct 
action of Ca^ "^  influx independent of PKA (General Discussion, section 8.3).
7.4.2 Forskolin
In the presence of the AC activator (50pM forskolin), there was a significant increase in 
the levels of activin P-A subunit in both CAl and CA3 regions of the organotypic slice 
cultures. This again shows the importance of elevation of cAMP, via AC activation, on 
the increased staining intensity of activin P-A subunit. In the CAl region, activation of 
type 1 AC might result in the elevation of cAMP in the post-synapse, the cAMP then 
activates PKA. The cAMP and PKA might act on the activin p-A mRNA via an unknown 
mechanism resulting in the elevation of activin p-A levels. Also, the increased cAMP 
levels due to forskolin might activated the same pathway as the one which results from 
Ca^  ^influx i.e. Ca^VAC/cAMP/PKLA mediated pathway.
The increase in the activin p-A subunit immunostaining in the CAl region was greater in 
the presence of elevated intracellular calcium levels than following elevation of cAMP 
levels. This might suggest that Ca^’*' elevation is more potent in activation of activin P-A 
subunit than cAMP. However, dose-response studies have not been conducted, hence it is
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not known if either A23187 or forskolin effects are maximal -  only single concentrations 
were tested for each drug. Alternatively, Ca^  ^might be acting independent of activation 
of ACl and that this effect is more powerful. These data also indicated that the 
intracellular signalling in the CAl and CA3 were similar when the organotypic slice 
cultures were stimulated by either increased intracellular Ca^  ^or increase cAMP levels.
Studies have recently shown that the levels of activin p-A mRNA are rapidly and 
transiently induced in neurons of adult rat brain by excitatory synaptic input (Andreasson 
and Worley, 1995). In fact, activin p-A mRNA was elevated in the granule cells of the 
DG (Andreasson and Worley, 1995; Inokuchi et a l, 1996). Since there was an increase in 
the staining intensity of activin P-A in the CAl and CA3 in this study, it will be logical to 
assume that these increases are a result of increases in mRNA levels in the CAl and CA3 
similar to those in the DG. This also indicates for the first time that the induction of 
activin p-A also occurs in the CAl and CA3.
The organotypic slice cultures were stimulated for 4 hours, which, is time point broadly 
con'esponding to LTP2 (Abraham et a l, 1991). LTP2 has been shown to be dependent on 
de novo protein synthesis (Otani et a l, 1989; Bliss and Collingridge, 1993). Hence, in 
this investigation the expression of activin p-A might play a role in the maintenance of 
LTP in the CAl and CA3 regions of the hippocampus. In fact, activin p-A has been 
suggested to play a role in maintenance of LTP in the DG (hiokuchi et a l, 1996) and this 
maintenance is dependent on NMDA receptor activation. Since LTP induction in the 
CAl region is NMDA receptor dependent, it can be assumed that activin p-A has a role
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in LTP maintenance via NMDA receptor activation while in the CA3 region, activin p-A 
role in LTP maintenance might be via NMDA receptor independent. It can also be 
suggested that the increased levels of P-activin protein is a result of the presence of pre­
transcribed p-activin mRNAs since LTP2 is independent of transcription. However, this 
remains to be investigated and the presence of activin mRNA has never been reported.
7.4.3 Summary
In conclusion, activation of activin P-A in the CAl and CA3 sub-regions of organotypic 
slice culture are affected by elevation of Ca^ '*’ and cAMP. These elevations result in an 
increase in the expression of activin p~A in both regions of the hippocampus. Thus 
activin P-A expression can be elevated by an appropriate stimulus in all three regions of 
the hippocampus. This may suggest that increased activin P-A expression plays a 
fundamental role in the process of synaptic plasticity, in'espective of the nature of the 
stimulus that triggers the plasticity.
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Chapter 8 
General Discussion
8.1 Aims of the Study
The aim of the thesis was to investigate in vitro the mechanisms regulating the activation
or expression of the following synaptic related proteins in the rat hippocampal slices:
(i) Pyk2 is non-receptor tyrosine kinase which has been shown to cause the 
activation src which then results in induction of LTP (Huang et ah, 2001),
(ii) Src is also a non-receptor tyrosine kinase which induces LTP via potentiation of 
NMDARs (Huang et a l, 2001),
(iii) MAPK plays a critical role in LTP induction via activation of CREB resulting in 
increase protein synthesis (Kanterewicz et a l, 2000),
(iv) aCaMKII is necessary and sufficient for LTP induction, and can, by itself, 
enhance the efficacy of synaptic transmission (Lisman et a l, 2002),
(v) MAP2 is important in prolonged structural changes that are associated with LTP 
(Sanchez et a l, 2000),
(vi) p-activin activation is a result of LTP induction (Inokuchi et a l , 1996).
Hence, these proteins have all been implicated in the induction and/or maintenance of
LTP in the hippocampus. Two major effectors of NMDA receptor activation, Ca^  ^and
cAMP, are likely to play a major role in the activation of these plasticity-related proteins.
Although the elevation of activation or expression of these proteins has been studied
extensively in the DG and CAl prior to this study, little is known about the regulation of
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the activation or expression of these proteins in the CA3 region of the hippocampus. The 
present study provides insight into the regulation of these proteins in CA3 region.
In this study both organotypic hippocampal slice cultures and acute hippocampal slices 
were employed. The advantages and disadvantages of each technique are listed in table 
8 . 1.
8.2 Effect ofA23187 and Forskolin on hippocampus
Forskolin at 50pM concentration has been shown to induce both early and late phases of 
LTP in the CA3 region, with synaptic efficiency remaining elevated for up to 6 hours 
(Huang et al., 1994). Forskolin also induces LTP in the CAl region at this concentration 
(Huang et al., 1994). However, reportedly only the late phase can be induced by forskolin 
in the CAl region (Huang et a l, 1994). Forskolin was shown to completely occlude 
electrical stimulation induction of LTP in the CA3 region, and the action of forskolin was 
greatly reduced after LTP induced by electrical stimulation (Weisskopf et a l, 1994). This 
suggested that after LTP the action of forskolin and MF LTP interact in acute 
hippocampal slices. It should be noted that 50pM forskolin does not have any toxic effect 
as shown by long-term viability of slices after this treatment (Weisskopf et a l, 1994; 
E-uang et a l, 1994).
A23187 at concentrations of l-7pM has been widely used to increase the intracellular 
concentration of Ca^  ^in cultured cells and tissue slices (Lev et a l, 1995). There have 
been no studies to investigate the effect of A23187 on LTP induction in the hippocampus,
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however Cobb and coworkers (unpublished observations) showed depolarisation in the 
CAl region of the hippocampus on the addition of A23187. At low concentrations 
(<7pM), A23187 does not have any toxic effects (Lev et a l, 1995; Siciliano et a l, 1996). 
In this study the exposui e of organotypic slice cultures to A23187 (5pM) for 4 hours did 
not affect cell viability as assessed by dendritic MAP2 staining. Therefore the effects of 
A23187 reported in this thesis are likely to be related to physiological and not 
pathological responses.
In the CAl and DG, induction of LTP resulted in the increase influx of Ca^  ^via activated 
NMDA receptors (Bliss and Collingridge, 1993) while induction of LTP in CA3 resulted 
from elevation of cAMP (Weisskopf et a l, 1994). For most of the proteins monitored in 
this study, the mechanisms downstream of these triggers were shown to be similar in 
CA3, DG and CAl regions.
B.3 PyK2 phosphorylation
In this study Pyk2 activation, as a result of the elevation of intracellular Ca^ "^  was 
achieved in both the CAl and CA3 regions of the hippocampus. This activation of Pyk2 
was probably mediated by PKM^ since the activation was blocked by a PKM selective 
inhibitor, chelerythrine. Increases in intracellular Ca^  ^have been shown to activate PKC 
which in turn activates Pyk2 in the hippocampus (Siciliano et a l, 1996). Therefore in this 
study Pyk2 activation in the CA3 region of hippocampus might be achieved via a Ca^ '*’ 
proteolytic activation of PKC resulting in a catalytic fragment, PKM^. Another might be
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that presynaptic Ca^”^ might play a role, this however, will not involve PKA activation 
since cAMP was shown to reduce Pyk2 phosphorylation. Since the intracellular 
signalling leading to Pyk2 activation is similar in both CAl and CA3, it can be suggested 
that Pyk2 is involved in the signalling events leading to synaptic plasticity in all regions 
of the hippocampus.
There was no success with the investigation of phosphorylated Src, because there were 
problems with obtaining specific staining with the antibody. Thus the probability of an 
association between Pyk2 and total Src was investigated as an alternative approach. An 
association between Pyk2 and Src was established, since Src was immunoprecipitated 
along with Pyk2, the presence of Src suggested an association between the two. However, 
there was no increase in the association between Pyk2 and after stimulation, hence it 
raises the possibility that there is no Src activation by Pyk2 after Ca^  ^influx alone, and 
that some other signalling pathway activates Src. Most of the studies investigated the 
Pyk2-Src up-regulation of NMDARs in LTP (Ali and Salter, 2001) and it is worth 
mentioning at this point that direct contribution of Pyk2 and Src in LTP has not been 
tested in this study. In fact, direct involvement of the plasticity-related proteins in this 
study in LTP has not been monitored.
8.3 MAPK Phosphorylation
MAPK activation differed in CAl and CA3 regions of the hippocampus. Elevation of 
intracellular Ca^ '*' or cAMP resulted in the activation of MAPK in CAl with no effect in
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CA3. This suggests that there is a differential intracellular signalling in the two regions 
when p42 MAPK activation is involved. Therefore, Ca^ '*’ influx and cAMP elevation in 
the CAl region might involve the Ca^^/calmodulin dependent ACl and might be essential 
for p42 MAPK activation while in the CA3 region, Ca^ *^  and cAMP are not essential for 
p42 MAPK activation. So, although cAMP elevation and pre-synaptic Ca^ "^  influx are 
essential for LTP in the CA3 region (Weisskopf et al., 1994), activation of p42 MAPK 
might not be necessary for LTP in the CA3 region. Kanterewicz et al. (2000) showed that 
MF LTP in area CA3 did not require MAPK signalling and suggested that 
cAMP/PKA/Rapl/B-Raf/MEK pathway was involved in the activation of MAPK in the 
CAl region. Therefore, this data compliments work done by Kanterewicz et al. (2000), 
demonstrating that forskolin, which has been shown by many groups to induce LTP at the 
MF-CA3 synapses, fails to activate MAPK.
8.4 Expression of aCaMKil, MAP2 and ^-activin
Despite a difference in signalling (MAPK data), there were no differences in the protein 
induction detected (aCaMKII, MAP2 and p-activin) between the CA3, DG and CAl 
regions. However, the data implicated differential expression of aCaMKII and MAP2 
with increased Ca^ "^  influx playing an important role in the expression of aCaMKII and 
the importance of elevated cAMP levels in the expression of MAP2. The expression of P- 
activin was increased as a result of either an increase in intracellular Ca^ "*" or cAMP 
elevation.
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8.4.1 aCaMKII
A possible mechanism of activation of aCaMKII in the CA3 region might involve the 
pre-synaptic influx of Ca^  ^which results in increased glutamate release via 
Ca^Vcalmodulin dependent ACL However, this might not be the case since cAMP 
elevations had no effect on aCaMKII expression. Since forskolin can induce elevated 
protein synthesis-dependent LTP in the CA3 region (Huang et a l, 1994), this might 
suggest that aCaMKII expression is not a key component of LTP2. Alternatively, while it 
is clear that 50pM forskolin induces LTP in acutely prepared hippocampal slices, this has 
not been shown for slice cultures. It is conceivable that MF LTP is not induced in these 
studies, and so a role for aCaMKII in LTP2 cannot be ruled out. However, the results 
clearly demonstrate that Ca^ "^  influx is more important than cAMP for the regulation of 
aCaMKII at this time point. While the possibility was not tested in this study, it is 
conceivable that Pyk2 is involved in the pathways leading to increased aCaMKII 
expression. A23187, but not forskolin, activated Pyk2 in both CAl and CA3 regions, and 
a similar pattern was noted for the induction of aCaMKII. It would be of interest to test 
the ability of chelerythrine to attenuate the increased expression of aCaMKII after 
exposure to A23187.
8.4.2 MAP2
The mechanism of activation of MAP2 might involve increased activation of PKA.
MAP2 has been shown to be co-localised with AC2 and AC4 in both dendrites and cell
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bodies of the hippocampus (Baker et al., 1999). Both Ca^Vcalmodulin independent AC2 
and AC4 have been linked to certain forms of hippocampal synaptic plasticity (Baker et 
al, 1999). AC2 is thought to integrate inputs from multiple signalling pathways, while 
AC4 can act as a coincidence detector of paired Gs and Gi inputs. Hence, it is possible 
that there exist two (or more) parallel pathways involving cAMP that encode different 
forms of synaptic plasticity. MAP2, in this case, might be affected by these two types of 
adenylate cyclases in all the three regions of the hippocampus.
8.4.3 p-activin
Expression of p-activin might involve two independent processes. In the CA3 region, 
increased pre-synaptic Ca^  ^influx results in increased transmitter release via activation of 
ACl. Therefore, in CA3 region, A23187 should always produce same effects as 
forskolin. However, that is not the case in MAP2 and also as already mentioned above 
A23187 has not been shown to elevate cAMP levels i.e. increased intracellular Ca^  ^ as 
result of the ionophore has not been shown to activate ACl either presynaptically or 
postsynaptically.
8,4.4 mTOR Kinase and expressions of aCaMKII and MAP2
This study also investigated the affect of mTOR kinase inhibitor on the translation of 
aCaMKII and MAP2 mRNAs. Rapamycin had no effect on the expression of aCaMKII
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or MAP2 (in activated hippocampal slices) in both dendrites and cell bodies of all regions 
of the hippocampus. Hence, the data suggests that translation of aCaMKII and MAP2 (in 
activated hippocampal slices) follows a rapamycin-insensitive pathway i.e. mTOR kinase 
does not play a role in the translation of these two genes. However, basal levels of MAP2 
were reduced in both dendrites and cell bodies in the presence of rapamycin, suggesting a 
rapamycin-sensitive pathway. The effect of rapamycin was similar in all three regions of 
the hippocampus, thereby re-enforcing the idea that the CA3 inti'acellular signalling 
pathway for induction of both aCaMKII and MAP2 is similar to those in CAl and DO.
8.5 Conclusion
The results of this study indicate that the factors regulating the expression of aCaMKII, 
MAP2 and p-activin and the phosphorylation of Pyk2 in the CA3 region are similar to 
those in the intensely studied DO and CAl regions. However these increases in protein 
expression/phosphorylation are differentially activated by the second messengers, Ca^ "*" 
and cAMP (table 8.2). Thus the Ca^^and cAMP-dependent pathways activated during 
synaptic plasticity may serve distinct functions by regulating discrete proteins during the 
various temporal phases of the response to stimulation. However, MAPK 
phosphorylation in the CA3 region was not affected by the modulation of Ca^ "^  and 
cAMP. Hence, it will be of interest to investigate further the stimuli necessary for MAPK 
activation in the CA3 region.
158
General Discussion
This general similarity in intracellular signalling is surprising, considering the distinct 
mechanisms involved in triggering LTP in the CA3 region. However, these are some of 
the first investigations of proteins changes in the CA3 region after plasticity-related 
stimulation. It seems likely that a great deal of commonality will be found in the 
mechanisms of late phase LTP in these regions.
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Advantages Disadvantages
Organotypic slice 
cultures
Tissue-specific cell connection
Preservation o f local neuronal circuits
with appropriate innervation pattern
Easy application of drugs
Applicable to studies lasting a number of
days
Used in studies lasting days
• Slice viability, slices were 
necrotic after few days.
• Enormous variation in terms of 
cell number and tissue stnicture
• Large number of slices required 
for statistical significance
• Organotypic cultures do not 
reflect in vivo physiology
Acute hippocampal 
slices
• Neurons, their synapses and part o f the 
circuitry in which they are involved are 
well preserved and viable and in mature 
state, so that interpretation of results is 
directly applicable to the adult brain
• Thickness of the slice, allows efficient 
entry of most pharmacological reagents
• Amount of nervous tissue allows for 
quantitative biochemistry
Not useful for time periods in 
excess of 4 hours due to slice 
deterioration
Table 8.1 List of advantages and disadvantages of both organotypic slices and acute 
hippocampal slices
1 6 0
General Discussion
Ca^  ^ionophore (A23187) PKA activation (forskolin) LTP
hippo DG CA3 CAl hippo DG CA3 CAl CAl
Pyk2
activation
MAPK
activation
NE NE
aCaMKII
expression
NE NE NE NE
MAP2
expression
NE NE NE NE
p-activin
expression
Table 8.2 Summary of the effects of A23187 and forskolin on the 
activation/expression of plasticity-related proteins. The effects were investigated in 
both acute (Pyk2 and MAPK activation) and organotypic (aCaMKII, MAP2 and p- 
activin expression) hippocampal slices. Abbreviations: hippo- hippocampus; NE- no 
effect
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Appendix
Methods for long term potentiation experiments.
(Author: Kara McNair)
Male ICR mice (5-lOwks) were deeply anaesthetised with lOOmg/kg intra-peritoneal 
(i.p.) injection of urethane in sterile saline until paw withdr awal reflexes were completely 
abolished. Cardiac perfusion was carried out by insertion of a 19G needle into the left 
ventricle and perforating the right atrium with sharp dissecting scissors. Approximately 
60mls of oxygenated (95% 02, 5% C02), ice cold (2-4°C), modified artificial 
cerebrospinal fluid (mACSF) of the following composition (in mM) NaCl 87, KCl 2.5, 
NaHCOs 25, MgS0 4  0.7, NaH2 ? 0 4  1.25, D-Glucose 25, Sucrose 75 and CaCh 0.5, pH
7.4 -  7.5 was perfused through the heart. Low NaCl containing ACSF was used to reduce 
passive chloride entry which has previously been suggested to be actively responsible for 
neurotoxicity during slice preparation. For details regarding the use of the above mACSF 
see (Mellor & Nicol, 2001; Rasmussen & Aghajanian, 1989). All the above procedures 
were carried out in accordance with current Home Office legislation. The brain was then 
rapidly excised and placed in fresh, ice cold, oxygenated mACSF. Horizontal brain slices 
(400pM thick) were prepared using a VT-1000s vibrating microtome (Leica, Cambridge, 
UK). Throughout the slicing procedure the brain and slices were held in a chamber 
containing ice cold mACSF. They were then transferred to a petri dish also containing ice 
cold mACSF where the hippocampus was dissected free from surrounding brain tissue
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and a cut placed through the CA3 region to prevent the occurrence of epileptifomi 
activity. The hippocampal slices were initially stored at 35*^ C for 30 minutes in 
approximately 135mls of mACSF, then transferred to room temperature. The mACSF 
solution was gradually replaced (15mls every 15 minutes) with standard ACSF (sACSF) 
of the following composition (in mM): NaCl 124, KCl 3, NaHCOs 26, NaH2P0 4  1.25, 
MgS0 4  1, D-Glucose 10 and CaCh 2 (pH 7.4 -  7.5). Following complete changeover of 
ACSF solutions, individual hippocampal slices were held in a submerged recording 
chamber for 1 hour prior to electrophysio logical recordings. The slices were constantly 
perfused (flow rate l-2ml/min) with oxygenated, sACSF by means of a gravity fed 
system. They were maintained at a temperature of 28°C using a TC-20 temperature 
controller (Npi Electronics, Tamm, Germany).
Hippocampal slices were simultaneously stimulated with two bipolar stimulating 
electrodes (Nickel80/ chromium20 wire, 50pM thick). Placed field excitatory post 
synaptic potentials (EPSPs) were recorded using a standard walled glass electrode filled 
with sACSF. The micro electrodes were pulled on a horizontal Flaming-Brown P-87 
micropipette puller (Sutter Instruments Co., USA). Recording electrodes were mounted 
in electrode holders inserted into a digitimer head stage. The recording chamber and 
micromanipulators were supported on a steel plate which was itself mounted on an anti­
vibration table (Wentworth Laboratories, UK). The recording chamber was a submerged 
chamber designed in house (IBLS workshop, University of Glasgow) into which a 
temperature probe (Npi electronic, Tamm, Germany) and a silver/ silver chloride
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reference electrode was placed. A rigid plastic mesh was also placed within the recording 
chamber onto which the slice was placed. All stimulating and recording electrodes were 
mounted on micromanipulators (Narishige, Japan). To enable the positioning of 
electrodes in the slice, the slice was viewed using an OPMIl Zeiss overhead, dissecting 
microscope.
Synaptic potentials were initially amplified 100 fold using a Neurolog system (Digitimer, 
England, UK). Secondary 20-fold amplification was carried out using a Brownlee 
Amplifier (Model 440, Brownlee Precision, CA, USA). Signals above 5kHz were filtered 
using a low pass filter. Extraneous 50Hz noise was removed using a Hum Bug device 
(Digitimer, England, UK). Signals were digitised using a Pico42 A-D (analogue -  digital) 
converter and captured on a Viglen Pentium III P.C. using the Bristol LTP software 
fwww■ Itn-nrogram.com: Anderson & Collingridge, 2001).
Stimulation of the CAl pyramidal cell apical dendritic layer {stratum radiatum) was 
earned out using an isolated constant current stimulator (model D52A, Digitimer, UK) (
0 -  32mA). The stimulation strength was gradually increased to produce and input/ 
output curve (I/O curve) measuring EPSP slope output against current input. The current 
that produced 50% of the maximum EPSP slope was subsequently used in the remainder 
of the experiment.
The hippocampal slices were stimulated once every 30 seconds and a 30 minute stable 
baseline recording was obtained. Following this, three tetanic stimulations (lOOhz, 0.2ms
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pulse width, 10 minute intertrain interval) were delivered which induced a potentiation of 
the field EPSP slope. Stimulations then returned to one every 30 seconds for the duration 
of the recordings. Long term potentiation of responses was recorded for approximately
2.5 to 3.5 hours. Control slices were maintained in a holding chamber for the 
corresponding length of time. At the end of the recording, slices were removed and 
placed on an ice cold microscope slide, where the CAl region was dissected. This region 
was then snap frozen in liquid nitrogen and stored at -80°CS for further analysis. Data are 
expressed as a percentage of baseline EPSP slope response and presented as a mean ± 
S.E.M. Data was collected using LTP software (Anderson and Collingridge, 2001), and 
analysed using Microsoft Excel and MicroCal Origin packages. N values refer to the 
number of times a particular experiment was performed, each in a different slice taken 
ft'om a different animal.
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Figure 1 : Induction of LTP in the CAl region of the hippocampus following 3 tetanic 
stimulations of lOOHz (three arrows). Note the increase in the excitatiory post-syanptic 
potentiation (e.p.s.p.) after application of tetanus. The potentiation remained elevated for 2.5 
hours after LTP induction.
221
Appendix
250-1
200
Ï50-I6  100aI 50I
04
-50
n=4
— I—
100
— r—
150 200
—|—
250
— I
300
Time (min)
Figure 2: Induction of LTP in the CAl region of the hippocampus following 3 tetanic 
stimulations of lOOHz (three arrows). Note the increase in e.p.s.p. after application of tetanus. 
The potentiation remained elevated for 3.5 hours after LTP induction.
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